[
    {
        "pmid": "40733492",
        "title": "Integrated In Silico, In Vitro, and In Vivo Studies Reveal Mangiferin as a Promising Antiviral Agent Against H1N1/pdm2009 Influenza Virus.",
        "abstract": "ongoing global threat posed influenza virus exacerbated antigenic drift emergence antiviral resistance accentuates urgent need innovative therapeutic strategies molecular docking study revealed mangiferin strong binding affinity active site neuraminidase NA protein influenza virus AH1N1pdm09 binding energy 81 kcalmol vitro assay confirmed dosedependent inhibition NA ICsub50sub 8865 μM minimal cytotoxicity indicated CCsub50sub 3281 μM MDCK cells murine models administration mangiferin dosage 25 mgkg significantly mitigated weight loss decreased viral load nasal turbinate lung 1 log10 TCIDsub50sub enhanced survival rate 0 control group 20 mangiferintreated group 14 day postinfection addition mangiferin found modulate host immune response simultaneously inhibiting proinflammatory cytokines IL6 TNFα upregulating expression antiinflammatory IL10 antiviral IFNγ thus mitigating infectioninduced inflammation finding elucidate dual mechanism mangiferin involving direct inhibition NA immunomodulation thereby providing experimental evidence exploring dualmechanismbased antiinfluenza strategy resistant strain influenza",
        "mesh_terms": [
            "Influenza A Virus, H1N1 Subtype",
            "Animals",
            "Xanthones",
            "Antiviral Agents",
            "Neuraminidase",
            "Orthomyxoviridae Infections",
            "Molecular Docking Simulation",
            "Madin Darby Canine Kidney Cells",
            "Dogs",
            "Mice",
            "Cytokines",
            "Disease Models, Animal",
            "Humans",
            "Mice, Inbred BALB C",
            "Viral Load",
            "Viral Proteins",
            "Female",
            "Influenza, Human"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733492/"
    },
    {
        "pmid": "40721546",
        "title": "Factors associated with common prevalent diseases in the Sonali chicken farms of the different regions of Bangladesh: a retrospective study.",
        "abstract": "study aimed determine factor associated common disease prevalence Sonali chicken farm different region Bangladesh total 243 farm randomly selected four Bangladesh district collect retrospective data study found prevalent disease Newcastle Disease 7654 Infectious Bursal Disease 5144 Avian Influenza 2963 Colibacillosis 2263 Coccidiosis 6955 Brooder Pneumonia 3498 Ascariasis 2016 secondary group education level farmer 849 visitor allowance farm 819 farm dead bird buried 913 significantly P ≤ 005 higher prevalence ND potential flocklevel protective factor ND prevalence visitor allowed farm OR  050 95 CI 028092 P  0024 dead chicken disposal buried OR  021 95 CI 008056 P  0000 Farmers used deep well 569 clean feeder drinker every 3 day 722 higher prevalence P ≤ 005 IBD risk factor IBD Sonali chicken farmer idea vaccine transportation maintain temperature OR  177 95 CI 101313 P  0048 Rangpur district 448 farm used cefalexin 511 farm brooding period farm farmer idea chick grade higher prevalence P ≤ 005 AI farm whose farmer bought chick hatchery 367 noticeably P ≤ 005 higher prevalence colibacillosis Mymensingh district 800 male farmers farm 747 largescale farm 875 farm wood shaving used litter 778 higher prevalence P ≤ 005 coccidiosis Rangpur district 492 farm farmer practicing handwashing 415 maintain routine cleaning feeder drinker 436 use antibiotic brooding period 681 higher prevalence brooder pneumonia Kishoreganj district 300 male farmer 221 farmer primary education level 307 Largescale farm 25015200 birds 251 farm using wood shaving litter material 356 farm sourcing chick hatchery 230 farm used florfenicol 308 antibiotic brooding period significant P ≤ 005 higher prevalence Ascariasis Poor biosecurity improper waste management inexperience chick quality  antibiotic used missing regular vaccination make farm likely experience disease outbreaks",
        "mesh_terms": [
            "Animals",
            "Chickens",
            "Bangladesh",
            "Retrospective Studies",
            "Poultry Diseases",
            "Prevalence",
            "Risk Factors",
            "Animal Husbandry",
            "Farmers",
            "Farms",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40721546/"
    },
    {
        "pmid": "40703963",
        "title": "Avian influenza overview March-June 2025.",
        "abstract": "8 March 6 June 2025 365 highly pathogenic avian influenza HPAI AH5 virus detection reported domestic 167 wild 198 bird across 24 country Europe HPAI AH5N1 virus detection predominant mainly located western central southeastern Europe detection wild bird concerned waterfowl particularly swan geese also gull involved Poultry establishments particularly domestic duck chickens continued affected large number Hungary Poland mammals HPAI AH5N1 AH5N5 virus detection reported domestic cat red foxes Eurasian otter grey seals first time ever HPAI AH5N1 viral infection detected sheep United Kingdom Outside Europe United States America USA continued report AH5N1 virus detection dairy cattle virus found first time gray fox USA leopard cat South Korea longtailed weasel USA 8 March 6 June 2025 20 case avian influenza virus infection humans including four deaths reported six countries Bangladesh two AH5N1 cases Cambodia two AH5N1 cases China one AH10N3 one AH5N1 11 AH9N2 cases India one AH5N1 case Mexico one AH5N1 case Viet Nam one AH5N1 case AH5N1 human case ini  58 reported exposure poultry prior detection onset illness Given widespread circulation avian influenza virus animal populations human infection remain rare humantohuman transmission documented reporting period risk infection avian AH5 clade 2344b influenza virus currently circulating Europe remains low general public European UnionEuropean Economic Area EUEEA lowtomoderate occupationally otherwise exposed infected animal contaminated environments",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40703963/"
    },
    {
        "pmid": "40619741",
        "title": "From Bat to Worse: The Pivotal Role of Bats for Viral Zoonosis.",
        "abstract": "Zoonotic infection increasingly observed bat Chiroptera playing pivotal role here causal chain event elucidated Henipavirus family paramyxoviruses infections Deforestation combined climate change reduced food source Pteropus fruit bat attracted fruit tree planted around piggery Malaysia transmitting Nipah virus pig amplifying host pig farmer abattoir workers Similar scenario seen Australia Pteropus bat transmitted Hendra virus horse intermediate host human infections Pteropus bat contaminated palm sap collected Bangladesh Nipah virus fatal humantohuman transmission occurred annually Less direct evidence link coronaviruses carried Rhinolophus bat SARS COVID19 pandemic piglet epidemic China Rousettus bat living cave transmitted Marburg virus family filovirus miner Africa case human rabies North America caused bat lyssavirus family Rhabdoviruses Bats viral reservoir specie various virus family reovirus Hepacivirus Flavivirus family influenza viruses Bats flying mammal opened enormous evolutionary possibility resulting worldwide radiation 1400 species bat specie represented huge population come together extremely crowded resting place conducive viral transmission Bats evolved mechanism tolerate virus replication suppress associated pathology making healthy carrier many viruses speculated strategy bat avoid arm race virus resistance antiresistance mechanisms excretion virus highly pathogenic mammalian order could used biological weapon defend habitat intrusion mammalian competitors including humans hypothesis might explain increasing involvement bat virus emerging infectious disease observed recent decade expected future",
        "mesh_terms": [
            "Chiroptera",
            "Animals",
            "Humans",
            "Viral Zoonoses",
            "COVID-19",
            "Disease Reservoirs",
            "SARS-CoV-2",
            "Zoonoses",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40619741/"
    },
    {
        "pmid": "40577311",
        "title": "Inhibitory effects of a hot-water extract of cumin fruit on influenza A virus infection.",
        "abstract": "influenza virus IAV extremely contagious virus responsible seasonal flu global pandemics Cumin Cuminum cyminum L family Apiaceae spice widely used numerous Asian nations cumin fruit commonly termed cumin seed used traditional medicine treatment several ailments however effect IAV completely understood study investigated effect cumin fruit hotwater extract CWE IAV infection MadinDarby canine kidney MDCK cell infected IAV H1N1 used vitro experiments Preinfection treatment target cell CWE suppressed M1 protein expression dosedependent manner whereas postinfection treatment effect CWE concentration 125 µgmL higher also inhibited IAVinduced haemagglutination clathrindependent endocytosis Even plaque formation assay also conducted confirm efficacy CWE virus replication assay result showed CWE significantly reduced IAV replication However expression type interferon IFN IFNstimulated antiviral protein gene affected CWE virusinfected cells Furthermore presence cuminaldehyde CWE examined using highperformance liquid chromatography Cuminaldehyde detected CWE used study Moreover cell pretreated cuminaldehyde standard show inhibition IAV infection current vitro study showed CWE inhibited IAV infection without harming host cells Thus CWE may used prevent IAV infection limiting viral attachment absorption",
        "mesh_terms": [
            "Dogs",
            "Animals",
            "Plant Extracts",
            "Madin Darby Canine Kidney Cells",
            "Fruit",
            "Influenza A Virus, H1N1 Subtype",
            "Antiviral Agents",
            "Virus Replication",
            "Cuminum",
            "Water",
            "Endocytosis",
            "Influenza A virus",
            "Hot Temperature"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40577311/"
    },
    {
        "pmid": "40496833",
        "title": "Evaluation of country preparedness for Nipah and avian influenza zoonotic viral threats in Bangladesh.",
        "abstract": "Nipah avian influenza virus NiV AIV priority zoonotic pathogen Bangladesh also important globally pandemic potential understand current strengths area improvement opportunity enhance preparedness NiV AIV Bangladesh part USAID STOP Spillover program 47 relevant stakeholder surveyed two country lead primary surveillance system interviewed Data collected focusing four different areas research projects surveillance systems laboratories outbreak risk management systems Despite progress recent years study reveals significant gap preparedness detection response capacity across sector highlight importance prioritizing extended targeted surveillance biosafety solution laboratories early event detection resilient defense virus using One Health framework",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40496833/"
    },
    {
        "pmid": "40496144",
        "title": "Addressing influenza in Bangladesh: closing evidence and policy gaps with strategic interventions.",
        "abstract": "Since establishment National Influenza Surveillance Program 2007 Bangladesh significantly progressed monitoring influenza national international collaboration However collaboration translated actionable control policies coupled low vaccination coverage impose substantial health economic burden Bangladesh Critical gap remain understanding influenza burden among highrisk population barrier influencing vaccine uptake gap hinder development evidencebased strategy prevention control consequently leaving country vulnerable potentially catastrophic influenza epidemic challenge require multifaceted approach including continuous local data collection disease burden vaccine barriers vaccine costeffectiveness analyses design contextspecific interventions Leveraging existing infrastructure offer opportunity develop tailored strategy highrisk populations robust national influenza policy imperative mitigate burden reduce future pandemic threats",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40496144/"
    },
    {
        "pmid": "40483733",
        "title": "Synergistic effects of peptide mimics against enveloped viruses.",
        "abstract": "global health impact virus highlight urgent need innovative antiviral strategies study investigated synergistic potential two anthranilamidebased peptide mimic RK610 RK758 combination one peptide mimic RK610 combination cationic peptide Mel4 melimine murine hepatitis virus a coronavirus MHV1 influenza virus H1N1 Herpes simplex virus HSV1 Checkerboard assay demonstrated RK610RK758 synergy MHV1 H1N1 ∑FICI value 014 05 respectively RK610Mel4 showed potent synergy HSV1 ∑FICI  018 Cotreatment outperformed sequential application Transmission electron microscopy confirmed structural damage virions cytotoxicity assay indicated tested combination nontoxic MDCK A9 Vero cells except melimine RK610melimine A9 cells Biophysical analysis using DOPC 100  DOPC POPS 7030 lipid provided mechanistic idea peptidemimic interaction lipid envelopes Tethered bilayer lipid membrane tBLMs conjunction electrical impedance spectroscopy revealed peptide mimic combination reduced membrane conductance regardless lipid composition Quartz crystal microbalance dissipation monitoring QCMD revealed RK610 RK758 induced mass addition outer layer significantly increasing POPS DOPC RK610 increased surface pressure LangmuirBlodgett trough RK758 reduced it 610  758 610Mel4 combination raised maximum pressures DOPC  POPS RK758 destabilized monolayer 35 mNm plateau whereas combination restored stability finding highlight peptide mimic broadspectrum antiviral agent show synergy target viral envelopes paving way safer lowresistance therapeutics",
        "mesh_terms": [
            "Animals",
            "Antiviral Agents",
            "Peptides",
            "Influenza A Virus, H1N1 Subtype",
            "Chlorocebus aethiops",
            "Drug Synergism",
            "Dogs",
            "Vero Cells",
            "Murine hepatitis virus",
            "Cell Line",
            "Herpesvirus 1, Human",
            "Mice",
            "Madin Darby Canine Kidney Cells"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40483733/"
    },
    {
        "pmid": "40455719",
        "title": "Hydroethanolic extract of Schinus terebinthifolia as a promising source of anti-influenza agents: Phytochemical profiling, cheminformatics, molecular docking and dynamics simulations.",
        "abstract": "Although Schinus terebinthifolia commonly known Brazilian peppertree documented possess various biological activities anticancer antibacterial antioxidant properties antiinfluenza activity yet documented Here aqueousethanolic extract 30 vv ethanol solution prepared aerial part leaves stalks established determine whether rich source antiviral agents hydroethanolic plant extract TPC value 26411 mg GAEg DE exhibit promising IC50 value 1633 μgmL similar authentic quercetin IC50  1272 μgmL approximately 534 time higher gallic acid IC50  306 μgmL determined DPPH assay extract contains 171 mg gallic acid representative marker per gram dried plant material according HPLC analysis Using untargeted metabolomics analysis coupled series cheminformatics tool MetFrag SIRIUS CSIFingerID CANOPUS ultimately proved S terebinthifolia hydroethanolic extract contains simple phenolic eg methyl gallate ethyl gallate chlorogenic acid flavonoid afzelin myricitrin dicarboxylic acids germacrone anticipated plant extract exhibited antiinfluenza activity IC50 221 μgmL CC50  50 μgmL exert hemolytic activity concentration 2000 μgmL underscoring efficacy safe antiviral solution silico molecular docking dynamic simulation suggest neuraminidase capbinding domain influenza RNA polymerase PB2 preferentially targeted inhibition detected metabolites Owing diverse therapeutic effect secondary metabolites antiH5N1 activity newly developed plant extract currently investigation",
        "mesh_terms": [
            "Antiviral Agents",
            "Plant Extracts",
            "Molecular Docking Simulation",
            "Anacardiaceae",
            "Phytochemicals",
            "Ethanol",
            "Molecular Dynamics Simulation",
            "Neuraminidase",
            "Gallic Acid",
            "Humans",
            "Schinus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40455719/"
    },
    {
        "pmid": "40303010",
        "title": "Longitudinal Active Avian Influenza Surveillance in Bangladesh From 2017-2022 Reveals Differential IAV and H5 Infection and Viral Burden Associated With Bird Species, Sex, and Age.",
        "abstract": "Influenza virus major global health burden 650000 associated death annually Beyond seasonal illness influenza virus IAVs pose constant pandemic threat due novel emergent virus evolved ability jump natural avian host humans threat active surveillance circulating IAV strain wild domestic bird population vital pandemic preparedness response strategies Here report IAV surveillance data collected 2017 2022 wild domestic bird Bangladesh note evidence suggest male bird show higher risk IAV including highly pathogenic avian influenza HPAI AH5 virus positivity female birds data stratified control selection bias confounding variable test hypothesis male bird higher risk IAV positivity relative female birds association IAV AH5 largely held stratum double stratification suggested phenomenon largely specific ducks Finally show chickens male birds juvenile bird generally higher viral load compared counterparts observation warrant validation active surveillance across various populations effort could significantly contribute enhancement pandemic prediction risk assessment models",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Influenza in Birds",
            "Female",
            "Male",
            "Birds",
            "Influenza A virus",
            "Sex Factors",
            "Viral Load",
            "Age Factors",
            "Animals, Wild",
            "Chickens",
            "Longitudinal Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40303010/"
    },
    {
        "pmid": "40302763",
        "title": "Migratory Wave due to Conflicts: Risk of Increased Infection From Zoonotic Diseases.",
        "abstract": "Wars devastating effect component One Health approach humans animals ecosystems Wars resulting migratory wave massively disrupt normal animal health service surveillance Among consequences adversely impact early detection prevention control animal diseases Uncontrolled movement animal undisposed carcasses destruction wildlife habitats increased interface humans wildlife domestic animal contribute uncontrolled transmission spread zoonotic pathogen animal humans last millennium zoonotic disease Black Death triggered devastating war led death large fraction human population However also recent ongoing war carry risk uncontrollable increase zoonotic diseases significant zoonotic disease reported recent war African swine fever highly pathogenic avian influenza rabies leptospirosis brucellosis well foodborne waterborne zoonotic diseases Indeed alarming rate infection antimicrobialresistant pathogen iMycobacterium tuberculosisi go along wars seen current UkraineRussia conflict Considering human migration foodborne waterborne zoonotic disease key health threat refugee due consumption unsafe food lack safe water disruption water supply sanitation system review summarizes potential factor data associated increased risk zoonotic disease emergence transmission recent ongoing conflicts",
        "mesh_terms": [
            "Zoonoses",
            "Animals",
            "Humans",
            "Armed Conflicts",
            "Risk Factors",
            "Animals, Wild",
            "Animal Migration"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40302763/"
    },
    {
        "pmid": "40295852",
        "title": "Effects of oxidative stress on viral infections: an overview.",
        "abstract": "Viral infection trigger increased reactive oxygen specie ROS production reduced antioxidant response host leading redox stress inflammation apoptosis ultimately cell tissue damage contribute disease development better understanding ROS contributes viral pathogenesis critical development novel therapeutic interventions review discus current knowledge ROS production effect across various viral infections including severe acute respiratory syndromecoronavirus2 influenza virus dengue virus Zika virus hepatitis B virus hepatitis C virus human immunodeficiency virus infections improve future therapeutic preventive strategy infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40295852/"
    },
    {
        "pmid": "40271995",
        "title": "Epidemiology and evolutionary dynamics of H9N2 avian influenza virus in Bangladesh.",
        "abstract": "Low pathogenicity avian influenza LPAI H9N2 enzootic Bangladeshi poultry since 2006 H9N2 outbreak decrease egg production growth pose risk human health role avian host persistence evolution dispersion H9N2 poorly understood Bangladesh Hence study unveils intricate role major host specie virus maintenance evolution temporal seasonal pattern H9N2 Bangladesh 2006 2023 Multinomial logistic regression analysis indicated circulation H9N2 different specie interface significantly influenced seasons Bayesian phylogenetic analysis H9N2 sequence Bangladesh revealed two distinct lineages G1 Eurasian G1 lineage split two clusters coexisting 2019 point one cluster persisted Bayesian phylodynamic analysis G1 lineage unveiled frequent bidirectional viral transition among ducks chickens quails Chickens might pivotal source H9N2 Bangladesh higher number viral transition chicken duck quails Quails appear acquire viral transition chicken rather ducks suggesting quail epizootics primarily triggered spillover event chickens result suggest viral circulation commercial chicken despite vaccination vaccination approach revised assess vaccine efficacy extension vaccination backyard chicken quails",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Influenza A Virus, H9N2 Subtype",
            "Influenza in Birds",
            "Chickens",
            "Phylogeny",
            "Poultry Diseases",
            "Ducks",
            "Evolution, Molecular",
            "Quail",
            "Bayes Theorem",
            "Humans",
            "Seasons"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40271995/"
    },
    {
        "pmid": "40265471",
        "title": "Mutations in the influenza virus, primarily H5N1, enhance the virus's virulence, favor receptor interaction, and increase drug resistance.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40265471/"
    },
    {
        "pmid": "40226176",
        "title": "Addressing the Dual Threat of Dengue and Influenza in Bangladesh: A Perspective on the Prevention and Preparedness Strategies.",
        "abstract": "Bangladesh dengue fever influenza pose serious public health risk due high rate morbidity fatality Frequent outbreak caused dengue virus spread mosquito cause flulike symptoms particularly monsoon season Another infectious respiratory illness varies every year influenza illness frequently cocirculate tropical area like Bangladesh raising possibility coinfection putting vulnerable group higher risk purpose article explore effect dengue influenza coinfection Bangladesh looking present issue possible solution dual health burden perspective piece gather data authoritative sources including PubMed World Health Organization Directorate General Health Services Ministry Health Family Welfare Bangladesh European Center Disease Prevention Control Relevant literature dengue influenza incidence control measures coinfection dynamic reviewed Bangladesh dengue incidence still rise influenza infection climbed especially winter countrys healthcare system may overburdened simultaneous spread diseases particularly dengue rate keep rising influenza case rise lessen effect illnesses effective community awareness campaigns vector control initiatives early diagnosis technique crucial Bangladesh must emphasize increased preventative preparation measures better monitoring public health communication vaccine development research given twin danger posed dengue influenza lower likelihood coinfection avert future public health emergencies coordinated action essential",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40226176/"
    },
    {
        "pmid": "40013298",
        "title": "Use of ash filtrate as an alternative to chemical disinfectant and its antimicrobial efficacy.",
        "abstract": "study aim prepare ash filtrate AF household ash using inhousedesigned handmade filtration system observe antimicrobial efficacy sanitizing effects Household ash various plant source collected AF prepared handmade filtration system adding water pH stock AF measured 20 40 60 80 AF solution prepared adding distilled water appropriate proportion obtain wide range pH values antimicrobial efficacy AF iSalmonellai spp iin vitroi Newcastle disease virus NDV low pathogenic avian influenza virus LPAIV Hsub9subNsub2sub iin ovoi analyzed Contaminated egg individually sprayed dipped AF detect bacterial load eggshell surface experimental use AF egg sanitizer routine biosecurity operation broiler shed also evaluated prepared AF showed high alkalinity pH varied 107 820 contained higher amount K Na Cl alkaline AF dilution gradually inhibited Salmonella growth showed gradual pHdependent antibacterial efficacy Similarly AF dilution showed gradual decrease viral titer LPAIV H9N2 however antiviral activity velogenic strain NDV quite steady Applying AF egg sanitizer also reduced bacterial load significantly eggshell surface compared untreated eggs Moreover AF pH 105 experimentally used routine sanitization practice boiler shed resulted low bird mortality 10210 higher body weight gain low feed conversion ratio compared untreated control flock higher alkalinity AF responsible antimicrobial activity commercial disinfectants Consequently use AF lowcost effective natural antimicrobial agent replace chemical disinfectants",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40013298/"
    },
    {
        "pmid": "40001442",
        "title": "Decade-Long Trends in Antibiotic Prescriptions According to WHO AWaRe Classification Among Severe Acute Respiratory Infection Patients at Tertiary Hospitals in Bangladesh (2011-2020).",
        "abstract": "bBackgroundb aid development antimicrobial stewardship program ASPs analyzed pattern trend antibiotic prescription patient severe acute respiratory infection SARI utilizing WHOs AWaRe classification bMethodsb analyzed data hospitalbased influenza surveillance January 2011 December 2020 across nine Bangladeshi tertiarylevel hospitals Surveillance physician collected WHOdefined SARI patient data including demographics clinical characteristics antibiotic prescriptions Descriptive statistic parametric nonparametric test used analysis bResultsb 21566 SARI patient median age 20 year IQR 13345 66 male 91 prescribed least one antibiotic total 25133 antibiotic prescribed 470 thirdgeneration cephalosporins 165 macrolides 111 betalactambetalactamase inhibitors According AWaRe classification 287 Access group 713 Watch group none Reserve group downward trend Access group 304 251 ipi  0010 upward trend Watch group antibiotic prescription 696 749 ipi  0010 observed identified patient aged  5 year aOR 180 95 CI 144225 treated government hospital aOR 145 95 CI 135157 patient presence lung disease aOR 156 95 CI 135180 increased likelihood prescribed Watch group antibiotics bConclusionsb study reveals concerning pattern antibiotic overuse among SARI patient Bangladesh growing trend past decade towards increased Watch group antibiotic prescriptions onethird prescribed antibiotic Access group falling short twothirds threshold recommended WHO Effective ASPs crucial optimize antibiotic prescription mitigate risk antimicrobial resistance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40001442/"
    },
    {
        "pmid": "39939109",
        "title": "Seasonal influenza surveillance and vaccination policies in the WHO South-East Asian Region.",
        "abstract": "SouthEast Asia Region SEAR high population density recognised epidemiologist critical reservoir emergence global dissemination novel influenza strains making potential epicentre future influenza pandemics Despite significant risk SEAR country lack comprehensive seasonal influenza vaccination policies resulting low vaccine uptake across region review analysed latest National Influenza Programme factsheets 11 SEAR member state supplemented extensive manual literature search using electronic database government websites October 2022 three countriesIndia Bhutan Thailandhad established seasonal influenza vaccination policies Among them Bhutan Thailand policy cover five WHOrecommended highrisk groups national influenza surveillance system place across SEAR India Democratic Peoples Republic Korea claim full population coverage Influenza vaccine production capacity limited Bangladesh India Indonesia regions varied climatic condition insufficient local data obscured true burden influenza Thailand offer successful model country region beginning vulnerable group gradually expanding coverage effectively develop implement national influenza vaccination policies SEAR country must close evidence gap strengthening surveillance system provide accurate timely data prioritise contextspecific research leverage existing vaccine infrastructure enhance public education finally engage local international stakeholder establish strong international cooperation support effort improve pandemic preparedness",
        "mesh_terms": [
            "Humans",
            "Asia, Southeastern",
            "Health Policy",
            "Influenza Vaccines",
            "Influenza, Human",
            "Population Surveillance",
            "Seasons",
            "Vaccination",
            "World Health Organization"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39939109/"
    },
    {
        "pmid": "39893295",
        "title": "Integrative computational analysis of anti-influenza potential in Caesalpinia mimosoides Lamk hydroethanolic extract.",
        "abstract": "recent study used chemical analysis show Caesalpinia mimosoides aqueous extract contains high concentration simple phenolics strong antiinfluenza activity determined molecular docking method potential target inhibitor neuraminidase Therefore study objective evaluate whether aqueousethanol extract 30 vv plant specie exhibit greater antiviral activity aqueous plant extract C mimosoides hydroethanolic extract exhibited potent antioxidant activity DPPH assay ICsub50sub value 1501 µgmL comparable authentic quercetin ICsub50sub  1272 µgmL approximately 491 time greater standard gallic acid ICsub50sub  306 µgmL untargeted metabolomic analysis UPLCESI±QTOFMSMS subsequent stepwise computational metabolomics analyses identified extract primarily containing simple phenolic eg gallic acid ellagic acid shikimic acid chlorogenic acid flavonoid derivative eg quercetin taxifolin myricitrin afzelin bioactive components including dicarboxylic acid germacrone polyphenolrich extract showed strong antiinfluenza activity ICsub50sub 233 µgmL influenza APR834 virus cytotoxic effects indicated CCsub50sub greater 50 µgmL represents approximately 335fold increase effectiveness compared corresponding aqueous extract ICsub50sub  781 µgmL Furthermore extract demonstrated hemolytic activity even maximum concentration 2000 µgmL suggesting potential safe antiviral agent Molecular docking analysis revealed identified phytochemical simultaneously interact drugtarget binding sites neuraminidase NA PB2 subunit influenza RNA polymerase indicating potential polypharmacological effects antiviral activity ethanolicaqueous extract strain explored due versatile biological effect phenolic substances",
        "mesh_terms": [
            "Caesalpinia",
            "Plant Extracts",
            "Antiviral Agents",
            "Molecular Docking Simulation",
            "Neuraminidase",
            "Antioxidants",
            "Phenols",
            "Humans",
            "Animals",
            "Ethanol"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39893295/"
    },
    {
        "pmid": "39879546",
        "title": "Type I Interferon Targets Alveolar Macrophages to Promote Bacterial Pneumonia after Viral Infection.",
        "abstract": "Exposure influenza virus respiratory syncytial virus human metapneumovirus well known increase risk iStreptococcus pneumoniaei iSPni pneumonia humans Type IFN IFNI hallmark response acute viral infections alveolar macrophage AMs constitute first line airway defense opportunistic bacteria study reveals virusinduced IFNAR1 IFNI receptor signaling directly impairs AMdependent antibacterial protection Using iIfnar1i conditional knockout mouse models iin vivoi antibodies bone marrow chimeric mice reconstitution demonstrate IFNI intrinsically target AMs drive hypersusceptibility iSPni following influenza virus infection Importantly show respiratory syncytial virus human metapneumovirus infection induces robust IFNI signaling AMs coinciding lethal susceptibility secondary iSPni pneumonia contrast seasonal human coronavirus induces neither significant IFNI signaling AMs immune predisposition iSPni Therefore conclude IFNI inhibition AMs represents crucial mechanism underlying antibacterial complication following otherwise asymptomatic mild respiratory viral infections",
        "mesh_terms": [
            "Animals",
            "Macrophages, Alveolar",
            "Interferon Type I",
            "Receptor, Interferon alpha-beta",
            "Mice, Knockout",
            "Humans",
            "Mice",
            "Mice, Inbred C57BL",
            "Pneumonia, Bacterial",
            "Streptococcus pneumoniae",
            "Signal Transduction",
            "Influenza A virus",
            "Respiratory Syncytial Virus Infections",
            "Metapneumovirus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39879546/"
    },
    {
        "pmid": "39857537",
        "title": "Physicians' Intentions to Recommend Influenza Vaccine: A Multi-Centered Hospital-Based Study Using the Theory of Planned Behavior in Bangladesh.",
        "abstract": "Influenza remains significant public health challenge low middleincome country LMICs like Bangladesh vaccine uptake remains low despite substantial disease burden Physicians play vital role promoting vaccination yet intention influencing factor well understood conducted crosssectional study June October 2022 across four tertiarylevel hospital Bangladesh using questionnaire grounded Theory Planned Behavior TPB Hierarchical logistic regression employed identify factor associated vaccine recommendation intentions Among 972 physician average age 321 years 401 intended recommend administer influenza vaccine 853 agreed vaccination reduces risk 655 desired vaccination selfprotection 635 would vaccinate available work 853 anticipated Ministry Health support Male OR  19 95 CI 1523 married OR  15 95 CI 1119 physician likely recommend vaccination unit increase attitude score doubled likelihood recommending vaccine OR  20 95 CI 1430 Physicians influenza vaccine recommendation Bangladesh suboptimal influenced gender marital status attitudes Targeted educational intervention addressing attitudinal barrier leveraging institutional support could improve recommendation practices",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Influenza Vaccines",
            "Male",
            "Female",
            "Adult",
            "Cross-Sectional Studies",
            "Physicians",
            "Intention",
            "Influenza, Human",
            "Middle Aged",
            "Attitude of Health Personnel",
            "Surveys and Questionnaires",
            "Vaccination",
            "Theory of Planned Behavior"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39857537/"
    },
    {
        "pmid": "39839111",
        "title": "Geographical distribution and evolutionary dynamics of H4Nx avian influenza viruses.",
        "abstract": "H4Nx avian influenza virus AIVs isolated wild bird poultry also cross specie barrier infect mammal pigs muskrats widespread presence virus wild bird poultry ability transmitted interspecies make undeniable hazard poultry farming industry present study collected fecal swab sample wild bird poultry Guangdong Province January 2019 March 2024 various subtypes AIVs isolated including 19 strain H4 subtype AIVs analysis conducted internal gene 19 strains strain clustered together high homology highly pathogenic avian influenza virus HPAIV suggesting H4Nx AIV may reassorted HPAIV Two H4N8 strain phylogenetically related porcine H4N8 AIV Molecular characterization revealed virus study less pathogenic potential mammalianadapted mutations transmission dynamic H4Nx AIVs revealed Europe Asia especially Netherlands Bangladesh may center transmission may linked migration wild birds high migration rate Russia Netherlands Russia Bangladesh may also play role Therefore continuous systematic monitoring wild bird clarify spatial temporal distribution prevalence influenza virus wild bird significant early warning avian influenza outbreak poultry risk assessment public health safety",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39839111/"
    },
    {
        "pmid": "39812068",
        "title": "Identification of Natural Terpenoid Compounds as Potential Inhibitors of Nucleoprotein of Influenza A Virus using in silico Approach: ADMET, Molecular Docking, and Molecular Dynamic Simulation.",
        "abstract": "continue struggle prevention treatment influenza virus 2009 swine flu pandemic caused H1N1 strain influenza A resulted numerous fatalities threat influenza remains significant concern global health development novel drug targeting virus highly desirable objective study explore inhibitory potential terpenoid compound Nucleoprotein NP influenza virus highly effective drug target due ability facilitate transcription replication viral RNA silico research performed identify potential inhibitor NP Molecular docking study conducted assess binding terpenoid compound active site residue target protein promising hit subjected molecular dynamic simulation examine stability proteinligand complexes Additionally ADMET Absorption Distribution Metabolism Excretion Toxicity study Lipinskis rule five employed evaluate drug safety druglikeness compounds Docking study revealed terpenoid compound bind strongly active site residue NP protein Molecular dynamic simulation demonstrated stability proteinligand complex besthit compounds ADMET study Lipinskis filter indicated compound exhibit desirable drug safety druglikeness profiles work may contribute significantly drug discovery development therapeutic agent influenza virus identification terpenoid compound bind strongly NP protein exhibit favorable druglike property silico study provides promising foundation research development potential inhibitor targeting critical viral protein",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39812068/"
    },
    {
        "pmid": "39810749",
        "title": "Seroprevalence of SARS-CoV-2 in wet market workers in Dhaka, Bangladesh in 2022.",
        "abstract": "assessed transmission SARSCoV2 vaccine receipt representative sample wet market worker highly dense lowincome setting Wet market key many Asian settings including Dhaka Bangladesh fresh food including animal protein early 2022 assessed prevalence antiSARSCoV2 antibody random sample poultry vegetable worker 15 wet markets investigated association sociodemographic characteristic COVID19 vaccination 204 poultry worker 87 vegetable seller recruited COVID19 vaccine uptake similar 69 v 67 common vaccine whole inactivated vaccine Sinopharm Sinovac 44 Nearly 99 participant positive antiSARSCoV2 spike antibodies AntiSARSCoV2 nucleocapsid antibodies indicative recent infection 594 95 confidence interval 547640 evidence latter associated characteristics except vaccination adjusted odds ratio 049 95 confidence interval 023102 iPi  0093 ubiquity antispike high prevalence antinucleocapsid antibody consistent high transmission three previous pandemic waves Wet market potential role amplifying transmission airborne pathogens SARSCoV2 Avian Influenza Viruses important publicfacing hotspot close monitoring future emerging infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39810749/"
    },
    {
        "pmid": "39802431",
        "title": "Hybrid neural network models for time series disease prediction confronted by spatiotemporal dependencies.",
        "abstract": "infectious disease outbreak modeling remains gap addressing spatiotemporal challenge present established models study address gap evaluating four established hybrid neural network model predicting influenza outbreaks model analyzed employing time series data eight different country challenge model imposed spatial difficulties monthonmonth structure models prediction compared using MAPE RMSE well graphical representation generated employed models SARIMALSTM model excelled achieving lowest average RMSE score 6693 well reporting lowest RMSE score three eight country studied case also GAConvLSTMCNN model come second place average RMSE score 6846 Considering result ability follow seasonal trend actual values study suggests SARIMALSTM model robust spatiotemporal challenge compared model examination study•Evaluated established method unique imposed difficulty•Addressed spatiotemporal characteristic data•Proposed SARIMALSTM model based evaluation metrics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39802431/"
    },
    {
        "pmid": "39761238",
        "title": "Bifurcation analysis of an influenza A (H1N1) model with treatment and vaccination.",
        "abstract": "research us numerical simulation mathematical theory simulate analyze spread influenza virus existence uniqueness positivity boundedness solution established investigate fundamental reproduction number guaranteeing asymptotic stability equilibrium point endemic diseasefree also examine qualitative behavior models Using Lyapunov method RouthHurwitz criteria explore local global stability state present finding graphically research assesses control policy proposes alternatives performing bifurcation analysis establish prevention strategies investigate transcritical Hopf backward bifurcation analytically numerically demonstrate disease transmission dynamics novel study Contour plots box plots phase portrait highlight key characteristic controlling epidemics diseases persistence depends fundamental reproduction quantity validate outcomes fit model clinical data influenza case Mexico Colombia October 1 2020 March 31 2023 aiming analyze trends identify critical factors forecast influenza trajectory national levels Additionally assess efficacy implemented control policies",
        "mesh_terms": [
            "Humans",
            "Influenza, Human",
            "Influenza A Virus, H1N1 Subtype",
            "Mexico",
            "Vaccination",
            "Colombia",
            "Influenza Vaccines",
            "Basic Reproduction Number",
            "Computer Simulation",
            "Models, Theoretical"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39761238/"
    },
    {
        "pmid": "39708674",
        "title": "Molecular detection and epidemiological distribution of poultry respiratory viral pathogens in commercial chicken flocks in Bangladesh.",
        "abstract": "Respiratory viral infection considerable detrimental impact animal health well significant financial consequence poultry industry primary aim study investigate major pathogen involved respiratory disease poultry coinfection rate epidemiological distribution commercial chicken farm Bangladesh June 2022 December 2023 300 pooled sample swabs live birds respiratory tissue dead birds collected selected poultry farm respiratory outbreak noticed Samples screened five important respiratory pathogen circulating Bangladesh including H9N2 low pathogenic avian influenza virus LPAIV H5N1 highly pathogenic avian influenza virus HPAIV infectious bronchitis virus IBV Newcastle disease virus NDV infectious laryngotracheitis virus ILTV Onestep qPCR performed using either TaqMan probebased SYBR Green chemistry total 140 flock 4667  found infected respiratory pathogen including 1857  H5N1n  26 20  H9N2 n  28 50  IBV n  70 3715  NDV n  52 071  ILTV n  1 2640  n  37 mixed infection present present study also revealed coinfection several respiratory pathogen 2640  caused serious synergistic pathogenic effect complicating factor poultry infections Bangladesh study common season infection layer broiler broiler breeder Sonali spring infection exhibited consistent pattern Nevertheless investigation revealed continuous cocirculations various respiratory viruses resulting complex environment poultry industry information also help raise farmerlevel disease awareness prevent control spread viruses",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Chickens",
            "Poultry Diseases",
            "Respiratory Tract Infections",
            "Coinfection",
            "Influenza in Birds",
            "Prevalence",
            "Virus Diseases",
            "Influenza A Virus, H5N1 Subtype"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39708674/"
    },
    {
        "pmid": "39706340",
        "title": "Gene flow and its sporadic spillover: H10 and N5 avian influenza viruses from wild birds and the H10N5 human cases in China.",
        "abstract": "January 30 2024 China announced first human case H10N5 influenza infection Prior this human case H10N7 H10N8 reported appropriate reexamine evolution future epidemiological trend H10 N5 subtypes avian influenza virus AIVs study analyzed reassortment characteristic first humanderived H10N5 AIV AZhejiangZJU012023 well evolutionary dynamic wild birdderived H10 N5 subtypes AIVs past decade finding indicate humanderived H10N5 AIV exhibited low pathogenicity AbeangooseKoreaKNU102022H10N7 AmallardNovosibirskregion962k2018H12N5 identified potential reassortment parents virus existed since 2022 several isolation reported Bangladesh Phylogenetic analysis showed H10Ny HxN5 AIVs China clustered differently based East AsianAustralian eastern Central AsianIndian western migratory flyways H10Ny HxN5 AIV reassortant strain may cause human infection accidental spillover possible another center AIV evolution mutation reassortment may developing along migratory flyway northeastern Asia distinct Europe Americas Chinas Yangtze River Delta Pearl River Delta closely monitored ensure safety public",
        "mesh_terms": [
            "China",
            "Animals",
            "Humans",
            "Phylogeny",
            "Influenza in Birds",
            "Birds",
            "Reassortant Viruses",
            "Influenza, Human",
            "Influenza A virus",
            "Animals, Wild",
            "Gene Flow",
            "Evolution, Molecular"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39706340/"
    },
    {
        "pmid": "39701824",
        "title": "Viral Acute Lower Respiratory Tract Infections (ALRI) in Rural Bangladeshi Children Prior to the COVID-19 Pandemic.",
        "abstract": "Acute lower respiratory tract infection ALRIs remain leading infectious cause death among child  5 years virus contributing large proportion cases Little known epidemiology etiology viral ALRI rural Bangladesh enrolled 3 23monthold child ALRIs attending subdistrict hospital outpatient clinic Sylhet district Bangladesh Trained study physician ascertained case obtained nasopharyngeal swab detect 19 respiratory virus multiplex PCR using Luminex Integrated System NxTAG Respiratory pathogen panel August 2016 September 2017 enrolled 1477 children Median age 10 months 581 male Fortyseven percent presented autumn midJune midOctober third temperature ≥ 101°F 954 cough previous 3 days 720 fast breathing 800 chest indrawing Alveolar consolidation occurred 239 44 hypoxemic saturation  90 room air Nineteen percent required hospitalization 791 discharged within 48 h respiratory virus identified 818 majority 758 single virus isolation Rhinoenterovirus commonly identified HRVHEV 379 followed respiratory syncytial virus RSV 202 human metapneumovirus hMPV 117 Rhinoenterovirus detected yearround RSV detected AugustNovember hMPV DecemberMarch Respiratory virus identified majority 82 child 2 year age presenting ALRI rural hospital Bangladesh finding implication future study potentially surveillance antimicrobial stewardship vaccine program planning policy",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Infant",
            "Male",
            "Female",
            "Respiratory Tract Infections",
            "Rural Population",
            "COVID-19",
            "Viruses",
            "Nasopharynx",
            "Seasons",
            "SARS-CoV-2",
            "Acute Disease",
            "Metapneumovirus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39701824/"
    },
    {
        "pmid": "39701118",
        "title": "Evaluation of a point-of-care immunochromatographic assay for enteric fever in Dhaka, Bangladesh: a prospective diagnostic accuracy study.",
        "abstract": "shortage rapid accurate lowcost assay diagnosing enteric fever dualpath platform typhoid DPPT assay high accuracy retrospective study banked plasma samples aimed evaluate diagnostic accuracy DPPT assay prospective study using fingerstick capillary blood prospective diagnostic accuracy study enrolled child younger 18 years presented Bangladesh Shishu Hospital Institute Dhaka Bangladesh least 3 day fever collected blood nasal swabs following assay assess accuracy DPPT blood culture serological assay typhoid fever DPPT assay Widal Testit molecular assay identify alternative aetiology eg respiratory syncytial virus RSV influenza dengue virus Rickettsia spp primary outcome study sensitivity specificity DPPT assay diagnosis enteric fever evaluated accuracy combined antihaemolysin E antilipopolysaccharide IgA reading using DPPT assay distinguishing cultureconfirmed enteric fever alternative aetiology using receiver operating characteristic area curve AUC Given imperfect reference standard diagnostics enteric fever used Bayesian latent class models incorporating result typhoid alternative aetiology diagnostics estimate sensitivity specificity DPPT assay also subgroup analysis assay across multiple biological variables Aug 17 2021 July 16 2022 enrolled 501 participant presented least 3 day fever 223 45 501 participant female 278 55 male 77 participant cultureconfirmed enteric fever 62 Salmonella enterica serotype Typhi 15 Salmonella enterica serotype Paratyphi A 70 culturenegative PCRconfirmed alternative aetiology 34 influenza B 22 dengue virus seven Rickettsia spp six RSV one participant coinfected RSV dengue virus AUC DPPT fingerstick capillary blood distinguishing typhoid alternative aetiology 0·969 95 CI 0·9430·994 latent class analysis sensitivity DPPT 93 95 credible interval CrI 8797 specificity 89 8593 balanced accuracy higher DPPT 91 95 CrI 8794 blood culture 81 7885 Testit 77 7479 Widal 70 6773 Assay performance vary sex age duration fever presentation antibiotic use presentation Salmonella serotype sample type pointofcare DPPT assay achieved high diagnostic accuracy enteric fever highly endemic community assay potential improve clinical outcome enteric fever allowing rapid diagnosis treatment could facilitate appropriate antimicrobial use National Institute Health Bill  Melinda Gates Foundation Child Health Research Foundation",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Bangladesh",
            "Prospective Studies",
            "Female",
            "Male",
            "Child, Preschool",
            "Child",
            "Sensitivity and Specificity",
            "Infant",
            "Point-of-Care Systems",
            "Adolescent",
            "Antibodies, Bacterial",
            "Chromatography, Affinity",
            "Salmonella typhi"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39701118/"
    },
    {
        "pmid": "39660154",
        "title": "Updated WHO list of emerging pathogens for a potential future pandemic: Implications for public health and global preparedness.",
        "abstract": "Historically pandemic constitute major nuisance public health debilitating impact global health previous occurrence causing major mortality worldwide adverse outcome limited health outcome ravage social economic political landscapes World Health Organization WHO stand front pandemic response strategizing contain mitigate impact human environment also intervenes regional disease outbreak pose threat global health strategic technical guidance resource allocations expert support emerging pathogens aftermath COVID19 pandemic discussion currently underway global preparedness potential future pandemic effect previous pandemic underscore need improve global health preparedness upcoming pandemics WHOs July 2024 updated list emerging pathogen serf potential tool foster global health readiness future pandemic represents change worlds approach emerging reemerging pathogens shifting focus specific pathogen adopting broader familyfocused approach new list recognizes shortcoming previous list adopts forwardthinking proactive flexible approach dealing familiar unfamiliar pandemic risks incorporating Prototype Pathogens Pathogen X risk classification set pace developing tool guideline practice updated list highpriority pathogen seek gear research development toward combating neutralizing virulence pathogens Recent outbreak Cholera Mpox Dengue fever Africa Avian influenza H5N2 Mexico Nipah virus disease Bangladesh Oropouche virus Americas necessitate intensifying regional disease surveillance Research organization institution must prioritize incorporating tool approach shared learning collective action established COVID19 pandemic recent public health emergency Preparedness Resilience Emerging Threats PRET Initiative outlined WHO",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39660154/"
    },
    {
        "pmid": "39654774",
        "title": "Cross-neutralization of Influenza A by SARS-CoV-2 specific neutralizing antibodies and polyclonal plasma: Is pre-exposure to SARS-CoV-2 protective against Influenza A?",
        "abstract": "According sparse information various countries seasonal influenza virus circulation drastically decreased COVID19 pandemic Here show crossreactivity antiSARSCoV2 antibody influenza viruses Plasma sample collected 311 SARSCoV2 infected individuals sample tested antibody titer SARSCoV2 ELISA seasonal influenza virus strain influenza AH1N1 AH3N2 BYamagata BVictoria using Hemagglutination Inhibition Assay HAI addition SARSCoV2 antibodypositive Influenza antibodynegative sample n  16 investigated determine SARSCoV2 antibodyneutralizing potential influenza virus microneutralization MN assay SARSCoV2 genome sequenced using Illumina nextgeneration sequencing insilico protein structural analysis performed identify epitope antibody binding similarity SARSCoV2 influenza viruses Among 16 sample contain antibody Influenza strain H1N1 H3N2 five showed high MN titer≥20 six showed moderate MN titer≥10 capability neutralize Influenza A Subsequent insilico analysis revealed efficient binding 8 kcalmol found antibody SARSCoV2 delta variant ΔG influenza AH1N1 HA Hemagglutinin AH3N2 HA AH1N1 NA Neuraminidase AH3N2 NA glycoprotein 124 93 101 117 kcalmol respectively investigation revealed neutralizing antibody delta variant crossreacted Influenza virus might protect influenza virus reduce shift seasonal influenza circulation COVID19 pandemic finding warrant study explain probable mechanism crossreactivity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39654774/"
    },
    {
        "pmid": "39653855",
        "title": "SNARE mimicry by the CD225 domain of IFITM3 enables regulation of homotypic late endosome fusion.",
        "abstract": "CD225Dispanin superfamily contains membrane protein regulate vesicular transport membrane fusion event required neurotransmission glucose transport antiviral immunity However CD225 domain control membrane trafficking remained unknown show CD225 domain contains SNARElike motif enables interaction cellular SNARE fusogens Prolinerich transmembrane protein 2 PRRT2 encodes SNARElike motif enables interaction neuronal SNARE proteins mutation region disrupt SNARE binding linked neurological disease Another CD225 member interferoninduced transmembrane protein 3 IFITM3 protects cell influenza virus infection IFITM3 interacts SNARE protein mediate late endosomelate endosome homotypic fusion late endosomelysosome heterotypic fusion IFITM3 bind syntaxin 7 STX7 cell vitro mutation abrogate STX7 binding cause loss antiviral activity influenza virus Mechanistically IFITM3 disrupts assembly SNARE complex controlling homotypic fusion accelerates trafficking endosomal cargo lysosomes result suggest SNARE modulation play previously unrecognized role diverse function performed CD225 proteins",
        "mesh_terms": [
            "Endosomes",
            "Humans",
            "Membrane Proteins",
            "Membrane Fusion",
            "RNA-Binding Proteins",
            "Qa-SNARE Proteins",
            "SNARE Proteins",
            "Influenza A virus",
            "Animals",
            "Lysosomes",
            "HEK293 Cells",
            "Protein Binding",
            "Protein Domains"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39653855/"
    },
    {
        "pmid": "39647217",
        "title": "The evolution of hemagglutinin-158 and neuraminidase-88 glycosylation sites modulates antigenicity and pathogenicity of clade 2.3.2.1 H5N1 avian influenza viruses.",
        "abstract": "Clade 2321 H5N1 avian influenza virus AIV evolved several subclades However effect glycosylation biological characteristic hemagglutinin HA andor neuraminidase NA H5N1 AIVs remains unclear Here determined global prevalence clade 2321 H5N1 AIVs deglycosylated residue 158 HA HA158 glycosylated residue 88 NA NA88 predominant via multiple sequence analysis deglycosylation residue NA 88 NA88 observed clade 2321a new clade 2321e H5N1 AIVs Interestingly NA88 coupled acquisition 158 glycosylation site HA HA158 clade 2321e H5N1 AIVs China clade 2321a new H5N1 AIVs exhibiting HA158NA88 pattern predominant Bangladesh Meanwhile temporal distribution strain HA158 NA88 highly consistent implementation Re6 vaccine China recombinant H5N1 AIVs constructed using reverse genetic system showed acquisition HA158 glycosylation site facilitated viral evasion Re6 antisera virus lacking glycosylation site HA158 NA88 resulted reduced NA activity replication mammalian cells pathogenicity chicken mouse compared virus alternative glycosylation patterns Therefore acquisition HA158 clade 2321e H5N1 AIVs enables evasion Re6 vaccination pressure virulence clade 2321 H5N1 AIVs modulated absence glycosylation site HA158 NA88 finding highlighted importance epidemiological surveillance timely updating vaccine H5 AIVs",
        "mesh_terms": [
            "Animals",
            "Neuraminidase",
            "Influenza A Virus, H5N1 Subtype",
            "Glycosylation",
            "Hemagglutinin Glycoproteins, Influenza Virus",
            "Influenza in Birds",
            "Chickens",
            "Virulence",
            "Mice",
            "Evolution, Molecular",
            "China",
            "Phylogeny",
            "Mice, Inbred BALB C"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39647217/"
    },
    {
        "pmid": "39645377",
        "title": "Burden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021.",
        "abstract": "capacity anticipate future health issue important policy maker practitioner USA insight facilitate effective planning investment implementation strategies Forecasting trend disease injury burden crucial policy maker also garner substantial interest general populace lead betterinformed public integration new data sources refinement methodologies inclusion additional causes improved previous forecasting effort within scope Global Burden Diseases Injuries Risk Factors Study GBD produce forecast state national level USA various possible scenarios developed comprehensive framework forecasting life expectancy healthy life expectancy HALE causespecific mortality disabilityadjusted lifeyears DALYs due 359 cause disease injury burden 2022 2050 USA 50 state Washington DC Using GBD 2021 Future Health Scenarios modelling framework forecasted driver disease demographic drivers risk factors temperature particulate matter mortality year life lost YLL population nonfatal burden addition reference scenario representing probable future trajectory explored various future scenario potential impact next several decade human health alternative scenario comprised four risk elimination scenario including safer environment improved behavioural metabolic risks improved childhood nutrition vaccination combined scenario three USAspecific scenario based risk exposure attributable burden bestperforming US state improved high adult BMI high fasting plasma glucose FPG improved smoking improved drug use encompassing opioids cocaine amphetamine others Life expectancy USA projected increase 78·3 year 95 uncertainty interval 78·178·5 2022 79·9 year 79·580·2 2035 80·4 year 79·881·0 2050 sex combined increase forecasted modest compared country around world resulting USA declining global rank 202250 forecasted period among 204 country territory GBD 49th 66th projected decline female life expectancy West Virginia 1990 2050 little change Arkansas Oklahoma Additionally 2023 projected almost change female life expectancy many states notably Oklahoma South Dakota Utah Iowa Maine Wisconsin Female HALE projected decline 1990 2050 20 state remain unchanged three others Drug use disorder low back pain projected leading Level 3 cause agestandardised DALYs 2050 agestandardised DALY rate due drug use disorder projected increase considerably 2022 2050 19·5 6·934·1 combined risk elimination scenario show USA could gain 3·8 additional year 3·64·0 life expectancy 4·1 additional year 3·94·3 HALE 2050 versus reference scenario Using USAspecific scenarios forecasted USA could gain 0·4 additional year 0·30·6 life expectancy 0·6 additional year 0·50·8 HALE 2050 improved drug use scenario relative reference scenario Life expectancy HALE likewise projected 0·40·5 year higher 2050 improved adult BMI FPG improved smoking scenario compared reference scenario However increase scenario would substantially improve USAs global ranking 2050 from 66th 204 life expectancy reference scenario 63rd64th three USAspecific scenarios indicating USAs bestperforming state still lagging behind country rank throughout forecasted period Regardless estimated 12·4 million 11·313·5 death could averted 2022 2050 USA follow combined scenario trajectory rather reference scenario would also 1·4 million 0·72·2 fewer death 28year forecasted period improved adult BMI FPG 2·1 million 1·32·9 fewer death improved exposure smoking 1·2 million 0·91·5 fewer death lower rate drug use deaths finding highlight alarming trajectory health challenge USA which left unaddressed could lead reversal health progress made past three decade US state decline global health standing states evidence alternative scenario along published study suggests collaborative evidencebased strategies opportunity change trajectory health outcome USA investing scientific innovation healthcare access preventive health care risk exposure reduction education forecast clearly show time act now future countrys health wellbeingas well prosperity leadership position science innovationare stake Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Adult",
            "Aged",
            "Female",
            "Humans",
            "Male",
            "Middle Aged",
            "Cause of Death",
            "Disability-Adjusted Life Years",
            "Forecasting",
            "Life Expectancy",
            "Risk Factors",
            "United States",
            "Cost of Illness",
            "Population Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39645377/"
    },
    {
        "pmid": "39642540",
        "title": "Identification of novel influenza virus H3N2 nucleoprotein inhibitors using most promising epicatechin derivatives.",
        "abstract": "Influenza virus leading cause acute respiratory tract infections posing significant global health threat Current treatment option limited increasingly ineffective due viral mutations study aimed identify potential drug candidate targeting nucleoprotein H3N2 subtype Influenza virus focused epicatechin derivative employed series computational approaches including ADMET profiling druglikeness evaluation PASS predictions molecular docking molecular dynamic simulations Principal Component Analysis PCA dynamic crosscorrelation matrix DCCM analyses free energy landscape assessments Molecular docking dynamic simulation revealed strong stable binding interaction derivative target protein complex 01 81 exhibiting highest binding affinities Additionally ADMET profiling indicated favorable pharmacokinetic property compounds supporting potential effective antiviral agents Compound 81 demonstrated exceptional quantum chemical descriptors including small HOMOLUMO energy gap high electronegativity significant softness suggesting high chemical reactivity strong electronaccepting capabilities property enhance Compound 81s potential interact effectively H3N2 nucleoprotein Experimental validation strongly recommended advance compound toward development novel antiviral therapy address global threat influenza",
        "mesh_terms": [
            "Influenza A Virus, H3N2 Subtype",
            "Antiviral Agents",
            "Catechin",
            "Molecular Docking Simulation",
            "Molecular Dynamics Simulation",
            "Nucleoproteins",
            "Humans",
            "Molecular Structure"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39642540/"
    },
    {
        "pmid": "39634627",
        "title": "The growing risk of avian influenza (H5N1) in dairy cows: Clinical, economic, and public health consequences.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39634627/"
    },
    {
        "pmid": "39605779",
        "title": "A systematic review on reverse-zoonosis: Global impact and changes in transmission patterns.",
        "abstract": "Reverse zoonosis zooanthroponosis transfer pathogen human animals Although less studied zoonotic diseases phenomenon pose significant risk animal public health increasing humananimal interaction driven urbanization globalization environmental change exacerbated occurrence reverse zoonosis review evaluated global impact transmission pattern reverse zoonosis highlighting anthropogenic intrinsic factor contributing emergence study performed systematic review included 91 scientific article published 2000 2022 covering viral bacterial parasitic fungal protozoal reverse zoonoses study indicated viral infections particularly respiratory virus severe acute respiratory syndrome coronavirus2 influenza highest incidence reverse zoonosis followed bacterial infection like tuberculosis methicillinresistant iStaphylococcus aureusi United States India Hong Kong among reported region reverse zoonotic events Major risk factor identified include environmental degradation climate change antimicrobial resistance global wildlife trade review underscore need enhanced surveillance systems interdisciplinary collaboration stringent regulation wildlife trade animal husbandry practice mitigate risk associated reverse zoonosis Understanding dynamic humananimal pathogen transmission crucial developing effective also sustainable strategy protect animal population well public health emerging infectious diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39605779/"
    },
    {
        "pmid": "39584394",
        "title": "Reassortment of newly emergent clade 2.3.4.4b A(H5N1) highly pathogenic avian influenza A viruses in Bangladesh.",
        "abstract": "bABSTRACTbAvian influenza active surveillance conducted Bangladesh January 2022 November 2023 livepoultry market LPMs Tanguar Haor wetlands predominant virus circulating LPMs low pathogenic avian influenza LPAI AH9N2 clade 2321a highly pathogenic avian influenza HPAI AH5N1 viruses NonH9N2 LPAIs found Tanguar Haor lower prevalence LPMs Starting June 2023 detected novel genotype clade 2344b AH5N1 virus duck LPMs HA NA gene virus related 2020 European clade 2344b H5N1 virus AEurasian WigeonNetherlands12020 Netherlands1 However analysis five gene segments sequence identified three distinct genotype BDG2 BDG3 BDG4 BDG2 virus closely related clade 2344b H5N1 virus detected Japan nearby region since November 2022 BDG3 virus reassortants gene segment Eurasian LPAI viruses BDG4 virus similar BDG2 viruses NS gene accrued contemporary Bangladeshi clade 2321a AH5N1 viruses ability clade 2344b virus displace longentrenched 2321a AH5N1 virus Bangladesh unknown",
        "mesh_terms": [
            "Bangladesh",
            "Animals",
            "Influenza in Birds",
            "Influenza A Virus, H5N1 Subtype",
            "Reassortant Viruses",
            "Phylogeny",
            "Ducks",
            "Genotype",
            "Poultry Diseases",
            "Poultry",
            "Influenza A Virus, H9N2 Subtype"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39584394/"
    },
    {
        "pmid": "39482762",
        "title": "Low detection of H5N1 virus in commercial chickens with a low-level of vaccination coverage against H5N1 virus infection in Bangladesh.",
        "abstract": "Bangladesh reported  560 H5N1 outbreak poultry eight human case since 2007 Commercial chicken farm mostly affected Commercial chicken farm across country use imported vaccine H5N1 virus however vaccine use local circulatory isolates H5N1virus Vaccination may limited effectiveness chicken mismatch term subtypes clades test this conducted mixedmethod study assess impact ongoing vaccination H5N1 virus H5N1 viral shedding freshly dropped feces chicken raised commercial farm exclusively vaccinated vaccinate chickens Initially collected vaccination coverage data active farm subdistrict eight division district 25 vaccinated 25 nonvaccinated chicken farm selected randomly sample collection sample tested detect avian influenza virus using rRTPCR total 5092 poultry farm surveyed among 1284 25 chicken farm administered vaccine H5N1 virus total 21 400 tested farm 5 chicken feces sample tested positive AIVs three positive H5N1 subtype clade 2321 three H5N1 positive farms 1 33 vaccinated 2 67 unvaccinated chicken farm administered vaccine H5N1 found protective detection H5N1 viral RNA aOR 039 95 CI 032048 H5N1 isolates clade 2321 sequenced study formed cluster vaccine strain AduckGuangdongS13222010 H5N1 Re6 overall low vaccination coverage low detection H5N1 virus commercial chicken make difficult assess effectiveness vaccine reducing H5N1 viral shedding",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39482762/"
    },
    {
        "pmid": "39482682",
        "title": "Comparative analysis of innate immune responses in Sonali and broiler chickens infected with tribasic H9N2 low pathogenic avian influenza virus.",
        "abstract": "H9N2 avian influenza virus circulating Bangladesh since 2006 affecting multiple avian specie resulting economic losses recent emergence tribasic strains along coinfections increased risk poultry health Therefore study aimed compare immune response Sonali crossbred commercial broiler chicken infected tribasic H9N2 low pathogenic avian influenza LPAI virus Following H9N2 infection proinflammatory IL6 IL8 IL1β TNFα antiviral IFNβ IFNγ cytokine expression observed trachea lungs intestine lymphoid tissue Sonali broiler chicken 1 day post infection dpi 10 dpi qPCR Sonali chicken exhibited significantly higher proinflammatory antiviral cytokine expression trachea 37 day post infection dpi broiler chicken showed lower immune responses Broiler chicken displayed prolonged IL6 IL8 IL1β expression lung 310 dpi compared Sonali chickens intestine broiler chicken showed higher IL6 IL8 expression peak 13 dpi Sonali chicken IL1β elevated 10 dpi response H9N2 viruses broiler chicken exhibited stronger early IFNβ response delayed IFNγ response lymphoid organ compared Sonali chickens suggests distinct immune profile chicken type response H9N2 infection information shed light function innate immunity pathophysiology currently circulating tribasic H9N2 virus could assist effective controlling avian influenza virus spread poultry designing vaccines",
        "mesh_terms": [
            "Animals",
            "Influenza A Virus, H9N2 Subtype",
            "Chickens",
            "Influenza in Birds",
            "Immunity, Innate",
            "Cytokines",
            "Poultry Diseases",
            "Lung",
            "Intestines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39482682/"
    },
    {
        "pmid": "39440811",
        "title": "A Strategic Framework of SARS-CoV-2 Genomic Surveillance in Bangladesh.",
        "abstract": "global pandemic caused SARSCoV2 underlined significance strict genomic surveillance track virus evolution possible emergence new variants particularly densely populated country like Bangladesh study outline strategic framework genomic surveillance track evolution virus Bangladesh June 2021 December 2022 National SARSCoV2 Variant Surveillance NSVS program involving collaboration across 4 major institute 13 hospital nationwide aimed capture variant SARSCoV2 throughout country utilizing standardized procedures modern sequencing technology stringent quality control promoting data accuracy timely detection new variant concern sequenced 2200 genomes documenting prevalence Delta variant initially followed emergence Omicron variant BA1 BA2 BA5 XBB affecting transmission rate vaccine efficacy differently clinical manifestation variant differed symptom occurring frequently Delta case vice versa Vaccinated individual affected Omicron case compared Delta cases variant responsible two major COVID19 wave country significant clinical effects Phylogenetic analysis placed local SARSCoV2 variant within global context indicating Delta variant likely entered India Omicron Europe research highlight significance collaborative surveillance strategy guiding public health choice critical role genomic analysis monitoring virus evolution shaping targeted pandemic responses Bangladeshs contribution significantly enhance global insight COVID19s genomic evolution",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "COVID-19",
            "SARS-CoV-2",
            "Genome, Viral",
            "Genomics",
            "Phylogeny",
            "Male",
            "Female",
            "Adult",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39440811/"
    },
    {
        "pmid": "39434717",
        "title": "Molecular epidemiology of avian influenza viruses and avian coronaviruses in environmental samples from migratory bird inhabitants in Bangladesh.",
        "abstract": "Migratory bird natural reservoir major respiratory virus avian influenza virus AIV avian coronavirus AvCoV Transmission virus migratory bird domestic bird increase prevalence disease cause severe economic public health concern Bangladesh study focused active surveillance major respiratory viral pathogen migratory birds molecular identification viruses phylogenetic origin conduct study 850 environmental sample 830 fecal samples 10 soil samples 10 water samples collected three consecutive winter season three division Dhaka Sylhet Mymensingh pooled according year collection locations resulting total 184 tested samples Using genespecific primer probe TaqManand SYBR Greenbased RTqPCR assays sample screened AIV AvCoV respectively 184 pooled samples 37 found positive respiratory pathogens Furthermore 37 2011 positive respiratory pathogens 1196 AIV ini  22 815 AvCoV ini  15 first time Bangladesh AIV H4N2 H4N6 AvCoVs found fecal sample migratory bird surveillance Phylogenetic analysis HA NA gene AIV polymerase gene Orf 1 AvCoV revealed strain share close phylogenetic relationship isolates wild bird Europe Asia Bangladeshi strain Eurasian ancestry might pose significant threat migratory bird flying Asian flyways might also potential source virus introduction spread poultry raised land finding emphasize significance ongoing AIV AvCoV surveillance migratory bird Bangladesh",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39434717/"
    },
    {
        "pmid": "39415853",
        "title": "Public Health Risk from Influenza Viruses: A Scientometric Analysis of Influenza Research.",
        "abstract": "Seasonal influenza novel H1N1 influenza 2009 present worldwide difficulty public health sectors difficult distinguish significant research output due rising quantity paper mentioning infectious disease aimed identify scientometric analysis influenza diseases aimed highlight progress made discipline researcher affiliated documents hindex used evaluate publication performance highly cited papers retrieved scientometric data using keywords Influenza Flu Orthomyxoviridae Antiviral agents Antiviral drugs all 59013 document retrieved Web Science 2011 2020 exported data Biblioshiny Microsoft Excel tool included source year active authors active journals countries Also made use quantitative analysis scientometric indicator knowledge mapping VOSviewer visualization software creating network visualization maps found paper written English language 402027 author listed 4443 core journals researcher found Palese P produced 155 received hindex 55 author Li highest contributions 313 publications global influenza research Europe North America productive impactful continents influenza research published journals study help hospital librarian library professional understand status research influenza given point time",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39415853/"
    },
    {
        "pmid": "39382006",
        "title": "Continuing evolution of H5N1 highly pathogenic avian influenza viruses of clade 2.3.2.1a G2 genotype in domestic poultry of Bangladesh during 2018-2021.",
        "abstract": "characterized 15 H5N1 HPAI virus different small mediumscale poultry flock across Bangladesh 20182021 based complete genome sequences antigenic relatedness H5N1 HPAI virus different timepoints analysed 20202021 4211 flock tested positive least one respiratory infections 1579 showing influenza virus 877 tested positive HPAIV H5N1 Coinfections two four pathogen detected 158 flocks Phylogeny gene constellation analysis based complete genome sequence 15 HPAI virus revealed continuing circulation H5 clade 2321a genotype G2 viruses HA protein study isolates functionally meaningful mutation caused loss Nlinked glycosylation site T156A modified antigenic site S141P mutation receptor binding pocket E193RK Consequently antigenic analysis revealed significant loss crossreactivity virus different host specie periods virus displayed oseltamivir resistance marker position V96 I97 S227 N275 N1 numbering NA protein addition PB2 M1 NS1 proteins significant mutation noticed associated polymerase activity increased virulence mammal study isolates result highlight need intensified genomic surveillance HPAI circulating poultry Bangladesh establishing appropriate control measure decrease circulation virus poultry country",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Influenza in Birds",
            "Influenza A Virus, H5N1 Subtype",
            "Poultry Diseases",
            "Phylogeny",
            "Genotype",
            "Poultry",
            "Chickens",
            "Evolution, Molecular",
            "Genome, Viral"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39382006/"
    },
    {
        "pmid": "39366729",
        "title": "Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021.",
        "abstract": "Smoking leading behavioural risk factor mortality globally accounting 175 million death nearly 4·30 billion year life lost YLLs 1990 2021 pace decline smoking prevalence slowed recent year many countries although strategy recently proposed achieve tobaccofree generations none implemented date Assessing could happen current trend smoking prevalence persist could happen additional smoking prevalence reduction occur important communicating effect potential smoking policies analysis use Institute Health Metrics Evaluations Future Health Scenarios platform forecast effect three smoking prevalence scenario allcause causespecific YLLs life expectancy birth 2050 YLLs computed scenario using Global Burden Disease Study 2021 reference life table forecast causespecific mortality scenario reference scenario forecast could occur past smoking prevalence risk factor trend continue Tobacco Smoking Elimination 2023 Elimination2023 scenario quantifies maximum potential future health benefit assuming zero percent smoking prevalence 2023 onwards whereas Tobacco Smoking Elimination 2050 Elimination2050 scenario provides estimate country considering policy steadily reduce smoking prevalence 5 Together scenario underscore magnitude health benefit could reached 2050 country take decisive action eliminate smoking 95 uncertainty interval UI estimate based 2·5th 97·5th percentile draw carried multistage computational framework Global agestandardised smoking prevalence estimated 28·5 95 UI 27·929·1 among male 5·96 5·766·21 among female 2022 reference scenario smoking prevalence declined 25·9 25·226·6 among males 30·0 26·132·1 among female 2022 2050 scenario forecast cumulative 29·3 billion 95 UI 26·832·4 overall YLLs among male 22·2 billion 20·124·6 YLLs among female period Life expectancy birth scenario would increase 73·6 year 95 UI 72·874·4 2022 78·3 year 75·980·3 2050 Elimination2023 scenario forecast 2·04 billion 95 UI 1·902·21 fewer cumulative YLLs 2050 compared reference scenario life expectancy birth would increase 77·6 year 95 UI 75·179·6 among male 81·0 year 78·583·1 among females Elimination2050 scenario forecast 735 million 675808 141 million 131154 cumulative YLLs would avoided among male females respectively Life expectancy 2050 would increase 77·1 year 95 UI 74·679·0 among male 80·8 year 78·382·9 among females Existing tobacco policy must maintained smoking prevalence continue decline forecast reference scenario addition substantial smokingattributable burden avoided accelerating pace smoking elimination Implementation new tobacco control policy crucial avoiding additional smokingattributable burden coming decade ensure gain past three decade lost Bloomberg Philanthropies Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Life Expectancy",
            "Forecasting",
            "Smoking",
            "Prevalence",
            "Female",
            "Male",
            "Global Burden of Disease",
            "Adult",
            "Middle Aged",
            "Global Health",
            "Aged",
            "Young Adult",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39366729/"
    },
    {
        "pmid": "39367477",
        "title": "Effective community-based interventions to prevent and control infectious diseases in urban informal settlements in low- and middle-income countries: a systematic review.",
        "abstract": "impact rapid urbanization taking place across world posing variegated challenges Especially term communicable disease risk concentrated urban poor area basic amenity inadequate systematic review synthesizes evidence effective communitybased intervention CBIs aimed preventing controlling infectious disease among urban poor low middleincome country LMICs systematic review conducted following PRISMA Preferred Reporting Items Systematic Reviews MetaAnalysis guidelines comprehensive search across five major database conducted capture literature CBIs published 2011 2021 Scientific article design reported type CBIs effective preventing controlling infectious disease tuberculosis diarrhea typhoid dengue hepatitis B C influenza COVID19 included Screening selection study done two pair independent researcher using predefined eligibility criteria risk bias included study assessed using modified checklist outlined Cochrane Handbook Systematic Reviews Interventions Effective Public Health Practice Project EPHPP Analysis effective CBIs guided conceptual framework integrated CBIs neglected tropical disease NTDs narrative synthesis carried out Geographical restriction limited LMICs paper published English 18260 identified papers 20 study met eligibility criterion included review Communitybased screening socioeconomic support communitybased vector control behavior change communication capacity building community health worker CHWs health education e mhealth intervention found effective CBIs Diversified CBIs found effective specific diseases including tuberculosis TB diarrhea dengue influenza ARI hepatitis B C Bundling intervention found effective specific diseases However difficult isolate effectiveness individual intervention within bundle sociocultural context considered designing implementing CBIs effectiveness intervention inextricably linked social context stakeholder dimensions broader societal issues System approach recommended emphasizing contextspecific multicomponent intervention address social determinant health Integrating intervention public health strategy community involvement crucial sustainable outcomes finding guide design future intervention better prevention control communicable disease urban poor areas PROSPERO CRD42021278689",
        "mesh_terms": [
            "Humans",
            "Developing Countries",
            "Communicable Disease Control",
            "COVID-19",
            "Community Health Services",
            "Communicable Diseases",
            "Urban Population",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39367477/"
    },
    {
        "pmid": "39304265",
        "title": "Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.",
        "abstract": "Uptodate estimate stroke burden attributable risk trend global regional national level essential evidencebased health care prevention resource allocation planning aimed provide estimate period 19902021 estimated incidence prevalence death disabilityadjusted lifeyear DALY count agestandardised rate per 100 000 people per year overall stroke ischaemic stroke intracerebral haemorrhage subarachnoid haemorrhage 204 country territory 1990 2021 also calculated burden stroke attributable 23 risk factor six risk cluster air pollution tobacco smoking behavioural dietary environmental metabolic risks global regional level 21 GBD region Sociodemographic Index SDI quintiles using standard GBD methodology 95 uncertainty interval UIs individual future estimate derived 2·5th 97·5th percentile distribution generated propagating 500 draw multistage computational pipeline 2021 stroke third common GBD level 3 cause death 7·3 million 95 UI 6·67·8 deaths 10·7 9·811·3 deaths ischaemic heart disease COVID19 fourth common cause DALYs 160·5 million 147·8171·6 DALYs 5·6 5·06·1 DALYs 2021 93·8 million 89·099·3 prevalent 11·9 million 10·713·2 incident strokes found disparity stroke burden risk factor GBD region country territory SDI well stagnation reduction incidence 2015 onwards even increase stroke incidence death prevalence DALY rate southeast Asia east Asia Oceania country lower SDI people younger 70 years Globally ischaemic stroke constituted 65·3 62·467·7 intracerebral haemorrhage constituted 28·8 28·328·8 subarachnoid haemorrhage constituted 5·8 5·76·0 incident strokes substantial increase DALYs attributable high BMI 88·2 53·4117·7 high ambient temperature 72·4 51·1 179·5 high fasting plasma glucose 32·1 26·738·1 diet high sugarsweetened beverage 23·4 12·735·7 low physical activity 11·3 1·834·9 high systolic blood pressure 6·7 2·511·6 lead exposure 6·5 4·511·2 diet low omega6 polyunsaturated fatty acid 5·3 0·510·5 Stroke burden increased 1990 2021 contribution several risk factor also increased Effective accessible affordable measure improve stroke surveillance prevention with emphasis blood pressure lifestyle environmental factors acute care rehabilitation need urgently implemented across country reduce stroke burden Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Global Burden of Disease",
            "Risk Factors",
            "Stroke",
            "Global Health",
            "Disability-Adjusted Life Years",
            "Incidence",
            "Prevalence",
            "Quality-Adjusted Life Years",
            "Male",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39304265/"
    },
    {
        "pmid": "39298357",
        "title": "Wastewater Surveillance for Influenza A Virus and H5 Subtype Concurrent with the Highly Pathogenic Avian Influenza A(H5N1) Virus Outbreak in Cattle and Poultry and Associated Human Cases - United States, May 12-July 13, 2024.",
        "abstract": "part response highly pathogenic avian influenza AH5N1 virus outbreak US cattle poultry associated human cases CDC partner monitoring influenza virus level detection H5 subtype wastewater Among 48 state District Columbia performed influenza testing wastewater May 12July 13 2024 weekly average 309 site 38 state sufficient data analysis 11 site four state reported high level influenza virus H5 subtype testing conducted 203 site 41 states H5 detection 24 site nine states detection high level CDC state local health department evaluated data influenza surveillance system partnered wastewater utility agriculture department investigate potential sources Among four state high influenza virus level detected wastewater three state corresponding evidence human influenza activity influenza surveillance systems Among 24 site H5 detections 15 identified animal source within sewershed adjacent county including eight milkprocessing inputs Data early investigation help health official optimize use wastewater surveillance upcoming respiratory illness season",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Disease Outbreaks",
            "Wastewater",
            "Cattle",
            "United States",
            "Influenza, Human",
            "Poultry",
            "Influenza A Virus, H5N1 Subtype",
            "Influenza in Birds",
            "Influenza A virus",
            "Cattle Diseases",
            "Wastewater-Based Epidemiological Monitoring",
            "Poultry Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39298357/"
    },
    {
        "pmid": "39207215",
        "title": "Phylodynamics of high pathogenicity avian influenza virus in Bangladesh identifying domestic ducks as the amplifying host reservoir.",
        "abstract": "High pathogenicity avian influenza HPAI virus H5N1 first emerged Bangladesh 2007 Despite use vaccine chicken since 2012 control HPAI HPAI H5Nx virus continued infect poultry wild birds resulting notable mass mortality house crow iCorvus splendensi first HPAI H5Nx virus Bangladesh belonged clade 222 followed clade 2342 2321 virus 2011 implementation chicken vaccination 2012 virus mostly replaced clade 2321a virus recently clade 2344b h viruses study reconstruct phylogenetic history HPAI H5Nx virus Bangladesh evaluate role major host specie maintenance evolution HPAI H5Nx virus Bangladesh reveal role heavily impacted crow virus epidemiology Epizootic wave caused HPAI H5N1 H5N6 virus amongst house crow occurred annually winter Bayesian phylodynamic analysis clade 2321a revealed frequent bidirectional viral transition domestic ducks chickens house crow markedly skewed towards ducks domestic duck might source reservoir HPAI H5Nx Bangladesh number viral transition duck chicken house crow far numerous transitions result suggest viral circulation domestic bird despite vaccination crow epizootics acting sentinel vaccination strategy need updated use effective vaccinations assess vaccine efficacy extension vaccination domestic ducks key reservoir",
        "mesh_terms": [
            "Animals",
            "Influenza in Birds",
            "Ducks",
            "Bangladesh",
            "Phylogeny",
            "Disease Reservoirs",
            "Chickens",
            "Influenza A Virus, H5N1 Subtype",
            "Crows",
            "Animals, Wild",
            "Influenza A virus",
            "Poultry Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39207215/"
    },
    {
        "pmid": "39202713",
        "title": "Antimicrobial Susceptibility and Genomic Profiles of Multidrug-Resistant <i>Staphylococcus aureus</i> from Nasopharynx of Asymptomatic Children in Dhaka, Bangladesh.",
        "abstract": "Children carrying iStaphylococcus aureusi nasopharynx higher risk contracting systemic infection Due lack sufficient information regarding carriage study conducted explore prevalence antibiotic susceptibility genomic profile iS aureusi isolated nasopharyngeal sample 163 randomly selected asymptomatic Bangladeshi child aged 515 years Antibiotic susceptibility pattern genomic analysis sample conducted using standard microbiological method genomic tools carriage confirmed 44 27 child mostly well nourished without respiratory symptom last 3 months Higher carriage observed among younger age group 510 years completed vaccine pneumonia ipi  0002 influenza ipi  0004 Among isolates 841 multidrugresistant 475 n  40 methicillinresistant iS aureusi MRSA isolates 100 resistant cefixime higher resistance ampicillin 955 penicillin 909 Among three investigated isolates two ST80 ID1 ID52 one novel strain ID19 presence iaphiSitphi iblaIi iblaZi idha1i ifosBi ilmrSi imepAi inorAi iteti38 genes current research demonstrates high incidence multidrugresistant iS aureusi report first instance ST80 asymptomatic child Bangladesh",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39202713/"
    },
    {
        "pmid": "39137554",
        "title": "Amplification of avian influenza virus circulation along poultry marketing chains in Bangladesh: A controlled field experiment.",
        "abstract": "prevalence avian influenza virus commonly found increase dramatically bird transported farm live bird markets Viral transmission dynamic along marketing chain are however poorly understood address gap implemented controlled field experiment altering chicken supply live bird market Chattogram Bangladesh Broilers backyard chicken traded along altered intervention conventional control marketing chain tested avian influenza virus different time points Upon arrival live bird market odds detecting avian influenza virus differ control intervention groups However 12 h later intervention group odds lower particularly broilers indicating viral shedding live bird market resulted partly infection occurring transport trade Curtailing avian influenza virus prevalence live bird market requires mitigating risk marketing chain node preceding chickens delivery live bird markets",
        "mesh_terms": [
            "Animals",
            "Influenza in Birds",
            "Chickens",
            "Bangladesh",
            "Poultry Diseases",
            "Prevalence",
            "Influenza A virus",
            "Transportation",
            "Animal Husbandry",
            "Virus Shedding",
            "Marketing",
            "Commerce"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39137554/"
    },
    {
        "pmid": "39134084",
        "title": "The panzootic spread of highly pathogenic avian influenza H5N1 sublineage 2.3.4.4b: a critical appraisal of One Health preparedness and prevention.",
        "abstract": "Changes epidemiology ecology H5N1 highly pathogenic avian influenza devastating wild bird poultry populations farm communities wild mammal worldwide originated farmed poultry H5N1 virus spread globally wild birds transmission many mammal avian species resulting 2024 transmission among dairy cattle associated human cases ecological change pose challenge mitigating impact H5N1 highly pathogenic avian influenza wildlife ecosystems domestic animals food security humans H5N1 highly pathogenic avian influenza highlight need One Health approach pandemic prevention preparedness emphasising multisectoral collaboration among animal environmental public health sectors Action needed reduce future pandemic risk preventing transmission highly pathogenic avian influenza among domestic wild animal people focusing upstream driver outbreaks ensuring rapid response risk assessment zoonotic outbreaks Political commitment sustainable funding crucial implementing maintaining prevention programmes surveillance outbreak responses",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Influenza A Virus, H5N1 Subtype",
            "Influenza in Birds",
            "One Health",
            "Influenza, Human",
            "Birds",
            "Animals, Wild",
            "Zoonoses",
            "Poultry",
            "Disease Outbreaks"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39134084/"
    },
    {
        "pmid": "39101088",
        "title": "Characterization of infectious laryngotracheitis virus isolated from commercial layer chickens in Bangladesh during the year 2021-2022.",
        "abstract": "Infectious laryngotracheitis virus ILTV responsible causing infectious laryngotracheitis ILT rapidly spreading extremely transmissible disease chickens current research aim isolate characterize ILTV layer chicken Bangladesh total 345 sample trachea larynx lungs collected ILTsuspected dead sick layer chicken 32 ILTsuspected farm three different outbreak district Gazipur Tangail Mymensingh Bangladesh outbreak year 20212022 Rapid detection kit examined sample avian influenza virus AIV Newcastle disease virus NDV ILTVspecific primer used screen 72 NDV AIVnegative sample polymerase chain reaction PCR Using chorioallantoic membrane CAM study isolated ILT virus 9 10dayold seronegative embryonated chicken egg ECEs using selected PCRpositive samples virus confirmed using nucleotide sequencing agar gel immunodiffusion test AGIDT viral neutralization test VNT pathogenicity evaluation using mortality index chicken embryo MICEs intratracheal pathogenicity index ITPI result indicated among PCRpositive 10 samples two AlimILT1001 AlimILT1000 found positive using ECEs two field isolates ILTVs shown amplicon size ICP4 genebased PCR phylogenetic study ICP4 gene revealed recent isolates close similarity ILTV isolates Turkey Bangladesh Australia AGIDT revealed strong precipitation line due ILTVspecific antibody reacting field viruses VNT neutralized isolates conventional ILTV antibodies pathogenicity testing indicated AlimILT1001 MICE ITPI value 077 063 whereas AlimILT1000 071 057 ILTV isolates similarity isolates Turkey Bangladesh Australia highly virulent chickens",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39101088/"
    },
    {
        "pmid": "39082530",
        "title": "Investigating whether H5N1 is a risk to human populations in Brazil.",
        "abstract": "",
        "mesh_terms": [
            "Humans",
            "Brazil",
            "Influenza A Virus, H5N1 Subtype",
            "Influenza, Human",
            "Animals",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39082530/"
    },
    {
        "pmid": "39066264",
        "title": "Role of miRNA in Highly Pathogenic H5 Avian Influenza Virus Infection: An Emphasis on Cellular and Chicken Models.",
        "abstract": "avian influenza virus particularly H5N1 strain pose significant ongoing threat human animal health Recent outbreak affected domestic wild bird massive scale raising concern virus spread mammals review focus critical role microRNAs miRNAs modulating proinflammatory signaling pathway pathogenesis influenza virus IAV emphasis highly pathogenic avian influenza HPAI H5 viral infections Current research indicates miRNAs play significant role HPAI H5 infections influencing various aspect disease process review aim synthesize recent finding impact different miRNAs immune function viral cytopathogenicity respiratory viral replication Understanding mechanism essential developing new therapeutic strategy combat avian influenza mitigate effect human animal populations",
        "mesh_terms": [
            "Animals",
            "MicroRNAs",
            "Influenza in Birds",
            "Influenza A Virus, H5N1 Subtype",
            "Chickens",
            "Humans",
            "Virus Replication",
            "Disease Models, Animal",
            "Influenza, Human",
            "Host-Pathogen Interactions"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39066264/"
    },
    {
        "pmid": "39046228",
        "title": "Unusual A(H1N7) influenza A virus isolated from free-range domestic ducks in Bangladesh, 2023.",
        "abstract": "Bangladesh freerange duck farm provide opportunity generation novel influenza virus evidenced emergence unusual AH1N7 virus 2023 Continued surveillance environment potential emergence influenza virus novel property remains priority",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39046228/"
    },
    {
        "pmid": "39024624",
        "title": "Cost-effectiveness of seasonal influenza vaccination in WHO-defined high-risk populations in Bangladesh.",
        "abstract": "Bangladesh carry substantial health economic burden seasonal influenza particularly among World Health Organization WHOdefined highrisk populations implemented modelling study determine costeffectiveness influenza vaccination five highrisk group pregnant women child five year age adult underlying health conditions older adult ≥60 years healthcare personnel inform policy decision risk group prioritisation influenza vaccination Bangladesh implemented Markov decisionanalytic model estimate impact influenza vaccination target risk group obtained model input hospitalbased influenza surveillance data unpublished surveys published literature preferentially study Bangladesh followed regional global ones used qualityadjusted life year QALY health outcome interest also estimated incremental costeffectiveness ratio ICERs risk group comparing cost QALY vaccinating compared vaccinating group ICER represents additional cost needed achieve one year additional QALY given intervention considered willingnesstopay threshold ICER less one gross domestic product GDP per caput highly costeffective one three time GDP per caput costeffective per standard Bangladesh threshold range USD 2462 USD 7386 estimated ICERs USD 99 USD 87 USD 4 USD 792 USD 229 per QALY gained healthcare personnel older adult ≥60 child aged less five years adult comorbid conditions pregnant women respectively risk groups ICERs willingnesstopay threshold Bangladesh Vaccinating pregnant woman adult comorbid condition highly costeffective per additional life year gained vaccinating healthcare personnel older adult ≥60 child five year costsaving per additional life year gained Influenza vaccination target risk group Bangladesh would either costsaving costeffective per guideline GDPbased thresholds",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Cost-Benefit Analysis",
            "Influenza, Human",
            "Female",
            "Influenza Vaccines",
            "Adult",
            "Middle Aged",
            "Child, Preschool",
            "World Health Organization",
            "Infant",
            "Quality-Adjusted Life Years",
            "Pregnancy",
            "Aged",
            "Male",
            "Vaccination",
            "Young Adult",
            "Adolescent",
            "Markov Chains",
            "Seasons",
            "Health Personnel"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39024624/"
    },
    {
        "pmid": "39021479",
        "title": "Post-discharge mortality among patients hospitalised with severe acute respiratory infection, Bangladesh, 2012-2019: a prospective observational study.",
        "abstract": "Enhancing outcome posthospitalisation requires understanding predictive factor adverse events study aimed estimate postdischarge mortality rate among patient severe acute respiratory infection SARI Bangladesh identify associated factors document reported cause death January 2012 December 2019 conducted followup call patient family 30 day discharge assess status patient SARI Proportions death within 30 day discharge estimated comparative analysis demographics clinical characteristics influenza illness decedent survivor performed using multivariable Cox regression models Among 23360 patient SARI median age 20 years IQR 1548 65 male 351 15 died hospitalisation 23009 patient alive discharge 20044 87 followed 633 32 death within 30 day discharge child 18 years difficulty breathing adjusted hazard ratio aHR 18 95 CI 1130 longer hospital stay aHR 11 95 CI 1111 heart disease aHR 85 95 CI 32231 associated higher postdischarge death risk Among adult ≥18 years difficulty breathing aHR 23 95 CI 1730 chronic obstructive pulmonary disease aHR 17 95 CI 1422 intensive care unit admission aHR 52 95 CI 19140 linked elevated postdischarge death risk Influenza virus detected 13 46351 inhospital SARI death 10 65633 postdischarge SARI deaths Nearly one twenty patient SARI died hospitalisation within 1 month discharge twothirds death occurring postdischarge Seasonal influenza vaccination recommended mitigate influenzaassociated mortality enhance postdischarge outcomes hospital consider developing safedischarge algorithms reinforcing postdischarge care plans establishing outpatient monitoring recently discharged patients Centers Disease Control Prevention CDC Atlanta Georgia USA U01GH002259",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39021479/"
    },
    {
        "pmid": "39013116",
        "title": "South Asia's COVID-19 History and Surveillance: Updated Epidemiological Assessment.",
        "abstract": "study update finding COVID19 pandemic surveillance first conducted South Asia 2020 2 additional year data region assess whether COVID19 transitioned pandemic endemic point World Health Organization WHO ended public health emergency status COVID19 May 5 2023 First aim measure whether expansion contraction pandemic South Asia around declaration Second use dynamic genomic surveillance method describe history pandemic region situate window declaration within broader history Third aim provide historical context course pandemic South Asia addition updating traditional surveillance data dynamic panel estimate original study study used data sequenced SARSCoV2 variant Global Initiative Sharing Influenza Data GISAID identify appearance duration variant concern used Nextclade nomenclature collect clade designation sequence Pangolin nomenclature lineage designation SARSCoV2 Finally conducted 1sided test determine whether regional weekly speed transmission rate per 100000 population greater outbreak threshold 10 ran test iteratively 6 month data across sample period Speed region remained outbreak threshold year time declaration Acceleration jerk also low stable 1day persistence coefficient remained statistically significant positive 1168 7day persistence coefficient negative 0185 suggesting limited cluster effect case given day predict case 7 day forward Furthermore shift parameter either 2 recent week around May 5 2023 indicate overall change persistence measure around time declaration December 2021 onward Omicron predominant variant concern sequenced viral samples rolling test speed equal 10 statistically insignificant across entire pandemic COVID19 continued circulate South Asia rate transmission remained outbreak threshold well year ahead declaration COVID19 endemic region longer reach threshold pandemic definition standard enhanced surveillance metric confirm pandemic ended time declaration Prevention policy focus ahead future pandemics point policy emphasize epidemiological task force widespread testing contacttracing system",
        "mesh_terms": [
            "COVID-19",
            "Humans",
            "Asia",
            "SARS-CoV-2",
            "Pandemics",
            "Population Surveillance",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39013116/"
    },
    {
        "pmid": "39010948",
        "title": "Farm biosecurity practices affecting avian influenza virus circulation in commercial chicken farms in Bangladesh.",
        "abstract": "Avian influenza virus AIV major concern livestock wildlife human health many country world including Bangladesh AIV endemic poultry requiring improving biosecurity Bangladesh investigated variation biosecurity practice commercial chicken farm affected AIV infection status help guide AIV mitigation strategies collected pooled fecal swab 225 farm tested sample AIV matrix gene followed H5 H7 H9 subtyping using rRTPCR found 396 chicken farm AIV positive 13 14 positive subtypes H5 H9 respectively Using generalized linear mixed effect model identified many 12 significant AIV risk factors Two major factor promoting AIV risk cannot easily addressed short term farm size proximity farm live bird market However ten significant determinant AIV risk readily addressed important one limiting access visitor reducing predicted AIV risk 42 6 isolation treatment sick bird 42 7 prohibiting access vehicle poultry shed 38 8 improving hand hygiene from 42 9 sharing farm worker across farm 37 8 limiting access wild bird poultry shed 37 8 finding applied developing practical costeffective measure significantly decrease prevalence AIV chicken farms Notably setting limited resources Bangladesh measure help government strengthen biosecurity practice poultry industry limit possibly prevent spread AIV",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39010948/"
    },
    {
        "pmid": "39005150",
        "title": "Incidence of Hospitalization due to Influenza-Associated Severe Acute Respiratory Infection During 2010-2019 in Bangladesh.",
        "abstract": "Global influenzaassociated acute respiratory infection contribute 35 million severe illness requiring hospitalization annually 90 hospitalization occurring among child  5 year developing countries Bangladesh inadequate availability nationally representative robust estimate influenzaassociated hospitalization limit allocation resource prevention control measures study used data hospitalbased influenza surveillance HBIS system Bangladesh 2010 2019 healthcare utilization survey determine hospital utilization pattern catchment area estimated annual influenzaassociated hospitalization number rate age group Bangladesh using methods adjusted 6dayaweek enrollment schedule selective testing specimen child five healthcareseeking behavior based proportion symptomatic community participant seeking healthcare within past week estimated national hospitalization rate multiplying agespecific hospitalization rate corresponding annual national census population Annual influenzaassociated hospitalization rate per 100000 population age ranged 31 95 CI 2736 2011 139 95 CI 130149 2019 Children  5 year old highest rate influenzaassociated hospitalization ranging 114 95 CI 90138 2011 529 95 CI 481578 2019 followed adult aged ≥ 65 year rate ranging 46 95 CI 3457 2012 252 95 CI 213292 2019 national hospitalization estimate age 20102019 ranged 47891 236380 per year impact influenzaassociated hospitalization Bangladesh may considerable particularly young child older adults Targeted interventions influenza vaccination age groups prioritized evaluated",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Hospitalization",
            "Influenza, Human",
            "Child, Preschool",
            "Child",
            "Infant",
            "Adult",
            "Incidence",
            "Adolescent",
            "Middle Aged",
            "Young Adult",
            "Aged",
            "Female",
            "Male",
            "Respiratory Tract Infections",
            "Infant, Newborn",
            "Aged, 80 and over",
            "Acute Disease"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39005150/"
    },
    {
        "pmid": "39000138",
        "title": "Exploring the Efficacy of Peptides and Mimics against Influenza A Virus, Adenovirus, and Murine Norovirus.",
        "abstract": "ongoing battle viral pandemic continues possibility future outbreaks search effective antiviral compound combat diverse range virus continues focal point research study investigated efficacy two natural antimicrobial peptide AMPs lactoferricin LL37 two synthetic AMPs melimine Mel4 nine AMP mimic 758 1091 1096 1083 610 NAPL 3BIPL 4BIPL Sau22 influenza virus strain H1N1 H3N2 human adenovirus 5 HAdV5 murine norovirus 1 MNV1 compound tested using virus pretreatment cell pretreatment postcell entry treatment assays electron microscopy circular dichroism CD alongside evaluation cytotoxicity host cells virus pretreatment AMP mimic 610 Sau22 relatively low ICsub50sub value influenza strain H1N1 235 693 µM respectively H3N2 37 534 µM respectively Conversely natural synthetic AMPs active strains nonenveloped viruses AMP Mel4 mimic 1083 moderate activity HAdV5 Mel4 ICsub50sub  474 µM 1083 ICsub50sub  472 µM whereas AMPs none mimics active norovirus LL37 ICsub50sub  42 µM lactoferricin ICsub50sub  2318 µM melimine ICsub50sub  48 µM Mel4 ICsub50sub  86 µM Transmission electron microscopy demonstrated mimic targeted outer envelope influenza viruses AMPs targeted capsid nonenveloped viruses CD showed Mel4 adopted αhelical structure membrane mimetic environment mimic 758 remained unstructured diverse activity different virus group probably influenced charge hydrophobicity size and case natural synthetic AMPs secondary structure finding underscore potential peptide mimic promising candidate antiviral therapeutic enveloped nonenveloped viruses",
        "mesh_terms": [
            "Norovirus",
            "Animals",
            "Humans",
            "Mice",
            "Antiviral Agents",
            "Influenza A virus",
            "Antimicrobial Peptides",
            "Influenza A Virus, H3N2 Subtype",
            "Dogs",
            "Adenoviridae",
            "Influenza A Virus, H1N1 Subtype",
            "Madin Darby Canine Kidney Cells",
            "Antimicrobial Cationic Peptides"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39000138/"
    },
    {
        "pmid": "38983680",
        "title": "Prevalence of influenza and other acute respiratory illnesses in patients with acute myocardial infarction in Bangladesh: A cross-sectional study.",
        "abstract": "Several study imply influenza respiratory illness could lead acute myocardial infarction AMI data lowincome country scarce investigated prevalence recent respiratory illness confirmed influenza AMI patients also exploring relationship infarction severity defined STelevation MI STEMI high troponin levels crosssectional study held Dhaka tertiary hospital May 2017 October 2018 involved AMI inpatients study examined selfreported clinical respiratory illness CRI week AMI onset confirmed influenza using baseline realtime reverse transcription polymerase chain reaction qRTPCR 744 patients 113 reported recent CRI prominently 2017 influenza season 357 qRTPCR testing found evidence influenza 15 546 patients positive among STEMI cases Frequencies CRI higher patient STEMI high troponin levels although relationship statistically significant adjusting variables risk STEMI significantly greater influenza season unadjusted analysis relative risk 109 95 confidence interval CI 102118 however relationship significant adjusted analysis adjusted relative risk 103 95 CI 091116 Bangladesh many AMI patient recent respiratory illness history showing evidence influenza However illness showed significant relationship AMI severity research needed understand relationship better investigate potential benefit infection control measure influenza vaccination reducing AMI incidence",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38983680/"
    },
    {
        "pmid": "38920751",
        "title": "RSV Infection in Refugees and Asylum Seekers: A Systematic Review and Meta-Analysis.",
        "abstract": "Respiratory diseases including respiratory syncytial virus RSV infections common reason seeking healthcare among refugee asylum seekers systematic review metaanalysis designed appraise available evidence RSV infection among individual refugee camps Three medical database PubMed Embase Scopus well preprint repository medRxivorg searched eligible observational studies collected case pooled randomeffects metaanalysis model Heterogeneity assessed using Isup2sup statistics Funnel plot regression analysis calculated analyzing reporting bias Eventually six study retrieved three area Bangladesh Thailand Kenya pooled estimate 129704 case per 1000 sample 95 CI 66393 237986 RSV compared 110287 per 1000 people influenza 95 CI 73186 162889 136398 case per 1000 people 95 CI 84510 212741 human adenovirus HAdV 69553 per 1000 people 95 CI 49802 96343 parainfluenzavirus PIFV 60338 per 1000 people 95 CI 31933 111109 human metapneumovirus hMPV Using influenza reference group risk positive specimen greater RSV relative risk RR 1514 95 CI 1396 1641 HAdV RR 1984 95 CI 1834 2146 lower influenza B RR 0276 95 CI 0239 0319 PIFV RR 0889 95 CI 0806 0981 hMPV RR 0594 95 CI 0534 0662 summary high rate RSV infection documented among individual sheltered refugee camps stressing importance specifically designed preventive strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38920751/"
    },
    {
        "pmid": "38899002",
        "title": "Spatio-temporal pattern and associate meteorological factors of airborne diseases in Bangladesh using geospatial mapping and spatial regression model.",
        "abstract": "Airborne disease due climate change pose significant public health challenge Bangladesh Little known spatiotemporal pattern airborne disease district level country Therefore study aimed investigate spatiotemporal pattern associated meteorological factor airborne disease Bangladesh using exploratory analysis spatial regression models study used districtlevel reported case airborne disease meningococcal measles mumps influenza tuberculosis encephalitis meteorological data temperature relative humidity wind speed precipitation 2017 2020 Geospatial mapping spatial error regression model utilized analyze data 2017 2020 total 315 meningococcal 5159 measles 1341 mumps 346 influenza 4664 tuberculosis 229 encephalitis case reported Bangladesh Among airborne diseases measles demonstrated highest prevalence featuring higher incidence rate coastal Bangladeshi district Lakshmipur Patuakhali Coxs Bazar well Maulvibazar Bandarban district 2017 2020 contrast tuberculosis TB emerged second prevalent disease higher incidence rate observed district Khagrachhari Rajshahi Tangail Bogra Sherpur spatial error regression model revealed among climate variables mean iβi  956 standard error SE 348 maximum temperature iβi  119 SE 040 significant risk factor airborne disease Bangladesh Maximum temperature positively influenced measles iβi  274 SE 139 whereas mean temperature positively influenced meningococcal iβi  557 SE 250 mumps iβi  1199 SE 313 diseases finding study provide insight planning early warning prevention control strategy combat airborne disease Bangladesh similar endemic countries Preventive measure enhanced monitoring taken highrisk district airborne disease country",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38899002/"
    },
    {
        "pmid": "38892096",
        "title": "Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection.",
        "abstract": "Influenza virus IAVs pose significant global threat human health tightly controlled host immune response critical avoid detrimental effect IAV infection critical investigate association response Tolllike receptor TLRs influenza virus TLRs may act doubleedged sword balanced TLR response critical overall benefit host Consequently thorough understanding TLR response essential targeting TLRs novel therapeutic prophylactic intervention date limited number study assessed TLR IAV interactions Therefore research TLR interaction IAV infection conducted determine role hostvirus interaction disease causation clearance virus Although influenza virus vaccine available limited efficacy enhanced improve efficacy study discus current status understanding TLR response IAV infection strategy adopted IAVs avoid TLRmediated immune surveillance may help devising new therapeutic preventive strategies Furthermore recent advance use TLR agonist vaccine adjuvant enhance influenza vaccine efficacy discussed",
        "mesh_terms": [
            "Humans",
            "Toll-Like Receptors",
            "Influenza, Human",
            "Animals",
            "Influenza Vaccines",
            "Influenza A virus",
            "Host-Pathogen Interactions",
            "Immunity, Innate",
            "Signal Transduction"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38892096/"
    },
    {
        "pmid": "38846423",
        "title": "Modifiable risk factors for asthma exacerbations during the COVID-19 pandemic: a population-based repeated cross-sectional study using the Research and Surveillance Centre primary care database.",
        "abstract": "substantial reduction asthma exacerbation COVID19 pandemic reason remain poorly understood investigated change modifiable risk factor might help explain reduction asthma exacerbations Multilevel generalised linear mixed model fitted examine change modifiable risk factor asthma exacerbation 20202022 compared prepandemic year 2019 using observational routine data general practice OxfordRoyal College General Practitioners Research Surveillance Centre Asthma exacerbation defined GP recorded asthma exacerbations prescription prednisolone accident emergency department attendance hospitalisation asthma Modifiable risk factor interest ownership asthma selfmanagement plan asthma annual review inhaledcorticosteroid ICS prescriptions influenza vaccination respiratorytractinfections RTI Compared 2019 n  550995 2020 n  565956 2022 n  562167 p  005 asthma exacerbation declined 671 519 611 proportion people had asthma exacerbation reduced 204 151 185 asthma selfmanagement plan increased 286 377 559 ICS prescription increased 699 720 711 influenza vaccination increased 142 254 553 current smoking declined 150 145 147 lowerRTI declined 105 53 81 upperRTI reduced 107 58 76 cluster effect GP practice asthma exacerbation p  0001 People asthma likely p  005 exacerbation LRTI seven timesx URTI ILI both twice current smoker 14x PPV vaccinated 13x seasonal flu vaccinated 101x took ICS 13x asthma review 109x People asthma less likely exacerbation selfmanagement plan 7 partially 4 fully COVID19 vaccinated identified change modifiable risk factor asthma exacerbation need maintained postpandemic era Asthma UK Centre Applied Research Health Data Research UK",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38846423/"
    },
    {
        "pmid": "38808441",
        "title": "Recent Insights into the Antimicrobial Properties of Phyllanthus emblica L.: A Comprehensive Review of Wonder Berry.",
        "abstract": "Phyllanthus emblica L Amla known therapeutic property used medicinal plant rich vitamin C bioactive phytochemical like polyphenols gallic acid chebulagic acid leutolin quercetin etc Different part plant used treat various viral bacterial fungal diseases review article summarizes recent literature relevant antiviral antibacterial antifungal effect P emblica variety bacteria Staphylococcus aureus Bacillus subtillus Enterococcus faecalis Salmonella typhi Escherichia etc fungi Alternaria alternate Botroyodiplodia theobromae Colletotrichum corcori Curvularia lunata Fusarium exquisite Fusarium solanii Aspergillus niger Candida albicans Colletotrichum gleosparoitis Macrophomina phaseolina viruses like Influenza virus strain H3N2 hepatitis B Human Immunodeficiency virus type1 HIV1 Simplex virus type 1 HSV1 type 2 HSV2 experimented Different technique used based way identification For example disc diffusion dilution methods sound diffusion Immunoperoxidase monolayer assay serum HBV HBsAg assay enzyme immunoassay etc present review analyzed summarized antimicrobial activity P emblica possible mechanism action provide future direction translating finding clinically",
        "mesh_terms": [
            "Humans",
            "Anti-Bacterial Agents",
            "Anti-Infective Agents",
            "Antifungal Agents",
            "Antiviral Agents",
            "Bacteria",
            "Fruit",
            "Fungi",
            "Microbial Sensitivity Tests",
            "Phyllanthus emblica",
            "Plant Extracts",
            "Viruses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38808441/"
    },
    {
        "pmid": "38741656",
        "title": "The impact of current and future climates on spatiotemporal dynamics of influenza in a tropical setting.",
        "abstract": "Although driver influenza well studied highincome setting temperate regions many open question remain burden seasonality driver influenza dynamic tropics temperate climates inverse relationship specific humidity transmission explain much observed temporal spatial pattern influenza outbreaks Yet relationship fails explain seasonality lack thereof tropical subtropical countries Here analyzed eight year influenza surveillance data 12 location Bangladesh quantify role climate driving disease dynamic tropical setting distinct rainy season find strong evidence nonlinear bimodal relationship specific humidity influenza transmission Bangladesh highest transmission occurring relatively low high specific humidity values simulated influenza burden current future climate Bangladesh using mathematical model bimodal relationship humidity transmission decreased transmission high temperatures accounting change population immunity climatedriven mechanistic model accurately capture temporal spatial variation influenza activity observed across Bangladesh highlighting usefulness mechanistic model lowincome country inadequate surveillance using climate model projections also highlight potential impact climate change influenza dynamic tropic public health consequences",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38741656/"
    },
    {
        "pmid": "38698353",
        "title": "Effect of maternal vaccination on infant morbidity in Bangladesh.",
        "abstract": "Risk factor infant mortality Africa south Asian country broadly discussed However infant morbidity largely underestimated analyzed data randomized vaccine trial Bangladesh identify assess effect risk factor infant morbidity Pregnant woman randomly assigned receive either inactivated influenza vaccine pneumococcal polysaccharide vaccine infant randomly assigned receive 7valent pneumococcal conjugate vaccine Hib conjugate vaccine week 6 10 14 data collected August 2004 December 2005 pair infant mother followed 24 week birth weekly visits Generalized estimating equation GEE repeated measurement Poisson regression model used identify risk factor evaluate effect longitudinal incidence total number episode respiratory illness fever RIF diarrhea disease ear problem pneumonia total 340 pregnant woman randomized mean age 25 years baseline mother infant characteristic similar two treatment groups Exclusive breastfeeding higher paternal education level common factor associated lower infant morbidity RIF adjusted  040 094 p  001 p  002 respectively diarrhea disease adjusted  039 095 p  001 p  004 respectively ear problem adjusted  020 076 p  001 p  001 respectively Maternal influenza vaccine significantly reduced incidence RIF adjusted  054 p  001 diarrhea disease ear problem p  005 Female infant lower incidence diarrhea disease adjusted  067 p  001 ear problem adjusted  012 p  001 Maternal influenza vaccination exclusive breastfeeding female children higher paternal education level significantly reduced infant morbidity within 24 week birth Bangladesh",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Female",
            "Pregnancy",
            "Adult",
            "Infant",
            "Influenza Vaccines",
            "Pneumococcal Vaccines",
            "Risk Factors",
            "Infant, Newborn",
            "Young Adult",
            "Morbidity",
            "Vaccination",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38698353/"
    },
    {
        "pmid": "38693163",
        "title": "Modelling the transmission dynamics of H9N2 avian influenza viruses in a live bird market.",
        "abstract": "H9N2 avian influenza virus AIVs major concern poultry sector human health country subtype endemic fitting model simulating H9N2 AIV transmission data field experiment characterise epidemiology virus live bird market Bangladesh Many supplied bird arrive already exposed H9N2 AIVs resulting many broiler chicken entering market infected many indigenous backyard chicken entering preexisting immunity susceptible chicken become infected within one day spent market owing high level viral transmission within market short latent periods brief 53 hours Although H9N2 AIV transmission substantially reduced moderate level cleaning disinfection effective risk mitigation also requires range additional intervention targeting market node along poultry production distribution network",
        "mesh_terms": [
            "Animals",
            "Influenza A Virus, H9N2 Subtype",
            "Influenza in Birds",
            "Chickens",
            "Bangladesh",
            "Poultry Diseases",
            "Models, Biological"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38693163/"
    },
    {
        "pmid": "38664271",
        "title": "Phylogeography and gene pool analysis of highly pathogenic avian influenza H5N1 viruses reported in India from 2006 to 2021.",
        "abstract": "India reported highly pathogenic avian influenza HPAI H5N1 virus outbreak since 2006 first human case reported 2021 included virus belonging clade 22 222 2221 2321a 2321c currently data gene pool HPAI H5N1 virus India Molecular clock phylogeography analysis HA NA genes phylogenetic analysis internal gene H5N1 virus India carried out Sequences reported 2006 2015 sequence 2021 available online database used analysis Five separate introduction H5N1 virus India observed via Indonesia Korea 2002 Bangladesh 2009 Bhutan 2010 China 2013 2018 clades 22 222 2221 2321a 2321c 2344b Phylogenetic analysis revealed eight reassortant genotypes H5N1 virus isolated human case showed unique reassortant genotype Amino acid marker associated adaptation mammal also present first report spatiotemporal origin gene pool analysis H5N1 virus India highlighting need increased molecular surveillance",
        "mesh_terms": [
            "India",
            "Influenza A Virus, H5N1 Subtype",
            "Animals",
            "Influenza in Birds",
            "Phylogeography",
            "Phylogeny",
            "Humans",
            "Influenza, Human",
            "Genotype",
            "Reassortant Viruses",
            "Neuraminidase",
            "Hemagglutinin Glycoproteins, Influenza Virus",
            "Birds",
            "Disease Outbreaks"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38664271/"
    },
    {
        "pmid": "38585332",
        "title": "Avian Influenza A (H5N1) Outbreak 2024 in Cambodia: Worries Over the Possible Spread of the Virus to Other Asian Nations and the Strategic Outlook for its Control.",
        "abstract": "Asia alarmed resurgence avian influenza H5N1 Cambodia 2024 H5N1 could swiftly transmitted wild bird poultry population along migration route via infection Circulation endemic H5N1 Asian poultry facilitates recurrent human transmission Cambodias role reservoir heightens potential danger uncoordinated containment surveillance across Southeast Asia correspondence address risk factors seasonal patterns transmission dynamics potential pathway global dissemination H5N1 underscore criticality supervising regional initiative aimed eliminating virus poultry humans potential escalation deadly influenza pandemic across Asia",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38585332/"
    },
    {
        "pmid": "38562199",
        "title": "Global vaccine coverage and childhood survival estimates: 1990-2019.",
        "abstract": "quantify association reduction child mortality routine immunization across 204 country territory 1990 2019 used child mortality vaccine coverage data Global Burden Disease Study used modified child survival framework applied mixedeffects regression model estimate reduction death child younger 5 year associated eight vaccines 1990 2019 diphtheriatetanuspertussis DTP measles rotavirus iHaemophilus influenzaei type b vaccine significantly associated estimated 869 95 confidence interval CI 572 1324 million fewer death child younger 5 year worldwide decrease represented 242 95 CI 198 289 reduction death relative scenario without vaccines DTP measles vaccine averted 467 95 CI 300 727 million 379 95 CI 254 568 million deaths respectively total reduction child mortality associated vaccines 842 95 CI 830 851 occurred 73 country supported Gavi Vaccine Alliance estimated 454 95 CI 298 692 million fewer death 2000 2019 largest reduction death associated four vaccine India China Ethiopia Pakistan Bangladesh in order size reduction Vaccines continue reduce childhood mortality significantly especially Gavisupported countries emphasizing need increased investment routine immunization programmes",
        "mesh_terms": [
            "Child",
            "Humans",
            "Infant",
            "Immunization Programs",
            "Vaccination",
            "Measles Vaccine",
            "Child Mortality",
            "Whooping Cough",
            "Measles",
            "Diphtheria-Tetanus-Pertussis Vaccine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38562199/"
    },
    {
        "pmid": "38550782",
        "title": "Association of biosecurity and hygiene practices with avian influenza A/H5 and A/H9 virus infections in turkey farms.",
        "abstract": "High pathogenicity avian influenza HPAI H5N1 outbreak pose significant threat health livestock wildlife humans Avian influenza virus AIVs enzootic poultry many countries including Bangladesh necessitating improved farm biosecurity measures However comprehension biosecurity hygiene practices well infection AIV turkey farms poorly understood Bangladesh Therefore conducted study determine prevalence AIV subtypes association biosecurity hygiene practice turkey farms collected oropharyngeal cloacal swab individual turkey 197 farm across 9 district Bangladesh March August 2019 tested swab sample AIV matrix gene M gene followed H5 H7 H9 subtypes using realtime reverse transcriptasepolymerase chain reaction rRTPCR found 2468 95 CI21542804 turkey sample AIV positive followed 595 95 CI 433797 H5 681 95 CI 506893 H9 subtype AH7 found Using generalized linear mixed model determined 10 significant risk factor associated AIV circulation turkey farms found absence sick turkeys presence footbaths absence nearby poultry farms concrete flooring avoidance mixing newly purchased turkey existing stock substantially reduce risk AIV circulation turkey farm odds ratio ranging 002 008 Furthermore absence nearby live bird markets limiting wild bird access visitor access improved floor cleaning frequency equipment disinfection practice also substantial impact lowering AIV risk farm odds ratio ranging 010 013 result study underscore importance implementing feasible costeffective biosecurity measure aimed reducing AIV transmission turkey farms Particularly resourceconstrained environment Bangladesh finding might assist governmental entity enhancing biosecurity protocol within poultry sector hence mitigating potentially averting transmission AIV spillover humans",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38550782/"
    },
    {
        "pmid": "38482525",
        "title": "H10N5 and H3N2 Outbreak 2024: The First-Ever Co-Infection With Influenza A Viruses Has Been Culpable for the Contemporary Public Health Crisis.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38482525/"
    },
    {
        "pmid": "38389580",
        "title": "A highly pathogenic avian influenza virus H5N1 clade 2.3.4.4 detected in Samara Oblast, Russian Federation.",
        "abstract": "Avian influenza AI global problem impacting bird mammals causing economic loss commercial poultry farm backyard settings 2022 8500 AI case reported worldwide H5 subtype responsible many outbreak wild domestic birds territory Russian Federation outbreak AI massively reported since 2020 among domestic bird specie wild bird species Wild migratory bird often serve natural reservoir AI viruses interaction bird specie lead emergence new highly pathogenic variant genetic recombination strains order combat widespread outbreak disease potential risk spread 2021 monitoring study conducted Samara Oblast southeastern region European Russian Federation study aimed diagnose characterize circulating AI virus variant among wild migratory bird waterfowl hunting area mass nesting Among 98 shot birds highly pathogenic AH5N1 AI virus detected Eurasian Teal Bolshechernigovsky district classified clade 2344 based cleavage site structure HA Phylogenetic analysis showed high relatedness identified strain Samara Oblast field isolates Russia Nigeria Bangladesh Benin article emphasizes importance monitoring AI virus spread wild poultry highlighting need timely information exchange assess risks comprehensive study necessary understand virus dissemination pathways",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38389580/"
    },
    {
        "pmid": "38381804",
        "title": "EPINEST, an agent-based model to simulate epidemic dynamics in large-scale poultry production and distribution networks.",
        "abstract": "rapid intensification poultry production raise important concern associated risk zoonotic infections Here introduce EPINEST EPIdemic NEtwork Simulation poultry Transportation systems agentbased modelling framework designed simulate pathogen transmission within realistic poultry production distribution networks provide example application broiler production Bangladesh modular structure model allows easy parameterization suit specific country system configurations Moreover framework enables replication wide range ecoepidemiological scenario incorporating diverse pathogen lifehistory traits mode transmission interaction multiple strain andor pathogens EPINEST developed context interdisciplinary multicentre study conducted Bangladesh India Vietnam Sri Lanka facilitate investigation spreading pattern various health hazard avian influenza Campylobacter Salmonella antimicrobial resistance countries Furthermore modelling framework hold potential broader application veterinary epidemiology One Health research extending relevance beyond poultry encompass livestock specie disease systems",
        "mesh_terms": [
            "Animals",
            "Poultry",
            "Chickens",
            "Influenza in Birds",
            "Zoonoses",
            "Epidemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38381804/"
    },
    {
        "pmid": "38361592",
        "title": "Monitoring and evaluation practices and operational research during public health emergencies in southeast Asia region (2012-2022) - a systematic review.",
        "abstract": "systematic review aimed explore monitoring evaluation ME operational research OR practice public health emergency PHE southeast Asian region SEAR last decade searched electronic database grey literature source study published 2012 2022 study written English included narrative synthesis undertaken total 29 study included review Among 25 study documented ME four study documented practices majority study India Bangladesh evidence found Sri Lanka Bhutan Myanmar TimorLeste ME surveillance program identified among PHE due COVID19 prevalent ME conducted response COVID19 cholera Nipah Ebola iCandida aurisi hepatitis A practice minimal reported India Indonesia India conducted COVID19 malaria whereas Indonesia focused COVID19 influenza SEAR country mechanism conducting ME noticeable limitation practices compelling need develop standard framework ME Additionally enhancing private sector engagement crucial strengthening preparedness PHE Furthermore necessity increase awareness importance conducting ME PHE",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38361592/"
    },
    {
        "pmid": "38342716",
        "title": "Influenza vaccination during the 2021/22 season: A data-linkage test-negative case-control study of effectiveness against influenza requiring emergency care in England and serological analysis of primary care patients.",
        "abstract": "present England 202122 endofseason adjusted vaccine effectiveness aVE laboratory confirmed influenza related emergency care use child aged 117 adult aged 50 serological finding vaccinated v unvaccinated adult hemagglutination inhibition assay Influenza vaccination routinely offered child aged 210 year adult aged 65 year  England 202122 offer extended child age 15 years adult aged 5064 years Influenza activity rose latter half 202122 season remaining comparatively low due COVID19 pandemic control measures Influenza AH3N2 strain predominated test negative design used estimate aVE vaccine type Cases control identified within sentinel laboratory surveillance system Vaccine history obtained National Immunisation Management Service NIMS influenza COVID19 vaccine registry linked emergency department presentation excluding accidents respiratory swabbing ≤ 14 day ≤ 7 day presentation Amongst adults 423 positive 32917 negative sample eligible inclusion 145 positive 6438 negative sample among children admitted hospital identified serology circulating AH3N2 ABangladesh40052020like strain 61  current season adult vaccinee titre ≥ 140 compared 17  unvaccinated 202021 202122 p  0001 found good protection influenza vaccination influenza requiring emergency care child 727  95  CI 527 843  modest effectiveness adult 261  95  CI 45 428  Adult higher AH1N1 81  95  CI 50 93  AH3N2 33  95  CI 6 53  Consistent protection observable across preschool primary secondary school aged children Imperfect test specificity combined low prevalence may biased estimate towards null limited influenza circulation study could determine difference vaccine types",
        "mesh_terms": [
            "Adult",
            "Child",
            "Child, Preschool",
            "Humans",
            "Influenza, Human",
            "Case-Control Studies",
            "Seasons",
            "Influenza A Virus, H1N1 Subtype",
            "Influenza A Virus, H3N2 Subtype",
            "COVID-19 Vaccines",
            "Pandemics",
            "Influenza Vaccines",
            "England",
            "Emergency Medical Services",
            "Vaccination",
            "Primary Health Care"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38342716/"
    },
    {
        "pmid": "38285519",
        "title": "Risk Factors for Poor Outcomes in Children Hospitalized With Virus-associated Acute Lower Respiratory Infections: A Systematic Review and Meta-analysis.",
        "abstract": "Acute lower respiratory infection ALRI caused respiratory virus among common cause hospitalization mortality children aimed identify risk factor poor outcome child 5 year old hospitalized ALRI caused respiratory syncytial virus RSV influenza severe acute respiratory syndrome coronavirus 2 SARSCoV2 searched Embase Medline Global Health database included observational study reporting risk factor poor outcome defined use supplemental oxygen mechanical ventilation intensive care unit admission prolonged hospital stay mortality published January 2011 January 2023 Two author independently extracted data study characteristics outcome risk factors Due limited data metaanalyses conducted RSVALRI poor outcome risk factor using random effect model least 3 studies included 30 studies RSVrelated ALRI significant risk factor based metaanalysis were neurological disease odds ratio OR 614 95 confidence interval CIs 2391577 Downs syndrome 543 302976 chronic lung disease 364 1311009 immunocompromised status 341 185629 prematurity 298 193459 congenital heart disease 280 184424 underlying disease 245 194309 age 2 month 229 178294 age 6 month 208 181239 viral coinfection 201 127319 low birth weight 188 119295 underweight 180 138235 influenzarelated ALRI chronic condition age 624 month identified risk factor poor outcomes Cardiovascular disease immunosuppression chronic kidney disease diabetes high blood pressure reported risk factor mortality due SARSCoV2 associated ALRI finding might contribute development guideline prophylaxis management ALRI caused RSV influenza SARSCoV2",
        "mesh_terms": [
            "Humans",
            "Risk Factors",
            "COVID-19",
            "Hospitalization",
            "Respiratory Tract Infections",
            "Infant",
            "Respiratory Syncytial Virus Infections",
            "Child, Preschool",
            "SARS-CoV-2",
            "Influenza, Human",
            "Infant, Newborn"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38285519/"
    },
    {
        "pmid": "38281495",
        "title": "Post-mortem investigation of deaths due to pneumonia in children aged 1-59 months in sub-Saharan Africa and South Asia from 2016 to 2022: an observational study.",
        "abstract": "Child Health Mortality Prevention Surveillance CHAMPS Network programme undertakes postmortem minimally invasive tissue sampling MITS together collection antemortem clinical information investigate cause childhood death across multiple countries aimed evaluate overall contribution pneumonia causal pathway death causative pathogen fatal pneumonia child aged 159 month enrolled CHAMPS Network observational study analysed death occurring Dec 16 2016 Dec 31 2022 CHAMPS Network across six country subSaharan Africa Ethiopia Kenya Mali Mozambique Sierra Leone South Africa one South Asia Bangladesh standardised approach MITS undertaken decedent within 2472 h death Diagnostic test included blood culture multiorganism targeted nucleic acid amplification test NAATs blood lung tissue histopathology examination various organ tissue samples interdisciplinary expert panel site reviewed case data attribute cause death pathogenesis thereof basis WHOrecommended reporting standards Pneumonia attributed causal pathway death 455 40·6 1120 decedents median age death 9 IQR 419 months Causative pathogen identified 377 82·9 455 pneumonia deaths multiple pathogen implicated 218 57·8 377 deaths 306 67·3 455 death occurred community within 72 h hospital admission presumed communityacquired pneumonia leading bacterial pathogen Streptococcus pneumoniae 108 35·3 Klebsiella pneumoniae 78 25·5 nontypeable Haemophilus influenzae 37 12·1 149 32·7 death occurred 72 h hospital admission presumed hospitalacquired pneumonia common pathogen K pneumoniae 64 43·0 Acinetobacter baumannii 19 12·8 pneumoniae 15 10·1 Pseudomonas aeruginosa 15 10·1 Overall virus implicated 145 31·9 455 pneumoniarelated deaths including 54 11·9 455 attributed cytomegalovirus 29 6·4 455 attributed respiratory syncytial virus Pneumonia contributed 40·6 childhood death analysis use postmortem MITS enabled biological ascertainment cause death majority 82·9 childhood death attributed pneumonia one pathogen commonly implicated case prominent role K pneumoniae nontypable H influenzae pneumoniae highlight need review empirical management guideline management severe pneumonia lowincome middleincome settings need research new improved vaccine pathogens Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Child",
            "Humans",
            "Infant",
            "Pneumonia",
            "Streptococcus pneumoniae",
            "Child Mortality",
            "South Africa",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38281495/"
    },
    {
        "pmid": "38278458",
        "title": "Arsenic trioxide inhibits the response of primary human B cells to influenza virus A in vitro.",
        "abstract": "Arsenic compound common environmental toxicant worldwide particularly enriched Northeast Southwestern United States Alps Bangladesh Exposure arsenic linked various detrimental health outcomes including cancer cognitive decline kidney damage group previously shown arsenic trioxide alters cell cytokine production current study demonstrate exposure arsenic compound alters B cell function vitro influenza model Human peripheral blood mononuclear cell PBMCs isolated blood cultured arsenic trioxide Assub3subOsub2sub subsequently challenged Influenza virus B cell showed decreased expression CD267 surface IgG CD80 treated Assub3subOsub2sub Taken together data suggest Assub3subOsub2sub affect activation surface antibody expression human peripheral B cells Overall suggests Assub3subOsub2sub exposure could cause impaired humoral immunity",
        "mesh_terms": [
            "Humans",
            "Arsenic Trioxide",
            "Leukocytes, Mononuclear",
            "Arsenicals",
            "B-Lymphocytes",
            "Orthomyxoviridae"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38278458/"
    },
    {
        "pmid": "38245668",
        "title": "Acceptability, cost-effectiveness, and capacity of a facility-based seasonal influenza vaccination among high-risk groups: a study protocol in selected tertiary care hospitals of Bangladesh.",
        "abstract": "Bangladesh seasonal influenza imposes considerable disease economic burden especially highrisk severe disease successful approach influenza prevention administration vaccine Many poor middleincome nations including Bangladesh national strategy program place seasonal influenza vaccines despite World Health Organizations WHO advice prioritize highrisk populations Additionally scarcity substantial data costeffectiveness seasonal influenza vaccination countries aim study determine acceptability health beliefs barriers intention receiving influenza vaccine among highrisk populations assess costeffectiveness implementing facilitybased seasonal influenza vaccination programme investigate required capacity potential seasonal influenza vaccination programme undertake study following STROBE guidelines conduct study inpatient outpatient department three selected tertiarylevel hospital leveraging ongoing hospitalbased influenza surveillance HBIS platform study population include WHOdefined four highrisk group excluding healthcare workers child six month eight years pregnant women elderly ≥ 60 years adult chronic diseases collect quantitative data participants acceptability health beliefs barriers vaccination intention using health belief model HBM patient meeting criterion highrisk population attending two public tertiarylevel hospitals one two public tertiarylevel hospitals arrange influenza vaccination campaign influenza season vaccine offered free cost highrisk patients second hospital vaccination offered vaccinated unvaccinated participant followedup month one year record influenzalike illness hospitalization death Additional data objective two collected patient symptom influenzalike illness ILI severe acute respiratory infection SARI one public one private hospital determine direct indirect cost associated influenza illness estimate required number influenza vaccines safe injections total storage volume utilizing secondary data use deterministic Markov decisionanalytic model estimate costeffectiveness facilitybased influenza vaccination Bangladesh result study enable National Immunization Technical Advisory Group Ministry Health  Family Welfare Bangladesh decide step take develop implement influenza vaccination strategy targeting highrisk populations Clinicaltrialsgov registration number NCT05996549 registration protocol version 20 took place August 2023 initial participant enrolled March 2022",
        "mesh_terms": [
            "Adult",
            "Aged",
            "Child",
            "Female",
            "Humans",
            "Pregnancy",
            "Bangladesh",
            "Cost-Benefit Analysis",
            "Influenza Vaccines",
            "Influenza, Human",
            "Seasons",
            "Tertiary Care Centers",
            "Vaccination",
            "Infant",
            "Child, Preschool",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38245668/"
    },
    {
        "pmid": "38214911",
        "title": "Predicting the potential impact of scaling up four pneumonia interventions on under-five pneumonia mortality: A prospective Lives Saved Tool (LiST) analysis for Bangladesh, Chad, and Ethiopia.",
        "abstract": "Pneumonia remains leading cause mortality underfive child outside neonatal period Progress slowed last decade necessitating increased effort scale effective pneumonia interventions used Lives Saved Tool LiST modelling software child mortality low middleincome settings prospectively analyse potential impact upscaling pneumonia intervention Bangladesh Chad Ethiopia 2023 2030 included Haemophilus influenzae type B Hib vaccination pneumococcal conjugate vaccine PCV oral antibiotics pulse oximetry oxygen pneumonia intervention analysis Outcomes interest number pneumonia death averted proportion death averted intervention change underfive mortality rate found 19 775 life child underfive could saved Bangladesh 76 470 Chad 97 343 Ethiopia scaling intervention coverage ≥90 2030 estimated reduction pneumonia death among child five range 4461 5791 respective countries Increased coverage oral antibiotics pulse oximetry oxygen show similar effect three countries averting 1880 2365 expected pneumonia deaths Scalingup PCV prominent effect especially Chad could avert 1404 expected pneumonia deaths Underfive mortality could reduced 142 per 1000 live birth Bangladesh 2252 per 1000 live birth Chad 548 per 1000 live birth Ethiopia analysis show high impact upscaling pneumonia interventions lack data regarding coverage indicator barrier research policy implementation requiring increased attention",
        "mesh_terms": [
            "Child",
            "Infant, Newborn",
            "Humans",
            "Infant",
            "Ethiopia",
            "Bangladesh",
            "Chad",
            "Prospective Studies",
            "Pneumonia",
            "Oxygen",
            "Vaccines, Conjugate",
            "Anti-Bacterial Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38214911/"
    },
    {
        "pmid": "38201109",
        "title": "Unveiling the Potent Antiviral and Antioxidant Activities of an Aqueous Extract from <i>Caesalpinia mimosoides</i> Lamk: Cheminformatics and Molecular Docking Approaches.",
        "abstract": "group previously demonstrated iCaesalpinia mimosoidesi Lamk exhibit many profound biological properties including anticancer antibacterial antioxidant activities However antiviral activity yet investigated Here aqueous extract iC mimosoidesi prepared aerial part leaves stalks trunks see whether exerts antiinfluenza H1N1 effect reduce organic solvent consumed extraction making desirable approach largescale production medical uses plant extract quantified contain 7 g gallic acid GA per 100 g dry sample determined using HPLC analysis also exerts potent antioxidant activity comparable authentic GA According untargeted metabolomics UPLCESIQTOFMSMS aid cheminformatics tool MetFrag version 21 SIRIUS version 583 CSIFingerID version 48 CANOPUS major metabolite best annotated gallic acid phenolic eg quinic acid shikimic acid protocatechuic acid sugar derivatives dicarboxylic acid deduced plant specie first time aqueous plant extract efficiently inhibited influenza H1N1 virus infection MDCK cell ICsub50sub 514 µgmL equal importance hemolytic activity absent plant extract signifying applicability safe antiviral agent Molecular docking suggested GA interacts conserved residue eg Arg152 Asp151 located catalytic inner shell viral neuraminidase NA sharing pocket antineuraminidase drugs laninamivir oseltamivir Additionally metabolite also found potentially interact active site hydrophobic 430cavity viral surface protein suggesting possibly synergistic effect various phytochemicals Therefore iC mimosoidesi aqueous extract may good candidate coping increasing influenza virus resistance existing antivirals",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38201109/"
    },
    {
        "pmid": "38186927",
        "title": "Co-infections and immune-evading viral hybrids: A perspective.",
        "abstract": "Coinfections occur two different type pathogen infect host time Initially may develop via primary infection later segue superinfection Although research suggests coinfections affect effect disease outcomes alternate evidence say otherwise disease outcome frequently influenced interaction many viruses virus interact coinfections poorly understood article aim shed light interaction virus cellular subcellular level clinical implication same article sought conducting thorough literature search Google Scholar ScienceDirect PubMed PubMed Central Dimensions EBSCO Host using keywords coinfections virus viral hybrids superinfection article pertinent concept included growing body evidence suggests formation hybrid viral particle HVPs conjugate cellular subcellular level formation HVPs bizarre may potentially profound effect clinical manifestations evidence formation HVPs couple viruses researcher fear existence several combinations including zoonotic viruses could detrimental human race individualas well communitylevel indepth understanding may help better management clinical manifestation disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38186927/"
    },
    {
        "pmid": "38179453",
        "title": "TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview.",
        "abstract": "Tollike receptor TLR agonists potent adjuvants gained attention vaccine research ability enhance immune responses study focus application improving vaccine efficacy key viral infections including hepatitis B virus HBV hepatitis C virus HCV human immunodeficiency virus HIV SARSCoV2 influenza virus flaviviruses including West Nile virus dengue virus chikungunya virus Vaccines crucial preventing microbial infections including viruses adjuvant play vital role modulating immune responses However still many disease effective vaccine lacking limited immune response posing significant threat human health use TLR agonist adjuvant viral vaccine formulation hold promise improving vaccine effectiveness tailoring adjuvant specific pathogens HBV HCV HIV SARSCoV2 influenza virus flavivirus protective immunity chronic emerging infectious disease elicited",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38179453/"
    },
    {
        "pmid": "38163807",
        "title": "A Rare Case of Primary Sjogren's Syndrome with Idiopathic Pulmonary Fibrosis with Variable Presentations: A case report.",
        "abstract": "diagnosed treated case Primary SjoGrens Syndrome Idiopathic Pulmonary Fibrosis IPF 65 year old woman presented dyspnoea multiple joint pain 5 year remained undiagnosed variable presentation initially established case mixed connective tissue disease consists Systemic Lupus Erythematosus SLE Systemic Sclerosis Dermatomyositis complained xerostomia xerophthalmia difficulty opening mouth progressive dysphagia solid food raynauds phenomenon addition noticed photosensitive rash oral ulcer difficulty raising arm head especially combing hair Examination revealed bi basal fine end inspiratory crepitation unaltered coughing bed side 6 minute walking test showed exertional desaturation SpO2 920 840 Grade 2 tenderness noted wrists knees elbow small joint hand foot except DIP However oral lesion dental carry found Unstimulated salivary flow rate 10 ml 15 minute sublingual salivary pool significantly reduced Schirmers test positive HRCT lung revealed reticulonodular shadowing honey combing traction bronchiectasis basal segment lobes suggestive usual interstitial pneumonia lungs Auto antibody test revealed ANA RA anti CCP anti d DNA negative CPK 63UL ENA Extractable Nuclear Antigen profile demonstrated positive Anti SS antibody remained insignificant anti SSB anti RNP anti Sm antibody anti Scl7o anti Jo1 According AmericanEuropean Consensus Criteria SjoGrens Syndrome meet criterion diagnosed Primary Sjogrens Syndrome finally diagnosed case Primary SjoGrens syndrome IPF patient treated pirfenidone prednisolone artificial tear vaccination Haemophilus influenzae Streptococcal pneumoniae 10 year survival rate patient nearly 800",
        "mesh_terms": [
            "Female",
            "Humans",
            "Aged",
            "Sjogren's Syndrome",
            "Idiopathic Pulmonary Fibrosis",
            "Lung",
            "Lupus Erythematosus, Systemic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38163807/"
    },
    {
        "pmid": "38138491",
        "title": "Exploring Cinnamoyl-Substituted Mannopyranosides: Synthesis, Evaluation of Antimicrobial Properties, and Molecular Docking Studies Targeting H5N1 Influenza A Virus.",
        "abstract": "pursuit innovative combination development novel antimicrobial antiviral medication garnered worldwide interest among scientist recent times Monosaccharides glycosides methyl αdmannopyranoside derivatives play significant role potential treatment viral respiratory pathologies study undertaken investigate assess synthesis spectral characterization methyl αdmannopyranoside derivative b2bb6b incorporating various aliphatic aromatic groups investigation encompassed comprehensive vitro antimicrobial screening examination physicochemical properties molecular docking analysis molecular dynamic simulations pharmacokinetic predictions unimolar onestep cinnamoylation reaction employed controlled condition produce methyl 6iOicinnamoylαdmannopyranoside b2b demonstrating selectivity C6 position represented pivotal step development potential antimicrobial derivative based methyl αdmannopyranoside Subsequently four additional methyl 6iOicinnamoylαdmannopyranoside derivative synthesized reasonably high yields chemical structure novel analog confirmed thorough analysis physicochemical properties elemental composition spectroscopic data vitro antimicrobial assay conducted six bacterial strain two fungal strains revealing promising antifungal property methyl αdmannopyranoside derivative comparison antibacterial activity Moreover cytotoxicity testing revealed compound less toxic supporting findings molecular docking study performed H5N1 influenza virus indicating significant binding affinity nonbonding interaction target protein 6VMZ Notably compound b4b 72 b6b 70 exhibited highest binding affinities Additionally 100 n molecular dynamic simulation conducted assess stability complex formed receptor 6VMZ methyl αdmannopyranoside derivative silico physiological conditions result revealed stable conformation binding pattern within stimulating environment silico pharmacokinetic toxicity assessment synthesized molecule performed using Osiris software version 291 Compounds b4b b6b demonstrated favorable computational pharmacological activities albeit low drug score possibly attributed higher molecular weight irritancy conclusion study showcase synthesis evaluation methyl αdmannopyranoside derivative promising candidate antimicrobial antifungal agents Molecular docking dynamic simulations along pharmacological predictions contribute understanding potential therapeutic utility although research may warranted address certain pharmacological aspects",
        "mesh_terms": [
            "Molecular Docking Simulation",
            "Mannose",
            "Influenza A Virus, H5N1 Subtype",
            "Anti-Infective Agents",
            "Anti-Bacterial Agents",
            "Antifungal Agents",
            "Molecular Structure",
            "Structure-Activity Relationship"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38138491/"
    },
    {
        "pmid": "38116452",
        "title": "The role of vaccination and environmental factors on outbreaks of high pathogenicity avian influenza H5N1 in Bangladesh.",
        "abstract": "High Pathogenicity Avian Influenza HPAI H5N1 outbreak continue wreak havoc global poultry industry threaten health wild bird populations sporadic spillover human mammals resulting widespread call vaccinate poultry Bangladesh vaccinating poultry since 2012 presenting prime opportunity study effect vaccination HPAI H5N1circulation poultry wild birds investigated efficacy vaccinating commercial poultry HPAI H5N1 along climatic socioeconomic factor considered potential driver HPAI H5N1 outbreak risk Bangladesh Using multivariate modeling approach estimated rate outbreak 18 time higher compared vaccination winter month three time higher chance outbreak summer months Variables resulting small significant increase outbreak rate relatively low ambient temperature time year literacy rate chicken duck density crop density presence highways may attributable low temperature supporting viral survival outside host higher literacy driving reporting rate density host reservoir spread virus increased connectivity Despite substantial impact vaccination outbreaks note HPAI H5N1 still enzootic Bangladesh vaccinated poultry flock high rate H5N1 prevalence spillover wild bird increased Vaccination Bangladesh thus bear risk supporting silent spread vaccine provides protection disease also infection finding underscore poultry vaccination part holistic HPAI mitigation strategy accompanied monitoring avoid silent spread",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38116452/"
    },
    {
        "pmid": "38115037",
        "title": "Characterizing deaths among adult patients with severe acute respiratory infection: during the pre- and COVID-19 pandemic periods in Bangladesh, 2018-2022.",
        "abstract": "Severe acute respiratory infection SARI leading cause mortality globally peaking COVID19 pandemic analyzed SARIassociated death preandpandemic period Bangladesh identify contributing factors analyzed data hospitalbased influenza surveillance nine tertiarylevel hospital Bangladesh considered March 2018February 2020 prepandemic period March 2020February 2022 pandemic period included adult ≥ 18 years participant study Surveillance physician identified WHOSARI case definition meeting inpatient collected demographics clinical characteristics outcome hospital discharge 30 day postdischarge performed rRTPCR influenza SARSCoV2 virus collected nasopharyngeal oropharyngeal swabs used multivariable Coxs regression model calculate hazard ratio HR factor associated SARI death adult patients enrolled 4392 SARI patient prepandemic 3824 SARI patient pandemic period Case fatality ratio higher pandemic 1362 521 inhospital 645 247 postdischarge 717 274 compared prepandemic 601 264 inhospital 201 89 postdischarge 4 175 p  0001 Prepandemic influenza detected 14 37264 SARI deaths Influenza detected pandemic 23 12521 SARSCoV2 418 218521 virus one SARI death History smoking presence 1 comorbid condition independently attributed SARI death adult prepandemic period SARI death patient also associated respiratory difficulty admission prepandemic aHR 236 95 CI165336 pandemic period aHR 230 95 CI 157335 accounting age sex smoking status presence 1 comorbid conditions detection influenza SARSCoV2 viruses pandemic SARI mortality increased influenzaassociated mortality declined SARSCoV2 caused third SARI deaths Postdischarge mortality higher inhospital mortality periods Limiting premature discharge strengthening postdischarge monitoring nursing service could reduce unexpected deaths Formative research better understand postdischarge mortality essential reduce SARI deaths",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38115037/"
    },
    {
        "pmid": "38070401",
        "title": "Mathematical modeling of the infectious spread and outbreak dynamics of avian influenza with seasonality transmission for chicken farms.",
        "abstract": "compartmental model timevarying contact rate seasonality effect corresponding nonautonomous model investigated model developed based six compartments susceptible latent infected asymptomatic treated recovered individuals determine effective reproduction number nonautonomous system analytic discussion show least one positive periodic solution exists Rsub0sub1 model simulated using RK45 numerical method parameter value model taken available literature numerical results observe degree seasonality vaccine efficacy significantly impact amplitude epidemic curve latentinfected phase plane show periodic solution exhibit perioddoubling bifurcation amplitude seasonality increases Finally model outcome compared actual field data found consistent",
        "mesh_terms": [
            "Humans",
            "Animals",
            "Chickens",
            "Influenza in Birds",
            "Farms",
            "Seasons",
            "Communicable Diseases",
            "Disease Outbreaks"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38070401/"
    },
    {
        "pmid": "40303708",
        "title": "The One Health Epidemiology of Avian Influenza Infection in Bangladesh: Lessons Learned from the Past 15 Years.",
        "abstract": "Avian influenza virus AIVs significant transboundary zoonotic pathogen concern animal human Since first report H5N1 AIV Bangladesh early 2007 resulted numerous outbreak across country hindering sustainable growth poultry industry economic loss different production system commercial backyard Highly pathogenic avian influenza HPAI virus low pathogenic avian influenza LPAI virus currently cocirculating causing infection poultry sector endemic manner Bangladesh well wild bird species introduction multiple clade H5N1 different poultry specie reassortment AIVs different pattern infection complicated epidemiological situation control created condition increase virulence virus host range potential zoonotic transmission risk viral transmission humanpoultry interface increasing time due inadequate surveillance early detection strategy practices ineffective biosecurity practice among poultry raisers complex supply chain backyard commercial poultry live bird market LBM systems Improving AIV surveillance poultry flock LBMs vaccination biosecurity awareness among poultry professional beneficial controlling disease burden poultry sector However human case AIV related poultry production marketing chain Bangladesh suggest One Health approach engaging various stakeholder public private would better option successfully controlling avian influenza outbreak Bangladesh review literature present comprehensive overview AIV infection status Bangladesh including description pathway zoonotic transmission different epidemiological interfaces genetic evolution virus need improvement disease control strategy incorporated early detection application effective vaccines increase proper biosecurity practice improvement awareness among poultry raisers trader consumer using One Health approach",
        "mesh_terms": [
            "Bangladesh",
            "Influenza in Birds",
            "Animals",
            "Humans",
            "One Health",
            "Poultry",
            "Influenza, Human",
            "Zoonoses",
            "Influenza A Virus, H5N1 Subtype",
            "Poultry Diseases",
            "Disease Outbreaks",
            "Birds"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40303708/"
    },
    {
        "pmid": "38031480",
        "title": "Association of recent respiratory illness and influenza with acute myocardial infarction among the Bangladeshi population: A case-control study.",
        "abstract": "Current evidence suggests recent acute respiratory infection seasonal influenza may precipitate acute myocardial infarction AMI study examined potential link recent clinical respiratory illness CRI influenza AMI Bangladesh Conducted 2018 influenza season Dhaka tertiarylevel cardiovascular CV hospital included 150 AMI case two control groups 44 hospitalized cardiac patient without AMI 90 healthy individuals Participants matched gender age groups study focused selfreported CRI laboratoryconfirmed influenza ascertained via quantitative realtime reverse transcription polymerase chain reaction qRTPCR within preceding week analyzed using multivariable logistic regression Results showed case reported CRI significantly frequently healthy control 273 vs 133 adjusted odds ratio aOR 221 95 confidence interval CI 105406 although significantly different control 273 vs 224 aOR 119 95 CI 065218 Influenza rate insignificantly higher among case controls study suggests recent respiratory illness may precede AMI onset among Bangladeshi patients Infection prevention control practices well uptake influenza vaccine may advocated patient high risk acute CV events",
        "mesh_terms": [
            "Humans",
            "Influenza, Human",
            "Influenza Vaccines",
            "Case-Control Studies",
            "Bangladesh",
            "Myocardial Infarction"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38031480/"
    },
    {
        "pmid": "38024265",
        "title": "Potential risk zones and climatic factors influencing the occurrence and persistence of avian influenza viruses in the environment of live bird markets in Bangladesh.",
        "abstract": "Live bird market LBMs critical poultry trade many developing country regarded hotspot prevalence contamination avian influenza virus AIV Therefore conducted weekly longitudinal environmental surveillance LBMs determine annual cyclic pattern AIV subtypes environmental risk zones role climatic factor AIV presence persistence environment LBM Bangladesh January 2018 March 2020 collected weekly fecal offal swab sample LBM tested using rRTPCR gene subtyped H5 H7 H9 used Generalized Estimating Equations GEE approach account repeated observation time correlate AIV prevalence potential risk factor negative binomial Poisson model investigate role climatic factor environmental contamination AIV LBM study period 378 sample tested AIV positive 188 AH5 AH9 was 154 found circulation H5 H9 cocirculation H5 H9 environmental surface yearround Generalized Estimating Equations GEE model reveals distinct seasonal pattern transmitting AIV H5 Specifically certain summer month exhibited substantial reduction risk 7090 9394 AIV H5 contamination respectively slaughtering zone showed significantly higher risk contamination H5 threefold increase risk compared birdholding zones negative binomial model found climatic factor like temperature relative humidity also significantly associated weekly AIV circulation increase temperature relative humidity decrease risk AIV circulation study underscore significance longitudinal environmental surveillance identifying potential risk zone detect H5 H9 virus cocirculation seasonal transmission well imperative immediate intervention reduce AIV LBMs Bangladesh recommend adopting One Health approach integrated AIV surveillance across animal human environmental interface order prevent epidemic pandemic AIV",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38024265/"
    },
    {
        "pmid": "38024264",
        "title": "Determinants for the presence of avian influenza virus in live bird markets in Bangladesh: Towards an easy fix of a looming one health issue.",
        "abstract": "Highly pathogenic avian influenza virus subtype H5N1 endangers poultry wildlife human health enzootic large part Asia live bird market LBMs putative hotspot maintenance amplification spread mitigate extent avian influenza virus AIV concern aimed increase quantitative understanding factor determining presence avian influenza virus LBM stalls 2016 2017 collected fecal offal sample 1008 stall 113 LBMs across Dhaka Rajshahi district Bangladesh stall sample pooled tested AIV matrix gene followed H5 H9 subtyping using rRTPCR detected Influenza viral RNA 49 stalls AIV positive samples 52 24 determined H5 H9 viruses respectively subtypes considerable health concern used generalized linear mixed effect modelling study AIV presence individual stall within LBMs function 13 20 risk factor identified FAO found small feasible improvement cleaning disinfection frequency installing running water stalls mixing different breed chicken cage large impact presence AIV stall Odds ratio 003005 Next cleaning vehicle used poultry transport selling waterfowl chicken stall buying stock directly commercial farms separating sick bird healthy ones avoiding access wild bird like house crows also major effect lowering risk stall AIV Odds ratio 016033 finding directly used developing practical affordable measure reduce prevalence AIV LBMs Also setting limited resource like Bangladesh mitigation may significantly contribute reducing AIV circulation amongst poultry spillover wildlife humans",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38024264/"
    },
    {
        "pmid": "37925315",
        "title": "Optimal timing of influenza vaccination among patients with acute myocardial infarction - Findings from the IAMI trial.",
        "abstract": "Influenza vaccination reduces risk adverse cardiovascular eventsThe IAMI trial randomly assigned 2571 patient acute myocardial infarction AMI receive influenza vaccine saline placebo index hospital admission conducted 30 center 8 country October 1 2016 March 1 2020 posthoc exploratory substudy compare trial outcome patient receiving early season vaccination n  1188 late season vaccination n  1344The primary endpoint wasthe composite allcause death myocardial infarction MI stent thrombosis 12 months Thecumulative incidence primary key secondary endpoint randomized treatment early late vaccination estimated using KaplanMeier method early vaccinated group primary composite endpoint occurred 36 participant 60 assigned influenza vaccine 49 84 assigned placebo HR 069 95 CI 045 107 compared 31 participant 47 assigned influenza vaccine 42 62 assigned placebo HR 074 95 CI 047 118 late vaccinated group P  0848 interaction HR scale 1 year observed similar estimate key secondary endpoint allcause death CV death statistically significant difference vaccine effectiveness adverse cardiovascular event timing vaccination effect vaccination allcause death one year pronounced group receiving early vaccination HR 050 95 CI 029 086 compared late vaccination group HR 075 35 CI 040 140 statistically significant difference group Interaction P  0335 conclusionthere insufficient evidence trial establish whether difference efficacy early late vaccinationbut regardless vaccination timing strongly recommend influenza vaccination patient cardiovascular diseases",
        "mesh_terms": [
            "Humans",
            "Influenza Vaccines",
            "Influenza, Human",
            "Myocardial Infarction",
            "Thrombosis",
            "Vaccination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37925315/"
    },
    {
        "pmid": "37881429",
        "title": "The novel immunobiotic <i>Clostridium butyricum</i> S-45-5 displays broad-spectrum antiviral activity <i>in vitro</i> and <i>in vivo</i> by inducing immune modulation.",
        "abstract": "iClostridium butyricumi known probiotic butyric acid bacterium improve intestinal environment study isolated new strain iC butyricumi infant feces evaluated physiological characteristic antiviral efficacy modulating innate immune response iin vitroi iin vivoi isolated iC butyricumi S455 showed typical characteristic iC butyricumi including bile acid resistance antibacterial ability growth promotion various lactic acid bacteria antiviral effect iC butyricumi S455 markedly reduced replication influenza virus PR8 Newcastle Disease Virus NDV Herpes Simplex Virus HSV RAW2647 cell iin vitroi suppression explained induction antiviral state cell induction antiviral IFNrelated gene secretion IFNs proinflammatory cytokines iIn vivoi oral administration iC butyricumi S455 exhibited prophylactic effect BALBc mouse fatal dos highly pathogenic mouseadapted influenza subtypes H1N1 H3N2 H9N2 challenge influenza virus iC butyricumi S455treated BALBc mouse showed increased level IFNβ IFNγ IL6 IL12 serum small intestine bronchoalveolar lavage fluid BALF correlated observed prophylactic effects Interestingly challenge influenza virus iC butyricumi S455treated BALBc mouse showed reduced level proinflammatory cytokine relatively higher level antiinflammatory cytokine day 7 postinfection Taken together finding suggest iC butyricumi S455 play antiviral role iin vitroi iin vivoi inducing antiviral state affect immune modulation alleviate local systemic inflammatory response caused influenza virus infection study provides beneficial effect new iC butyricumi S455 antiviral effect probiotic",
        "mesh_terms": [
            "Humans",
            "Animals",
            "Mice",
            "Antiviral Agents",
            "Influenza, Human",
            "Clostridium butyricum",
            "Influenza A Virus, H1N1 Subtype",
            "Influenza A Virus, H3N2 Subtype",
            "Influenza A Virus, H9N2 Subtype",
            "Cytokines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37881429/"
    },
    {
        "pmid": "40823621",
        "title": "Subacute oral toxicity study of maxing Kugan decoction on rats.",
        "abstract": "Maxing Kugan Decoction MKD traditional Chinese medicine prescription specifically designed respiratory infectious disease northwest region particularly targeting influenza winter spring seasons clinical efficacy established significant gap toxicological safety study aim evaluate subacute oral toxicity MKD rats focusing effect food consumption weight vital signs haematological parameters organ histology determine subacute oral toxicity MKD administered gavage 126 252 504 gkgday male female rat 90 days Meanwhile general behavior body weight food intake urine routine parameters blood biochemical hematological parameters coagulation parameters organ coefficient organ histopathology recorded analyzed result showed experimental rat healthy displayed evidence toxicity Furthermore mortality abnormality general conditions including diet weight noted level indicator changed administration level remained within normal range correlated dose gender Overall toxicological significance recorded Meanwhile histopathological analysis identify abnormal pathological change tissue structure cell morphology across organs significant delayed toxic reaction detected remission period Overall result indicated oral administration 504 gkg 60 time clinical dose humans MKD three month safe SD rat associated toxic side effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823621/"
    },
    {
        "pmid": "40823377",
        "title": "Bibliometric analysis of highly pathogenic avian influenza research globally from 2003 to 2023.",
        "abstract": "Despite decade research highly pathogenic avian influenza especially H5N1 understanding impact research output policy impact funding policies collaboration authors bibliometric measurable index elusive H5N1 research data retrieved PubMed database using H5N1 highly pathogenic influenza keywords combined Boolean operator OR evaluated growth pattern H5N1 research analysed using Microsoft Excel VOS viewer window version 1615 utilized analyzing keywords authors inputs collaboration amongst research institutesuniversities involved H5N1 research total 8411 article published within 2003 2023 retrieved trend published article indicates 2003 2004 lowest number articles highest observed 2009 2010 Since then gradual decline dominant article type original research article 8980 followed review 754 productive country Japan United States America China Egypt Africa top 15 author accounted 1240 total published data Keywords analysis revealed emergence newer keywords H5N8 wild birds mammals Nigeria however expected influenza virus avian H5N1 subtype dominant keyword Research institute background agriculture veterinary medicine dominated top 15 organization involved H5N1 research finding suggest research aimed developing therapeutic vaccines well continuous surveillance highrisk area urgently needed Furthermore finding provide baseline data stakeholder involved H5N1 research could inform future research funding policies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823377/"
    },
    {
        "pmid": "40819861",
        "title": "Exposure to suppressive antibiotic therapy in women with recurrent urinary tract infections and severity of infections: a retrospective population-based cohort study.",
        "abstract": "Women recurrent urinary tract infection UTIs often undergo intensive antibiotic exposure especially suppressive therapies Suppressive therapy recommended woman three UTIs past year two last 6 months However collateral longterm effect poorly studied assess whether suppressive therapy recurrent UTIs increase incidence severity future infection compared episodic UTI treatment Retrospective cohort study study conducted using data Information System Research Primary Care database including 58 million people Catalonia Two group woman recurrent UTIs ≥3 episodesyear compared suppressive antibiotic therapy ≥6 month treated episodically Primary outcome hospitalisation due pyelonephritis septicaemia COVID19 influenza pneumonia mortality infections 100month followup period Among 36 170 women 2898 8 treated continuous suppressive therapy Overall 69 population experienced severe infections higher incidence woman suppressive therapy 126 compared without 64 HR 150 95 CI 133 168 Pyelonephritis presented greatest difference HR 195 95 CI 164 233 followed septicaemia HR 134 95 CI 113 159 COVID19 HR 123 95 CI 101 150 Suppressive antibiotic therapy woman recurrent UTIs associated higher incidence severity future infections Future research focus clarifying causal relationship identifying potential mechanism involved",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40819861/"
    },
    {
        "pmid": "40818491",
        "title": "Optimization of the Monoclonal Antibody 3E1 through W32I Mutation Enhances Antiviral Efficacy against Influenza Virus Subtypes H1N1 and H3N2.",
        "abstract": "influenza virus caused global pandemic significant morbidity mortality underscoring need optimize antibody improved antiviral efficacy monoclonal antibody 3E1 effectively neutralizes Group 1 influenza subtypes H1 H5 inhibiting acidinduced conformational change hemagglutinin HA However neutralizing activity relatively weak Group 2 subtype H3 order broaden neutralizing activity wildtype 3E1 3E1WT Group 1 Group 2 viral strains singlepoint mutant 3E1L W32I 3E1H F103I double mutant 3E1HL F103I W32I designed generated study binding affinity microneutralizing activity antiviral mechanism mutant evaluated vitro Notably 3E1L mutant exhibited significantly enhanced antiviral activity H1N1 H3N2 compared 3E1WT inhibiting viral entry release vivo study also indicate 3E1L significantly enhances prophylactic therapeutic efficacy ANewYork612015CDCLV16A H1N1 AHong Kong1720148296 H3N2 Molecular dynamic simulation 3E1LHA complex revealed W32I mutation could reduce steric hindrance tryptophan position 32 complementaritydetermining region L1 loop HA conclusion W32I substitution enhances antiviral activity 3E1WT suggesting optimization 3E1L promising strategy development effective influenza therapy prevention",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818491/"
    },
    {
        "pmid": "40818177",
        "title": "Exploring social influences on healthcare user decision-making.",
        "abstract": "Commonly used choice model healthcare assume decisionmaking individualistic process individual group ie influencers fact impact decisionmaking purpose study examine different way influencers affect healthcare user decisionmaking important step towards improving choice model healthcare Two focus group n  12 41 semistructured interview conducted within range healthcare domains influenza vaccination birth care joint replacement prostate cancer treatment domains healthcare user physician interviewed Participants recruited collaboration GP hospital research panel Data analyzed grounded theory approach Results reveal three main element decisionmaking affected different social influence mechanisms informationgathering phase perception alternatives attribute level risk influenced information retrieved someone social network others experiences social norms preference formation phase relative importance attribute value alternative impacted social norms advice consideration influencers stake decision Finally process actual decisionmaking could deliberationbased intuitionbased discussion consultation others exact strength impact influence differed per healthcare domain study provides insight social influence healthcare user decisionmaking across multiple healthcare domain provides comparison domains Several connection influencers social influence mechanism choice construct identified finding help choice modeler develop model accurately reflect decisionmaking process health",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818177/"
    },
    {
        "pmid": "40818041",
        "title": "Double Trouble: A Case of ARDS as a Consequence of Influenza and Plasma Donation Causing Severe Neutropenia and Hypogammaglobulinemia.",
        "abstract": "Influenza infection known induce significant immunosuppression particularly vulnerable populations impact exacerbated underlying immunodeficiencies case report describes rapid deterioration previously healthy 30yearold male developed acute respiratory distress syndrome septic shock due methicillinresistant iStaphylococcus aureusi pneumonia bacteremia following Influenza infection patient history frequent plasma donations leading significant reduction immunoglobulin contributing increased susceptibility bacterial coinfection patients condition declined rapidly necessitating venovenous extracorporeal membrane oxygenation ECMO venoarterialvenous ECMO However despite treatment interventions continued deteriorate sustaining cardiac arrest death case highlight potential risk associated frequent plasma donations particularly role causing hypogammaglobulinemia predisposing individual severe bacterial infections study necessary explore effect immunoglobulin depletion plasma donation role development severe infection increased mortality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818041/"
    },
    {
        "pmid": "40817233",
        "title": "Standard treatment regimen with and without dexamethasone on outcome of children aged 3-7 years with empyema: a randomized double blind clinical trial.",
        "abstract": "Corticosteroids effective inhibitory effect inflammatory factor used adjunctive therapy viral pneumonia conducted study compare effect standard treatment regimen without dexamethasone outcome 37yearold child empyema randomized controlled trial conducted university hospital Iran June 2023 November 2024 Children aged 37 year empyema enrolled patient received standard antibiotic treatment Vancomycin Meropenem fibrinolytic agent alteplase dexamethasone group received additional intrapleural dexamethasone injections Randomization performed using block randomization block size 4 child outcome assessor blinded dexamethasone administration primary outcome length stay LOS secondary outcome including duration fever chest tube placement oxygen saturation CRP levels 47 patient dexamethasone group  23 489 subject n  23 girls LOS dexamethasone group median 95 day range 717 days significantly less control group median 16 day range 1024 days duration fever median 5 vs 11 days CRP level median 125 vs 21 dexamethasone group significantly lower control group significant difference observed two group term PCR COVID19 influenza pleural fluid smear culture blood culture oxygen saturation duration chest tube placement finding showed use dexamethasone decrease duration hospitalization duration fever CRP levels leading faster recovery child empyema Dexamethasone safe effective adjunctive therapy empyema children IRCT20240705062336N1 Retrospectively Registered 20241116",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817233/"
    },
    {
        "pmid": "40815640",
        "title": "Functional and epitope specific monoclonal antibody discovery directly from immune sera using cryo-EM.",
        "abstract": "Antibodies crucial therapeutics comprising substantial portion approved drug due safety clinical efficacy Traditional antibody discovery method laborintensive limiting scalability highthroughput analysis Here improved upon streamlined approach combining structural analysis bioinformatics infer heavy light chain sequence cryoEM cryoelectron microscopy map serumderived polyclonal antibody pAbs bound antigens Using ModelAngelo automated structurebuilding tool accelerated pAb sequence determination identified sequence match B cell repertoire via ModelAngeloderived hidden Markov model HMMs associated pAb structures Benchmarking result nonhuman primate HIV vaccine trial pipeline reduced analysis time week day higher precision Validation murine immune serum influenza vaccination revealed multiple protective antibodies workflow enhances antibody discovery enabling faster accurate mapping polyclonal response broad application vaccine development therapeutic antibody discovery",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815640/"
    },
    {
        "pmid": "40812020",
        "title": "From first infection to reinfection: Comparing Nucleocapsid antibody kinetics in vaccinated and unvaccinated adults.",
        "abstract": "Determining infection history individual prior immunity critical studying SARSCoV2 imprinting vaccine responses better understand response infection examine nucleocapsid protein antibody dynamic around first second SARSCoV2 infection vaccinated unvaccinated adults presence level nucleocapsidantibodies measured around first second SARSCoV2 infections Antibody waning measured accelerated failure time models firstinfections 958  885986  unvaccinated 894  865917  vaccinated participant seroconverted Vaccinated adult 455  shorter seropositivity event time ratio  055 95 CI 045066 secondinfections 891  769953  vaccinated 944  742990  unvaccinated participant 4fold rise antibody levels Regardless vaccination antibody level secondinfections significantly higher firstinfections finding suggest nucleocapsid serology inform researcher past infection regardless exposure status potentially differentiate initial infection reinfections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812020/"
    },
    {
        "pmid": "40811481",
        "title": "Euglycemic Diabetic Ketoacidosis in Pregnancy.",
        "abstract": "Diabetic ketoacidosis pregnancy rare serious complication caused insulin deficiency Hyperglycemia considered hallmark sign diabetic ketoacidosis however physiologic change pregnancy predispose pregnant woman developing euglycemic diabetic ketoacidosis plasma glucose level normal near normal Euglycemic diabetic ketoacidosis pregnancy pose many challenge diagnosis including sign symptom attributed pregnancy rapid progression sign symptoms nearnormal glucose levels Fetal acidosis also develops result maternal disease process fetal heart rate tracing diabetic ketoacidosis often feature minimal absent variability fetal tachycardia recurrent late decelerations Treatment focus correcting maternal acidosis electrolyte imbalances Despite state fetal heart rate tracing birth typically indicated fetal status improve time correcting maternal acidosis improve outcome prevent worsening complications early diagnosis intervention vital patient diabetic ketoacidosis collaborative multidisciplinary approach patient facilitate timely diagnosis initiation treatment present case study patient diagnosed euglycemic diabetic ketoacidosis secondary influenza required emergency cesarean birth due worsening maternal fetal status despite corrective interventions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811481/"
    },
    {
        "pmid": "40810539",
        "title": "Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, China.",
        "abstract": "Cancer patient particularly vulnerable bloodstream infection BSIs due immunocompromised status retrospective study Jiangxi Cancer Hospital 2019 2024 analyzed bacterial spectrum risk factors antimicrobial susceptibility profile BSIs cancer patients Logistic regression analysis performed identify risk factor associated multidrug resistance MDR Grampositive Gramnegative infections total 1161 bacteria isolated 954 oncological patient 1095 BSI episodes Among these 6279 Gramnegative bacteria iEscherichia colii 4088 iKlebsiella pneumoniaei 1907 prevalent Grampositive bacteria accounted 3721 isolates iStaphylococcus aureusi 2616 common Gramnegative infection prevalent patient breast gastrointestinal hepatobiliary pancreatic cancers whereas Grampositive infection common among lymphoma head neck lung cancers well patient undergoing invasive procedures High resistance rate observed ampicillin piperacillin cefazolin erythromycin whereas tigecycline nitrofurantoin exhibited low resistance rate among tested bacterial isolates Among Gramnegative bacteria 548 carbapenemase producer 1536 extendedspectrum βlactamase ESBL producers Moreover methicillin resistance observed 3604 iStaphylococcus aureusi 6683 coagulasenegative iStaphylococcusi isolates MDR observed 4019 Gramnegative 5092 Grampositive infections Hypoproteinemia OR 32 identified independent risk factor MDRBSIs caused Gramnegative bacteria high prevalence MDR bacteria BSIs among cancer patient highlight necessity individualized treatment continuous monitoring oncology settingsIMPORTANCEThis study address critical gap understanding epidemiology risk factor multidrugresistant bloodstream infection MDRBSIs oncology patient highburden region China analyzing thousand BSI episode 6 years study identifies predominant bacterial species resistance profiles key clinical procedural risk factor associated MDR high rate MDR among Gramnegative Grampositive pathogen underscore urgent need tailored antimicrobial stewardship infection control interventions individualized treatment strategies finding provide essential evidence guiding empirical antibiotic choice improving infection management protocol cancer care settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810539/"
    },
    {
        "pmid": "40806558",
        "title": "Unravelling the Viral Hypothesis of Schizophrenia: A Comprehensive Review of Mechanisms and Evidence.",
        "abstract": "Schizophrenia challenging multifactorial neuropsychiatric disease involves interaction genetic susceptibility environmental insults Increasing evidence implicates viral infection significant environmental contributors particularly sensitive neurodevelopmental periods review synthesis current finding viral hypothesis schizophrenia encompassing wide array neurotropic viruses including influenza viruses herpesviruses HSV1 2 CMV VZV EBV HHV6 8 hepatitis B C viruses HIV HERVs HTLV Zika virus BoDV coronaviruses including SARSCoV2 others pathogen contribute schizophrenia mechanism direct microinvasion persistent central nervous system infection immunemediated neuroinflammation molecular mimicry disturbance bloodbrain barrier Prenatal exposure viral infection trigger maternal immune activation resulting cytokinemediated alteration neurological development foetus persist adulthood Genetic study highlight role immunerelated loci including major histocompatibility complex polymorphisms modulating susceptibility infection neurodevelopmental outcomes Clinical data also support mild encephalitis hypothesis suggesting subset schizophrenia case involve lowgrade chronic neuroinflammation Although antipsychotic immunomodulatory effects adjunctive antiinflammatory therapy show promise particularly treatmentresistant cases Despite compelling associations pathogenspecific link remain inconsistent emphasising need longitudinal study integrative approach viromics unravel causal relationships review support multihit model viral infection interfere hereditary immunological susceptibilities enhancing schizophrenia risk Elucidating virusimmunebrain interaction may facilitate discovery biomarkers targeted prevention novel therapeutic strategy schizophrenia",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806558/"
    },
    {
        "pmid": "40803632",
        "title": "Antibiotic susceptibility according to age of clinical strains from hospital respiratory samples: A nationwide study.",
        "abstract": "study evaluated microbiological distribution sensitivity clinical strain respiratory sample inpatient antibiotic usually recommended treatment lower respiratory tract infection LRTI Using French SPARES Surveillance et Prévention de lAntibioRésistance en Etablissement de Santé database recorded respiratory microbiological sample collected 2022 409 hospital located region France distribution main bacterial specie resistance frequently prescribed antibiotic LRTI compared age group 1864 years 6579 years ≥ 80 years Among 48721 strains 477  isolated patient aged 1864 years 379  aged 6579 years 144  aged ≥ 80 years Enterobacteriaceae 301  360  351  respectively Pseudomonas aeruginosa 190  250  271  prevalent pathogens especially older patients Conversely Haemophilus influenzae 145  107  87  Streptococcus pneumoniae 83  56  34  rare older age Overall antibiotic resistance increased age across classes increasing order resistance levofloxacin 92  111  132  piperacillintazobactam 145  168  174  cefotaxime 274  343  395  doxycycline 282  374  395  cotrimoxazole 321  385  402  amoxicillinclavulanate 372  460  514  p  005 comparisons half strain resistant amoxicillin erythromycin large nationwide database respiratory samples older age associated high prevalence Enterobacteriaceae P aeruginosa betalactam resistance finding challenging current LRTI probabilistic treatment Conversely H influenzae S pneumoniae rarely observed patient 80 year age",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803632/"
    },
    {
        "pmid": "40803361",
        "title": "Clinical Characteristics of Influenza Pneumonia in Patients with Lung Adenocarcinoma Receiving Immunotherapy.",
        "abstract": "objective study examine general characteristics clinical manifestations laboratory findings imaging feature patient lung adenocarcinoma develop influenza pneumonia undergoing immunotherapy retrospective analysis conducted clinical data 48 patient lung adenocarcinoma pulmonary infection received immunotherapy standalone treatment September 2022 September 2024 Affiliated Hospital North China University Science Technology Clinical characteristic patient concurrent influenza pneumonia assessed compared noninfluenza pneumonia group patient influenza pneumonia group demonstrated significantly severe systemic symptoms elevated urea nitrogen levels reduced platelet counts decreased serum albumin levels lower Prognostic Nutritional Index values higher prevalence bilateral multilobed lung involvement Chest imaging frequently revealed ground glass opacities reticular patterns crazy paving sign Additionally group exhibited higher CURB65 score increased need intensive care unit admission comparison yielding ipi value 005 Hypotension emerged potential factor influencing mortality group odds ratio  9094 ipi  0041 Among 19 patient lung adenocarcinoma influenza pneumonia 895 coinfections pathogens Gramnegative bacterial infection common 647 iKlebsiella pneumoniaei subspecies iPseudomonas aeruginosai iHaemophilus parainfluenzaei identified leading pathogens Fungal infections primarily involving iAspergillusi species accounted 235 cases General characteristics clinical manifestations laboratory findings imaging feature essential reference diagnosis management lung adenocarcinoma complicated influenza pneumonia Particular attention directed blood pressure fluctuations careful monitoring low blood pressure especially accompanied bacterial infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803361/"
    },
    {
        "pmid": "40803328",
        "title": "Clonotype-enriched somatic hypermutations drive affinity maturation of a public human antibody targeting an occluded sarbecovirus epitope.",
        "abstract": "Investigating public antibody recognize conserved epitope critical vaccine development Identifying somatic hypermutations SHMs enhance antigen affinity public antibody key guiding vaccine design better protection pathogens propose affinityenhancing SHMs selectively enriched public antibody clonotypes surpassing background frequency seen antibody carrying V gene different epitope specificities Using M15 human IGHV459IGKV320 public antibody model compare SHM signature antibody use V gene recognize epitopes identified clonotypeenriched mutation light chain M15 showed that combination SHMs enhance binding previously uncharacterized Sarbecovirus epitope antibody response increasing sequential vaccination finding identify convergence clonotype enrichment feature affinityenhancing SHMs public antibodies help guide vaccine design aimed eliciting antibodies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803328/"
    },
    {
        "pmid": "40797503",
        "title": "Clinical characteristics and management of co-infected patients of influenza A and Aspergillus: Case series in the Southern China.",
        "abstract": "Influenza Aspergillus coinfection topic significant interest report 5 patient influenza Aspergillus coinfection of Upon admission patient diagnosed influenza virus infection elevated level inflammatory markers including Creactive protein serum amyloid A patient treated antiviral therapy upon admission Computed tomography imaging 5 10 day later detected improvement investigation indicated patient exhibited sign acute Aspergillus infection showing halo sign solidification along bronchi One patient diagnosed coinfection biopsy remaining patient diagnosed clinically based least 2 diagnostic marker such bloodBALF GM tNGS sputum culture coinfection diagnosis treatment supplemented antifungal voriconazole Followup computed tomography scan 4 patient revealed improvement 7 14 day antifungal treatment important note Aspergillus infection considered potential risk factor among patient influenza fail improve worsen despite receiving full antiviral treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797503/"
    },
    {
        "pmid": "40796188",
        "title": "Clinician Preferences for Oseltamivir Use in Children With Influenza in the Outpatient Setting.",
        "abstract": "Professional society recommend antiviral treatment child high risk severe complicated influenza disease regardless symptom duration However outpatient antiviral prescribing practice inconsistent aimed assess pediatric clinicians outpatient prescribing practice oseltamivir child influenza vignettebased study pediatric clinician conducted March June 2024 7 US childrens hospital affiliated clinics survey included 4 clinical influenza vignettes 3 represented scenario warranting treatment per national recommendations One vignette randomized explore impact symptom duration treatment preferences primary outcome proportion vignette respondent likely somewhat extremely recommend oseltamivir 1124 eligible participants 452 402 responded survey Successive wave analysis revealed evidence response bias Participants likely recommend oseltamivir 362 cases variation among specialty 296 emergency medicine 372 general pediatrics 486 infectious diseases P  001 among study site 286 507 P  018 adjusted clustering Longer symptom duration 2 v 4 days significantly decreased respondents likelihood recommend oseltamivir 309 18 P  001 demonstrate considerable nonadherence national influenza treatment recommendation variability regarding outpatient use oseltamivir treat child influenza indicates uncertainty perceived benefit oseltamivir relatively healthy pediatric population nonsevere disease Treatment standardization accordance national guideline rigorous monitoring subsequent outcome needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796188/"
    },
    {
        "pmid": "40794954",
        "title": "An advanced network pharmacology investigation of Shufeng Jiedu formula in the treatment for respiratory tract infection based on LC-MS, data mining, molecular docking, and molecular dynamic simulation.",
        "abstract": "Respiratory tract infection RTI continues nonnegligible cause global incidence rate mortality Shufeng Jiedu formula SFJD traditional Chinese remedy used treating RTI though mechanism well understood objective research uncover underlying molecular mechanism responsible effectiveness SFJD RTI Using UHPLCQOrbitrap HRMS assays chemical compound SFJDs ethanol aqueous extract fraction identified target herbal compound RTIrelated target acquired various database Key SFJDRTI target analyzed using Gene Ontology GO Kyoto Encyclopedia Genes Genomes KEGG tissueorganspecific analyses Molecular docking data mining dynamic simulation employed evaluate interaction major target main compounds total 94 31 compound determined aqueous ethanol extract fraction respectively Many compound demonstrated good oral bioavailability 6099 GO analysis revealed significant involvement inflammatory response gene silencing processes KEGG pathway highlighted connection viral infection signaling pathways lung primary target organ screed Biogps database 15 compound well eight key gene associated set 15 compound virtually fitted active site eight critical targets Isaindigotone resveratrol could form hydrogen bond interaction FOS JUN respectively FOS JUN classified differential gene COVID2019 HCoV229E H1N1 infected comprehensive result obtained MD simulation MMPBSA SASA analysis highlighted compounds potential serve effective inhibitor FOS JUN proteins Lastly resveratrol exerted high inhibitory effect influenza virus based MDCK cells summary provided framework integrated network pharmacology multiple virus infection model identify synergistic compound based network topology",
        "mesh_terms": [
            "Network Pharmacology",
            "Drugs, Chinese Herbal",
            "Molecular Docking Simulation",
            "Data Mining",
            "Humans",
            "Molecular Dynamics Simulation",
            "Respiratory Tract Infections",
            "Chromatography, Liquid",
            "Liquid Chromatography-Mass Spectrometry"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794954/"
    },
    {
        "pmid": "40793762",
        "title": "Rapid molecular detection of respiratory pathogens in patients admitted with suspected community-acquired pneumonia: secondary analysis of a randomized controlled trial.",
        "abstract": "randomized trial demonstrated implementing pointofcare POC PCR detection respiratory pathogen emergency department ED setting change overall antibiotic use led targeted treatment clinically relevant albeit nonsignificant reduction length stay study aimed assess diagnostic impact POCPCR testing patient suspected communityacquired pneumonia CAP ED study secondary analysis Danish multicenter randomized controlled trial RCT included patient aged ≥18 year admitted ED March 2021 February 2022 primary trial patient randomly assigned one two parallel groups i intervention group POCPCR addition standard care ii control group standard care SCO present secondary analysis focus exclusively patient intervention group POCPCR standard culturebased diagnostics performed diagnosis CAP determined expert panel intervention group 145 patient lower respiratory tract LRT specimen analyzed using POCPCR culture POCPCR identified notably microorganism compared culture 187 v 34 agreement positive result obtained POCPCR culture 6 19 316 iStreptococcus pneumoniaei 16 61 26 iHaemophilus influenzaei Concentrations ≥10sup7sup copiesmL detected POCPCR iS pneumoniaei iH influenzaei associated diagnosis CAP 67 patient identified iS pneumoniaei andor H iinfluenzaei 46 69 received targeted treatment 57 85 received adequate treatment 10 15 received inappropriate treatment rapid pathogen detection POCPCR likely improve diagnostic accuracy promote appropriate use antibiotic CAP patients finding suggest pointofcare POCPCR testing significantly enhance diagnostic accuracy CAP emergency department ED thereby facilitating targeted effective antimicrobial treatment light growing concern antimicrobial resistance pressing need rapid diagnostics acute care settings believe study hold considerable relevance clinical practice ED",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40793762/"
    },
    {
        "pmid": "40793352",
        "title": "Thermogenesis dynamics and influenza A virus: unveiling the intriguing interplay.",
        "abstract": "Maintaining body temperature critical brown adipose tissue BAT uuncoupling protein 1 UCP1u activation playing pivotal role heat generation metabolism Modulating thermoregulation pathway BAT help alleviate fever enhance metabolic wellbeing boost immune function viral infection influenza A review explores intricate link thermogenesis influenza virus IAV highlighting IAV impact body temperature regulation immune responses Mitochondrias function energy production heat generation UCP1mediated thermogenesis underscore significance regulating body temperature metabolic rate responsiveness environmental cue like cold exposure Understanding interplay among mitochondria UCP1 thermoregulation offer insight potential therapeutic intervention managing IAV infections regulatory mechanism governing thermogenesis influence adipose tissue thermogenesis various pathways affecting body temperature metabolic functions Additionally review underscore potential therapeutic target within thermogenesis pathway associated IAV infection regulatory mechanism improve prevention treatment strategies review underscore pivotal role thermogenesis mitochondrial function hosts response IAV infections emphasizing need research enhance management strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40793352/"
    },
    {
        "pmid": "40788911",
        "title": "Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.",
        "abstract": "Age  50 years risk factor pneumococcal disease indication vaccination France contrast influenza 2018 pneumococcal vaccine coverage rate VCR 45 adult atrisk contrast influenza VCR 436 aimed assess pneumococcal influenza VCR 2020 entire French population factor associated higher VCR including age 65 years retrospectively included adult covered National Health Service 2020 identified patient atrisk using validated algorithms assessed VCRs analysing pneumococcal vaccine reimbursed 2009 2020 13valent pneumococcal conjugate vaccine PCV13 23valent polysaccharide vaccine PPSV23 influenza vaccine reimbursed September 2020 March 2021 2020 identified 7336769 adult risk median age 670 years 842 comorbidities 245 immunocompromised overall pneumococcal VCR PCV13  PPSV23 99 seasonal influenza VCR 511 variable associated highest odds VCR age ≥65 years influenza odds ratio OR 414 pneumococcal vaccination OR 102 patient comorbidities pneumococcal VCR significantly increase aged 1865 year aged  65 year 72 94 even decreased 20 179 patient immunodeficiencies contrast influenza VCR increased significantly 355 679 OR 355 patient comorbidities 273 712 OR 557 immunodeficiencies France pneumococcal VCR increase 65 year age OR 102 contrast influenza VCR OR 414 increased significantly suggesting agebased recommendation pneumococcal vaccination probably benefit VCR atrisk elderly population",
        "mesh_terms": [
            "Humans",
            "Aged",
            "France",
            "Pneumococcal Vaccines",
            "Male",
            "Retrospective Studies",
            "Female",
            "Middle Aged",
            "Vaccination Coverage",
            "Pneumococcal Infections",
            "Adult",
            "Aged, 80 and over",
            "Vaccination",
            "Risk Factors",
            "Influenza Vaccines",
            "Young Adult",
            "Influenza, Human"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788911/"
    },
    {
        "pmid": "40788183",
        "title": "Clinical Evaluation of M1-c6v1 Oncolytic Virus Combined with Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma.",
        "abstract": "study evaluated safety tolerability preliminary efficacy M1c6v1 oncolytic virus combined immune checkpoint inhibitor ICIs camrelizumab vascular endothelial growth factor receptor 2 VEGFR2 inhibitor apatinib advanced hepatocellular carcinoma HCC singlearm investigatorinitiated openlabel clinical trial enrolled patient advanced HCC NCT04665362 Patients received M1c6v1 1×10⁹ CCID50 intravenously 5 day every 28 days camrelizumab 200 mg intravenously biweekly apatinib 250 mg orally daily Treatment continued 1 year disease progression intolerability withdrawal Primary endpoint safety tolerability secondary endpoint assessed efficacy based tumor response progressionfree survival PFS overall survival OS Thirteen patient enrolled 846 hepatitis B virus HBVrelated HCC 769 presenting tumor 10 cm treatment welltolerated 9215 adverse event AEs grade 1 2 common AEs included influenzalike symptom transient cytopenia viral shedding detected secretion excretion collected subjects 10 patient evaluable efficacy overall response rate ORR 70 710 7 partial response PR according mRECIST median OS PFS 154 89 month respectively combination M1c6v1 camrelizumab apatinib demonstrates acceptable safety profile promising efficacy advanced HCC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788183/"
    },
    {
        "pmid": "40788012",
        "title": "Heat shock protein A1L restricts influenza A virus by ubiquitination of NA.",
        "abstract": "Neuraminidase NA protein influenza virus IAV tetrameric envelope glycoprotein critical viral release spread wellcharacterized enzymatic function poorly resolved hostpathogen interactions However host factor targeted NA regulating NA activity largely uncharacterized Here identified host heat shock protein A1L HSPA1L novel NAbinding partner suppresses IAV replication Subsequent study revealed HSPA1L promotes NA ubiquitination K242 resulting NBR1dependent autophagic degradation Moreover recombinant H5N1 virus carrying NAsupK242Rsup mutation exhibited enhanced replication resistance HSPA1Lmediated viral suppression compared wildtype WT virus Collectively unveil intrinsic defense mechanism wherein HSPA1L antagonizes IAV promoting NBR1dependent autophagic degradation NA via sitespecific ubiquitinationIMPORTANCEIAV especially avian influenza virus H5N1 begin cause infection andor death new uncommon host especially sea mammal ruminants indicating virus adapting mammalian infections development substantially elevate concern pandemic potential zoonotic risk escalation necessitating deeper understanding hostIAV interaction develop effective antiviral countermeasures HSP70 family protein known modulate viral infections However specific role HSPA1L member HSP70 family IAV infection remains poorly characterized study demonstrate HSPA1L defends IAV regulating NA proteostasis Mechanistically HSPA1L directly bind NA promotes ubiquitination K242 mediates NBR1dependent autophagic degradation thereby suppressing viral replication study identifies HSPA1L promising target antiviral strategy IAV",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788012/"
    },
    {
        "pmid": "40786761",
        "title": "Haemophilus influenzae Acute Prosthetic Joint Infection: A Rare Case Report on Time-Critical, Pathogen-Specific Management.",
        "abstract": "Prosthetic joint infection PJIs serious complication arthroplasty often necessitating prolonged therapy revision surgeries Haemophilus influenzae uncommon cause PJI especially immunocompromised individual individual comorbidities fastidious nature frequently lead negative cultures delaying diagnosis targeted therapy report case 52yearold male rheumatoid arthritis immunosuppressive therapy presented acute right hip pain swelling purulent wound discharge 3 month revision total hip arthroplasty Initial workup revealed elevated inflammatory marker sign joint infection JI Conventional microbiological method including Gram stain acidfast bacillus testing enrichment culture inconclusive However syndromic multiplex polymerase chain reaction PCR using BioFire® JI panel detected H influenzae within 2 h intraoperative sample collection patient underwent debridement targeted antibiotic therapy implant retention DAIR Empirical therapy meropenem vancomycin promptly deescalated intravenous ceftriaxone based PCR results Clinical recovery marked rapid decline Creactive protein resolution symptoms successful switch oral therapy 6week 16week followup patient asymptomatic normal inflammatory marker radiographs functioning retained implant case underscore clinical value rapid syndromic testing detecting rare fastidious pathogen like H influenzae PJIs early identification facilitated timely DAIR targeted antibiotic therapy reduced hospital stays preserved implant approach highlight role molecular diagnostics enhancing antimicrobial stewardship improving clinical outcome complex orthopedic infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786761/"
    },
    {
        "pmid": "40780374",
        "title": "Gut derived (S)-Equol mitigates influenza viral pneumonia by modulating macrophage polarization via Nrf2 mediated AKT/ERK/NF-κb signaling pathways.",
        "abstract": "Respiratory virus including influenza virus IAV infection induces alteration gut microbiota structure function turn play essential role pathogenic process Alterations gut microbiota usually accompanied change metabolites specific relationship dynamic change gut microbiota serum metabolite influenza remains unclear study depicted dynamic change composition gut microbiota using metagenomic sequencing influenza mouse model mass spectrometry based metabolomic identified SEquol notable protective metabolite derived intestinal flora Serum SEquol level decreased initial infection phase increased gradually convalescence phase positively associated change Eggerthella Bifidobacterium species Antibiotic treatment reduced serum SEquol level exacerbated lung pathological damage Oral administration SEquol relieved disease severity controlled inflammatory infiltration Mechanistically SEquol activated Nrf2 macrophages thereby inhibited AKT ERK NFκB phosphorylation inhibition signaling pathway ultimately restrained proinflammatory cytokine release repressed proinflammatory macrophage polarization Moreover serum SEquol level lower influenza patient progressed phase negatively correlated serum level IL6 IL1β TNFα Collectively data highlighted gut derived SEquol promising postbiotic alleviating influenza pneumonia",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40780374/"
    },
    {
        "pmid": "40778490",
        "title": "Clinical Characteristics of Patients With Respiratory Infections After Nonpharmacological Interventions for COVID-19 in China Have Ended: Using Machine Learning Approaches to Support Pathogen Prediction at Admission.",
        "abstract": "aftermath COVID19 pandemic China witnessed surge respiratory virus infections presented considerable challenge primary health care systems study developed interpretable prediction model using complete blood count CBC test data model aim identify common respiratory virus infection patients studys derivation cohort included 7471 patient presented fever Central Hospital November December 2023 patient underwent diagnostic procedures including influenza Flu A Mycoplasma pneumoniae MP antibody testing CBC basis result CBC patients basic information modelling prediction machine learning ML performed external verification conducted Among developed models constructed two distinct version threeclass model one emphasizing high recall balancing precision recall final model refined manual parameter adjustment comprehensive network search highrecall model demonstrated superior performance detecting Flu A recall rate 810 Conversely precision‒recall balanced model exhibited enhanced accuracy identifying MP cases precision rate 843 interpretable ML model achieves accurate identification Flu MP infection febrile patient also address prevalent black box concern associated ML techniques technique aid clinician enhancing diagnostic efficiency accuracy Therefore improvement lead reduced medical expense minimizing unnecessary test treatments",
        "mesh_terms": [
            "Humans",
            "Machine Learning",
            "COVID-19",
            "China",
            "Male",
            "Female",
            "Middle Aged",
            "Influenza, Human",
            "Adult",
            "SARS-CoV-2",
            "Respiratory Tract Infections",
            "Aged",
            "Pneumonia, Mycoplasma",
            "Blood Cell Count",
            "Influenza A virus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778490/"
    },
    {
        "pmid": "40778160",
        "title": "Effective Aerosol Inoculation of Dose-Escalated Seasonal Influenza H3N2 Virus in Controlled Human Infection Model.",
        "abstract": "Human challenge model CHIMs instrumental advancing influenza research traditionally relied intranasal inoculation mimic natural aerosol transmission virus conducted doseescalation influenza CHIM study evaluate safety feasibility two modern aerosol delivery systems flowfocusing monodisperse aerosol generator FMAG medical nebulizer Fourteen healthy adult aged 1849 year exposed influenza APerth162009 H3N2 controlled inpatient setting Infection rate 75 34 FMAG 50 24 nebulizer higher dose Infections selflimited sinus congestion rhinorrhea cough common symptoms serious adverse event occurred Viral shedding reproducible across respiratory sites seroconversion occurred 33 infected participants Symptom timing viral kinetics comparable observed prior intranasal CHIMs Participants receiving nebulizerdelivered virus showed earlier viral detection oral cavity suggesting broader airway deposition finding demonstrate aerosol influenza challenge safe effective simulate natural infection accurately intranasal delivery reintroduction aerosolized influenza challenge provides robust platform studying transmission dynamics tissuespecific immune responses evaluating nextgeneration vaccine therapeutic condition better approximate realworld exposure demonstrated controlled human infection doseescalated H3N2 influenza virus via two safe effective aerosolization route provide accurate simulation realworld exposure intranasal delivery studying influenza transmission tissuespecific immune responses vaccinestherapeutics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778160/"
    },
    {
        "pmid": "40777507",
        "title": "Hybrid peptide DNA nanomaterials enable potent and broad-spectrum virus neutralization.",
        "abstract": "continued emergence antigenic drift drugresistant viral strain highlight need antiviral strategy deliver robust efficacy broad subtype coverage minimal offtarget toxicity demonstrate potent broadspectrum strategy employ hybrid biomaterials Urumin a host defense peptide honeycomb HC DNA origami spatially organized multivalent presentation enhanced antiviral efficacy Molecular dynamic simulation reveal Urumin penetrates destabilizes hemagglutinin HA trimer core disrupting influenza viral IAV entry Arranging Urumin trimeric cluster HC enables potent multivalent binding trimeric IAV enhancing antiviral efficacy nanomolar concentrations 1000fold effective free Urumin vitro assay confirm HCUrumin outperforms free Urumin blocking viral entry preserving cell viability IAV subtypes vivo study show compared free Urumin HCUrumin treatment reduces disease severity preserve physiological behavior decrease mortality infected mice maintaining virusspecific adaptive immune response without altering humoral immunity study offer advanced effective material platform strategy broadspectrum lowdose intervention human animal IAVs adapted combat virus patterning corresponding host defense peptide custom designed DNA nanostructures",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40777507/"
    },
    {
        "pmid": "40776896",
        "title": "Increase in serogroup W invasive meningococcal disease in England associated with pilgrimage to Saudi Arabia, January 2024 to June 2025.",
        "abstract": "England experiencing increase serogroup W invasive meningococcal disease IMD caused strain A meningococcal sequence type 11 clonal complex MenWcc11 Hajj strain sublineage Travelassociated nontravelassociated meningococci four strain substrains A1A4 accounted 32 59 MenW IMD case January 2024 June 2025 14 people returning Saudi Arabia household contacts eight 14 linked Umrah pilgrimage Communications MenACWY vaccination pilgrim yearround reinforced",
        "mesh_terms": [
            "Humans",
            "Saudi Arabia",
            "Male",
            "England",
            "Adult",
            "Female",
            "Meningococcal Infections",
            "Neisseria meningitidis",
            "Travel",
            "Meningococcal Vaccines",
            "Middle Aged",
            "Adolescent",
            "Child",
            "Serogroup",
            "Young Adult",
            "Neisseria meningitidis, Serogroup W-135",
            "Aged",
            "Meningitis, Meningococcal",
            "Disease Outbreaks",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776896/"
    },
    {
        "pmid": "40775301",
        "title": "A ductule dacryolith misdiagnosed as refractory conjunctivitis: a case report.",
        "abstract": "Dacryoliths located temporal canthus relatively rare presented case giant ductule dacryolith associated Haemophilus influenzae described clinical features female patient presented persistent secretion lateral canthal region right eye Surgical exploration performed bacterial culture tissue pathology analysis magnetic resonance imaging MRI examination completed huge ductule dacryolith found temporal canthus composed amorphous acidic substances bacterial culture result showed infection Haemophilus influenzae postoperative MRI result showed sign inflammation around lacrimal gland patients symptom disappeared immediately operation Ductule dacryoliths rare worth considering patient present unilateral lateral refractory conjunctivitis",
        "mesh_terms": [
            "Humans",
            "Female",
            "Diagnostic Errors",
            "Magnetic Resonance Imaging",
            "Conjunctivitis",
            "Lacrimal Duct Obstruction",
            "Lacrimal Apparatus Diseases",
            "Haemophilus Infections",
            "Eye Infections, Bacterial",
            "Calculi",
            "Haemophilus influenzae",
            "Dacryocystorhinostomy"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775301/"
    },
    {
        "pmid": "40775020",
        "title": "The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trial.",
        "abstract": "YKYY017 SARSCoV2 membrane fusion inhibitor report efficacy safety inhaled YKYY017 COVID19 patient mild moderate illness phase 2 trial ChiCTR2300075467 239 patient aged 1875 year mostly mild COVID19 randomly allocated receive aerosol inhalation 10 20 mg YKYY017 placebo daily primary endpoint change SARSCoV2 viral load baseline Day 4 mean ±SE difference viral load change baseline 048 ± 027 logsub10sub copiesmL 95 CI 101 006 20 mg group 027 ± 027 logsub10sub copiesmL 95 CI 079 026 10 mg group compared placebo group Viral load change visit Day 4 differ significantly placebo either 10 20 mg YKYY017 groups time sustained symptom recovery shorter 20 mg YKYY017 group median 11753 95CI 9533 14145 hours placebo group median 14300 95CI 13917 18687 hours HR 1552 95CI 1089 2214 p  00151 whereas 10 mg YKYY017 group showed similar statistically significant trend compared placebo p  00833 time sustained symptom alleviation shorter 20 10 mg YKYY017 group placebo group adverse event mostly mild moderate primary outcome met Following supplementary phase 1b trial planning another phase 23 trial using twicedaily 20 mg YKYY017 regimen assess efficacy safety",
        "mesh_terms": [
            "Humans",
            "Middle Aged",
            "Adult",
            "Male",
            "Female",
            "SARS-CoV-2",
            "Administration, Inhalation",
            "Viral Load",
            "Aged",
            "COVID-19 Drug Treatment",
            "COVID-19",
            "Adolescent",
            "Young Adult",
            "Antiviral Agents",
            "Treatment Outcome",
            "Double-Blind Method"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775020/"
    },
    {
        "pmid": "40774301",
        "title": "[Immunosuppression in Cancer: Strategies for Infection Prevention].",
        "abstract": "Antimicrobial prophylaxis important cornerstone reducing morbidity mortality cancer patients Important stride made recent year vaccination drug prophylaxes use growthfactor support detail change respective recommendation herePatients malignant disease recommended receive vaccination common respiratory pathogen COVID19 influenza pneumococci RSV influenza now trivalent vaccine pneumococcus now PCV20 preferred vaccine changed VZV vaccination using inactivated virussubunit also recommended prevent reactivations profound Bcell depletion caused CART cell therapy increasingly considered vaccination recommendationsIn highrisk situations antibiotic prophylaxis using fluoroquinolones used However due increasing resistance significant side effects approach critically evaluatedPosaconazole recommended standard prophylaxis patient neutropenia 7 day 05GL hematologic malignancies Isavuconazole offer effective alternative patient cannot tolerate posaconazole Interactions antifungal agent oncological therapy becoming increasingly relevant particular attention CYP450enzyme inducinginhibiting substances Nonpharmacological measure prevent fungal infection part recommendations include smoking cessationPharmacological prophylaxis COVID19 generally recommendedThe threshold primary growthfactorsupport lowered GCSF generally recommended risk febrile neutropenia 20 or patient inherent risk factor present 10 new longacting nonPEGcontaining GCSF preparation approved 2024Good collaboration oncologist general practitioner essential translate recommendation clinical practice",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Immunocompromised Host",
            "Neoplasms"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40774301/"
    },
    {
        "pmid": "40773213",
        "title": "Geroscience: A Translational Review.",
        "abstract": "incidence stroke heart failure dementia many cancers coronary artery disease physical disability rise exponentially age Geroscience relatively new discipline aim define modify agingrelated biologic pathways slow agerelated disability prevent agerelated diseases increase disabilityfree survival Medical therapy typically alter biologic pathway treat prevent specific diseases example 3hydroxy3methylglutarylcoenzyme reductase inhibitor statins cholesterollowering medication used prevent development progression atherosclerosis However diseasefocused treatment alter agings effect disease declining function eg statin significantly reduce noncardiovascular mortality cancer animal models treatment alter agings effect disease example mice caloric restriction increase mean lifespan 10 40 compared mouse fed ad libitum favorably affect multiple cellular pathway implicated aging including nutrient sensing protein synthesis autophagy inflammation adult obesity diabetes compared noncaloric restriction intervention groups randomization receive caloric restriction associated 15 reduction allcause mortality lower incidence weightrelated chronic diseases Rapamycin drug approved suppress posttransplant organ rejection increased mouse median lifespan 249 day female 154 day males rapamycin analogue everolimus improved antibody titer influenza vaccine older adults humans senescent cell increase abundance age characterized growth arrest apoptosis resistance altered secretome the set protein secreted cell extracellular space greater abundance senescent cell associated physical impairment increased mortality Reducing number cell animal model extends lifespan improves physical function grip strength mobility cardiac ejection fraction However potential health benefit reducing senescent cell human remain unclear Therapies inhibit aging biology caloric restriction metformin senolytics rapalogs may slow development progression disease functional decline humans",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40773213/"
    },
    {
        "pmid": "40773168",
        "title": "Using the CARD system for university-based pop-up vaccination clinics: A two-stage hybrid effectiveness-implementation study.",
        "abstract": "Mass vaccination clinic efficiently vaccinate large number people CARD system Comfort Ask Relax Distract vaccination delivery framework improve experience vaccine recipient providers twostage hybrid effectivenessimplementation study implemented sustained CARD universitybased vaccination clinic involving pharmacy student vaccinators Stage 1 beforeandafter study conducted across four COVID19 vaccination clinic NovemberDecember 2022 Stage 2 single cohort study whereby CARD sustained across four COVID19influenza vaccination clinic November 2023 stages vaccine recipient rated experience relative last vaccination iprimary outcomei symptom pain fear dizziness using surveys Pharmacy student vaccinator completed attitude behavior surveys subsample participated focus groups Stage 1 vaccine recipient period vs before reported better vaccination experience relative last vaccination 640 v 336 ipi  001 ini  181 Fear pain lower 11 vs 17 ipi  03 16 vs 21 ipi  02 respectively Stage 2 574 95 CI 531616 ini  542 vaccine recipient reported better experience Across stages pharmacy student positive attitude acceptability feasibility sustainability CARD reported high fidelity CARDrecommended interventions CARD recommended universitybased vaccination clinic improve vaccine recipient provider experiences",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Universities",
            "COVID-19",
            "Adult",
            "COVID-19 Vaccines",
            "Students, Pharmacy",
            "Vaccination",
            "SARS-CoV-2",
            "Middle Aged",
            "Surveys and Questionnaires",
            "Mass Vaccination",
            "Influenza Vaccines",
            "Young Adult",
            "Cohort Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40773168/"
    },
    {
        "pmid": "40772820",
        "title": "Influenza strains in focus: global approaches to the diagnosis, treatment, and control of H1N1, H3N2, H7N9, and H9N2.",
        "abstract": "Influenza virus various strain significant risk global health influenza various strain caused various periodic outbreak pandemics delve review study history threat possessed four prominent strain influenza H1N1 H3N2 H7N9 H9N2 also examines recent notable outbreak posed influenza strains 2009 H1N1 pandemic originated swine spread worldwide rapidly outbreak highlighted gap preparation response global healthcare system strain H3N2 long history frequent outbreak distress public health health care sector due evolution ability adapt 2013 China novel strain identified high mortality rate potential humantohuman transmission remains concern public health Another strain H9N2 though less infectious monitored ability cause pandemic future distinct genetic makeup sporadic human infection cause worry review outline difference similarities importance vigilant surveillance effective treatment strategies preparedness measure mitigate future influenza outbreaks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40772820/"
    },
    {
        "pmid": "40772746",
        "title": "[Fever, tetraparesis and confusion - neurological phenomena in influenza].",
        "abstract": "case study present unusual course 40yearold patient clinical sign viral infection leading gastrointestinal symptoms short term developed progressive ascending sensorimotor tetraparesis autonomic symptom well qualitative disturbance consciousness need intensive medical care Imaging revealed transverse myelitis diffusion disorder splenium socalled CLOCC lesion diagnosis mild encephalopathy reversible splenial lesion MERS longitudinally extensive transverse myelitis LETM made influenza B infection diagnosed causative disease immunologically triggered pathogenesis Immunosuppressive therapy indicated",
        "mesh_terms": [
            "Humans",
            "Male",
            "Adult",
            "Quadriplegia",
            "Influenza, Human",
            "Diagnosis, Differential",
            "Confusion",
            "Myelitis, Transverse",
            "Magnetic Resonance Imaging",
            "Fever of Unknown Origin",
            "Corpus Callosum",
            "Influenza B virus",
            "Diffusion Magnetic Resonance Imaging"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40772746/"
    },
    {
        "pmid": "40772686",
        "title": "A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants.",
        "abstract": "emergence severe acute respiratory syndrome coronavirus 2 SARSCoV2 variant necessitated continuous updating vaccines contrast antiviral remained effective target conserved viral protein essential viral life cycle However several mutation SARSCoV2 may affect efficacy United States US Food Drug Administration FDAapproved antiviral recently identified Detecting drugresistant SARSCoV2 mutant investigating escape mechanisms critical guide selection effective antiviral therapies study constructed attenuated recombinant rSARSCoV2 lacking open reading frame ORF protein 3a 7b expressing nanoluciferase Nluc rSARSCoV2 Δ3a7bNluc facilitate tracking viral infection Using virus selected drugresistant mutant main viral protease Mpro inhibitor nirmatrelvir passaging Δ3a7bNluc 10 time presence increasing concentration nirmatrelvir virus population enhanced resistance selected identified two nonsynonymous mutation L50F R188G Mpro encoded nonstructural protein 5 NSP5 gene Using reverse genetics generated rSARSCoV2 Δ3a7bNluc containing identified L50F R188G mutations individually combination assessed contribution nirmatrelvir resistance result indicate mutation involved escaping nirmatrelvir Altogether result demonstrate feasibility using rSARSCoV2 Δ3a7bNluc variant identify validate mutation confer resistance FDAapproved antiviral drug without concern conducting gain function GoF experiment wildtype WT form SARSCoV2 Smallmolecule antiviral drug used treatment severe acute respiratory syndrome coronavirus 2 SARSCoV2 infections However drugresistant SARSCoV2 mutant currently United States Food Drug Administrationapproved Mpro targeting antiviral identified Information SARSCoV2 escape mutant mutation affecting antiviral activity licensed antiviral remains limited study developed nanoluciferase Nlucexpressing attenuated recombinant rSARSCoV2 lacking ORF 3a 7b protein Δ3a7bNluc identify nirmatrelvirresistant mutant without biosafety concern associated gainoffunction GoF research using wildtype WT SARSCoV2 Using Δ3a7bNluc selected variant reduced sensitivity nirmatrelvir validated generation rSARSCoV2 Δ3a7bNluc containing candidate L50F R188G mutation Mpro result demonstrate feasibility using rSARSCoV2 Δ3a7bNluc safely identify validate drugresistant mutant overcoming concern originating adaptation study using WT SARSCoV2",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40772686/"
    },
    {
        "pmid": "40772137",
        "title": "A Case Report of Atypical Hemolytic Uremic Syndrome Presenting With Disseminated Intravascular Coagulation.",
        "abstract": "previously healthy sevenyearold boy presented clinical laboratory finding consistent atypical hemolytic uremic syndrome aHUS given thrombocytopenia microangiopathic hemolytic anemia MAHA acute kidney injury setting influenza A Notably also met diagnostic criterion disseminated intravascular coagulation DIC time presentation clinical finding including prolonged prothrombin time PT markedly elevated Ddimer low fibrinogen aHUS DIC share overlapping clinical features traditionally regarded distinct entities aHUS driven complement dysregulation DIC widespread activation coagulation cascade resulting microvascular thrombosis consumptive coagulopathy secondary fibrinolysis patient treated supportive care eculizumab terminal complement inhibitor leading rapid sustained clinical laboratory improvement without recurrence case highlight diagnostic therapeutic complexity concurrent aHUS DIC lends clinical support emerging hypothesis uncontrolled complement activation may contribute DIC underscore value early recognition complementdirected therapy atypical hemolytic uremic syndrome HUS",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40772137/"
    },
    {
        "pmid": "40771963",
        "title": "Glycosylation of canine tetherin is essential for its antiviral activity against H3N2 canine influenza virus.",
        "abstract": "Tetherin interferoninducedexpressing transmembrane protein utilizes unique topology restrict release enveloped virus surface cell membrane Nlinked glycosylation play important role protein posttranslational modifications investigate role glycosylation antiviral activity canine tetherin potential glycosylation site predicted mutated effect glycosylation site mutation treatment glycosylation inhibitor ability canine tetherin restrict H3N2 canine influenza virus CIV replication examined Mutations glycosylation site canine tetherin N72A N99A N7299A lead change intracellular distribution weakened even lost antiviral activity H3N2 CIV Similarly subcellular localization tetherin tunicamycin treatment altered antiviral activity weakened Colocalization analysis revealed colocalization canine tetherin H3N2 CIV protein weakened condition impaired glycosylation result indicate canine tetherin maintains localization cell membrane glycosylation exerts antiviral activity study provides new insight antiviral mechanism host restriction factor offer theoretical basis developing smallmolecule antiinfluenza strategy targeting glycosylation modifications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771963/"
    },
    {
        "pmid": "40771611",
        "title": "AVIAN INFLUENZA VIRUS: THE NEXT PANDEMIC?",
        "abstract": "Novel avian influenza virus continue circulate animal specie around world show propensity reassort acquire virulence factors raise concern virus may adapt humans Pandemic preparedness relied heavily vaccine stockpiles However avian influenza strain genetically drift time stockpiled vaccine often fail elicit protective immunity genetic variants Various strategy help overcome immune imprinting immunological hyporeactivity well broaden immune response variant viruses Adjuvants remain key strategy improving immunological response avian influenza antigens Today three vaccine approved United States H5N1 influenza virus though continued focus surveillance pandemic preparedness essential prepare possibility humantohuman spread highly pathogenic influenza virus",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Birds",
            "Influenza A Virus, H5N1 Subtype",
            "Influenza in Birds",
            "Influenza Vaccines",
            "Influenza, Human",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771611/"
    },
    {
        "pmid": "40771428",
        "title": "Shu-Feng-Jie-Biao Formula Ameliorates Influenza A Virus-Induced Acute Lung Injury by Inhibiting NF-κB and ERK MAPK Signaling Pathways.",
        "abstract": "ShuFengJieBiao formula SFJBF used treat acute respiratory infection dozen years study aimed explore mechanism effect treatment influenza Network pharmacology used explore underlying mechanism SFJBF influenza protective effect SFJBF vivo evaluated lung indexes body weight loss pathological change lungs antiinflammatory effect vivo evaluated flow cytometry ELISA RAW2647 cell stimulated imiquimod R837 used determine antiinflammatory effect SFJBF Neutrophils isolated bone marrow activated phorbol 12myristate 13acetate PMA validate effect active component SFJBF SFJBF protected body weight loss decreased lung indexes reduced total protein content lung mitigated pathological change mice SFJBF inhibited expression chemokines iCxcl2i iCcl2i cytokine iIl1bi IL6 accompanied decreased infiltration neutrophil lungs SFJBF inhibited expression iNOS MPO lungs synergistic role OSV SFJBF exhibited suppressing virusinduced cytokine expression reducing infiltration inflammatory monocyte lungs SFJBF inhibited phosphorylation ERK12 NFκBp65 thereby reducing secretion MIP2 TNFα MCP1 CCL5 vitro active component SFJBF including baicalin wogonin reduced production reactive oxygen specie ROS MIP2 MCP1 IL6 vitro SFJBF ameliorated virusinduced lung injury suppressing overactivated immune response via NFκB ERK MAPK signaling pathways thereby protecting mouse influenza virus infection SFJBF could considered potent therapeutic agent treating influenza",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771428/"
    },
    {
        "pmid": "40771164",
        "title": "Repeated Annual Seasonal Influenza Vaccination of Patients With Circulatory Disease as Secondary Prevention of Cardiovascular Events: an Additional Self-Controlled Case Series Analysis.",
        "abstract": "Aim assess effect annual seasonal flu vaccination 3 year risk acute respiratory infection ARI cardiovascular event CVE cardiological patient followed using two analytical methodsMaterial method prospective comparative study included 817 patient October 2012 CVE chronic noncommunicable diseases ARI recorded October 2012 November 2015 analyzed Vaccinated unvaccinated patient compared using survival curve selfcontrolled case series method paired 6month periods Differences considered statistically significant plt005Results analysis included 813 patient mean age 633±116 years 405 men 201213201314201415 season 454441 patients respectively vaccinated 1 2 3 vaccination received 60 57 285 patients respectively 413 unvaccinated Compared unvaccinated patients patient vaccinated three time developed first ARI later plt00001 relative risk developing cardiovascular complication CVC 088 95 confidence interval 065110 Among vaccinated patients fewer patient ARI plt0001 cardiovascular disease p002 summer compared winter also summer ARI developed 412 fewer patient unvaccinated p0002Conclusion use two analytical method allowed u identify additionally nonspecific persistent specific effect threeyear flu immunization cardiological patient summer need confirmed randomized placebocontrolled studies",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Influenza Vaccines",
            "Middle Aged",
            "Cardiovascular Diseases",
            "Influenza, Human",
            "Secondary Prevention",
            "Vaccination",
            "Seasons",
            "Prospective Studies",
            "Aged",
            "Russia"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771164/"
    },
    {
        "pmid": "40771119",
        "title": "Impact of the 2018 Western Japan Heavy Rain Disaster on Anti-influenza Virus Drug Prescribing: A Longitudinal Analysis Using the National Health Insurance Claims Database.",
        "abstract": "study evaluated relationship heavy rain disaster influenza comparing victim nonvictims investigated association 2018 western Japan heavy rain disaster influenza patient registered National Health Insurance Claims Database treated Hiroshima Okayama Ehime prefecture included retrospective cohort study conducted 1year postdisaster multivariate mixedeffects logistic regression analysis used assess association disaster antiinfluenza drug prescribing differenceindifferences analysis conducted assess antiinfluenza drug use 4month period immediately every 4 month year postdisaster study included 6 176 300 individual victims 36 076 060 2573 71 458 157 74 victim nonvictim groups respectively used antiinfluenza drug year following flood victim significantly likely nonvictims use antiinfluenza drug risk ratio 118 95 confidence interval CI 112142 victim used significantly antiinfluenza drug 4 month immediately postdisaster compared disaster odds ratio 362 95 CI 177741 Antiinfluenza drug use higher among victim 2018 Western Japan heavy rain disaster among nonvictims",
        "mesh_terms": [
            "Humans",
            "Japan",
            "Male",
            "Female",
            "Retrospective Studies",
            "Antiviral Agents",
            "Middle Aged",
            "Adult",
            "Influenza, Human",
            "Longitudinal Studies",
            "Aged",
            "Databases, Factual",
            "Drug Prescriptions",
            "National Health Programs",
            "Cohort Studies",
            "Logistic Models",
            "Child",
            "Adolescent",
            "Disasters"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771119/"
    },
    {
        "pmid": "40770623",
        "title": "The epidemiology of infectious meningitis in Ghana: a systematic review and meta-analysis.",
        "abstract": "Meningitis significant health concern associated high fatality rates particularly resourcelimited setting Ghana whose northern region lie within African Meningitis Belt Despite plethora primary research data meningitis Ghana systematic review provides comprehensive information guide prevention control management effort yet undertaken systematic review therefore aimed bridging gap describing epidemiology meningitis Ghana including prevalence aetiology antimicrobial resistance comprehensive review electronic databases including PubMed Scopus conducted 2nd 4th December 2023 following established PRISMA guidelines search encompassed article published 1975 2023 age limitation study participants data extraction performed peerreviewed journal article reporting primary findings Studies exclusively reported meningitis animal models vitro vivo excluded Studies sample size less ten excluded analysis metaanalysis carried determine pooled estimate meningitis prevalence country 71205 suspected meningitis case analysed study period 3865 confirmed pooled overall prevalence 1813 Specifically case occurred nonoutbreak outbreak period pooled prevalence 1622 2391 respectively case fatality rate ranged 20 47 1998 2015 082 286 2016 2021 three northern region  Upper East 3085435 Northern 163464 Upper West 1796388  relatively high meningitis prevalence Greater Accra Ashanti Regions prevalence ranging 08 329 Streptococcus pneumoniae Neisseria meningitidis Haemophilus influenzae predominant isolates accounting 048777 25695 090340 cases respectively bacterial isolates meningitis case susceptible ceftriaxone common Neisseria meningitidis serogroups W135 A Y X Serotype 1 dominated among Streptococcus pneumoniae serotypes disparity distribution meningitis Ghana highest prevalence occurring northern part country seems reduction case fatality rate years probably due intervention vaccinations Ceftriaxone continues suitable treatment option meningitis continuous surveillance meningitis aetiological agent  especially serotyping common pathogen  help guide national vaccination policy programmes",
        "mesh_terms": [
            "Ghana",
            "Humans",
            "Prevalence",
            "Meningitis, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770623/"
    },
    {
        "pmid": "40770596",
        "title": "Influenza vaccination uptake of health care workers in a tertiary hospital: Findings from qualitative research in Mysuru, India.",
        "abstract": "Vaccinating health care worker HCWs common way prevent influenzarelated infection transmission patient absenteeism HCWs India influenza contributes 130000 death per year yet vaccination uptake HCWs low Fifteen percent HCWs received one vaccination 5 years study explored social context influenza vaccine uptake among HCWs including physicians nurse medical student teaching hospital Mysuru South India generate insight inform influenza vaccination campaign targeting HCWs Qualitative methods including indepth interview HCWs structured observation various department hospital applied result indicate influenza vaccination uptake among HCWs low due personal factor related little perceived personal threat emphasis prevention technique avoid transmission cost vaccine needle anxiety Besides institutional factors absence recommendation superior lack promotion campaign contribute low uptake conclusion HCW vaccination education promotion regarding diminishing personal transmission risk influenza virus uniform vaccination guideline strategy improve access including burdened cost vaccine suggested",
        "mesh_terms": [
            "Humans",
            "India",
            "Influenza, Human",
            "Influenza Vaccines",
            "Qualitative Research",
            "Tertiary Care Centers",
            "Female",
            "Male",
            "Adult",
            "Health Personnel",
            "Vaccination",
            "Interviews as Topic",
            "Attitude of Health Personnel",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770596/"
    },
    {
        "pmid": "40770014",
        "title": "Top 10 drugs most frequently associated with adverse events of myocarditis and pericarditis.",
        "abstract": "Myocarditis pericarditis managed various treatments yet prior study case report indicate certain drug class may elevate risk inflammatory cardiac conditions research aimed systematically identify leading drug frequently associated myocarditis pericarditis cases Analyses carried using global database individual case safety report 1968 2024 identified drug frequently reported signal detection myocarditis pericarditis selecting top 10 drug based record count excluding used treatment inflammatory cardiac condition avoid potential confounding Two statistical indicators information component IC ICsub025sub reporting odds ratio ROR 95 confidence interval CI used conduct disproportionality analysis study following five drug consistently observed myocarditis pericarditis clozapine mesalazine smallpox vaccine influenza vaccine COVID19 mRNA vaccine leading drug differed condition nivolumab pembrolizumab ipilimumab valproate metronidazole appearing frequently myocarditis ribavirin sulfasalazine methotrexate omalizumab heparin pericarditis drug showed significant signal detection myocarditis ROR 8322 95 CI 81178533 IC 396 ICsub025sub 394 pericarditis 4216 41194316 366 364 Although finding allow causal inference finding highlight importance monitoring possible adverse carditis case prescribing drugs study encouraged investigate underlying mechanisms assess individual patient risk factors explore longterm impact associated myocarditis pericarditis relation drug",
        "mesh_terms": [
            "Myocarditis",
            "Humans",
            "Pericarditis",
            "Drug-Related Side Effects and Adverse Reactions",
            "Databases, Factual",
            "Male",
            "Adverse Drug Reaction Reporting Systems",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770014/"
    },
    {
        "pmid": "40769533",
        "title": "<i>Haemophilus influenzae</i> in bronchiectasis.",
        "abstract": "Bronchiectasis chronic respiratory disease characterised irreversible bronchial dilation persistent productive cough alternating period clinical stability exacerbations distorted airway impair mucus clearance making susceptible recurrent infection chronic inflammation iHaemophilus influenzaei common pathogen bronchiectasis according international registries employ several virulence mechanisms including adhesion intracellular invasionsurvival biofilm formation evasion antibiotic treatments establish infection mechanism allow iH influenzaei persist respiratory tract evade host immune defences Although role welldocumented airway diseases impact iH influenzaei bronchiectasis remains incompletely understood International guideline recommend eradication therapy iH influenzaei upon first isolation intervention advised iPseudomonas aeruginosai cases Longterm immunomodulatory treatment macrolides option patient bronchiectasis chronic iH influenzaei infection frequent exacerbations though carry risk promoting antibiotic resistance iPseudomonasienriched airway microbiome Studies indicate significant negative interaction iP aeruginosai iH influenzaei suggesting competitive relationship influence microbiome dynamic potentially affect clinical outcomes Currently insufficient evidence support vaccination nontypeable iH influenzaei chronic airway disease Despite frequent detection respiratory samples precise role iH influenzaei bronchiectasisrelated morbidity disease progression fully understood warrant investigation review examines impact iH influenzaei bronchiectasis pathophysiology progression comparing role chronic respiratory diseases",
        "mesh_terms": [
            "Humans",
            "Bronchiectasis",
            "Haemophilus influenzae",
            "Haemophilus Infections",
            "Anti-Bacterial Agents",
            "Host-Pathogen Interactions",
            "Lung",
            "Risk Factors",
            "Treatment Outcome",
            "Virulence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769533/"
    },
    {
        "pmid": "40768948",
        "title": "Point-of-need one-pot multiplexed RT-LAMP test for detecting three common respiratory viruses in saliva.",
        "abstract": "Respiratory viral infection pose significant global public health challenge partly due difficulty rapidly accurately distinguishing virus similar symptom point care hindering timely appropriate treatment limiting effective infection control prevention efforts Here developed multiplexed noninvasive salivabased reverse transcription loopmediated isothermal amplification RTLAMP test enables simultaneous detection three common respiratory infections severe acute respiratory syndrome coronavirus 2 SARSCoV2 Influenza Flu respiratory syncytial virus RSV single reaction via specific probe monitored realtime machinelearningenabled compact analyzer result demonstrate multiplexed assay effectively detect three target RNAs high accuracy Further testing spiked saliva sample showed strong agreement reverse transcription polymerase chain reaction RTPCR assay area curve AUC value 082 093 096 RSV Influenza SARSCoV2 respectively enabling rapid detection respiratory infection easily collected saliva sample point care device presented offer practical efficient tool improving outcome helping prevent spread contagious diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768948/"
    },
    {
        "pmid": "40766376",
        "title": "Immunomodulation of the Innate Host Response by Mesenchymal-Derived Versican during Influenza A Virus Infection.",
        "abstract": "Viral bacterial lung infection place significant burden public health Versican extracellular matrix ECM chondroitin sulfate proteoglycan coordinate innate immune response multiple experimental models Versicans potential immunomodulatory molecule make promising therapeutic target controlling hosts immune response lung infection However versicans contribution lung inflammation injury immune cell activity influenza virus IAV infection represents critical knowledge gap address central hypothesis mesenchymalderived versican proinflammatory enhances innate immune response IAV infection generated tamoxifeninducible mouse deficient mesenchymalderived versican B6 Col1a2CresupERTsupVcansuptm11Cwfsup Col1a2Vcansupsup report mesenchymalderived versican play critical role neutrophil monocyte dendritic cell migration lung airway early IAV infection Intriguingly mesenchymalderived versican deficiency substantial negative impact neutrophil emigration lungs found neutrophil less adhesive ECM Col1a2Vcansupsup mouse lung fibroblast mLFs significant decrease versican compared wildtype mLFs Additionally Col1a2Vcansupsup mLFs treated polyIC iin vitroi reduced cellassociated hyaluronan finding suggest fibroblastderived versican necessary adhesion lung fibroblast neutrophil transit lung interstitium airway pulmonary vasculature finding demonstrate mesenchymalderived versican key regulator early host immune response IAV",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40766376/"
    },
    {
        "pmid": "40766360",
        "title": "Stabilization of H5 highly pathogenic avian influenza hemagglutinin improves vaccine-elicited neutralizing antibody responses.",
        "abstract": "Transmission highly pathogenic avian influenza H5 clade 2344b expanded recent year infect large population bird mammals heightening risk human pandemic Influenza virus adapted transmission bird animal tend less stable hemagglutinin HA seasonal influenza viruses enabling membrane fusion comparatively high pH levels Here combine five mutation within H5 HA dramatically increase melting temperature promote stable closure HA trimer Structural analysis cryoelectron microscopy revealed stabilizing mutation create several new hydrophobic interactions maintaining local HA structure found vaccinating mouse stabilized H5 HA immunogen resulted higher hemagglutination inhibition neutralization titer nonstabilized comparators Epitope mapping vaccineelicited polyclonal antibody response using negative stain electron microscopy deep mutational scanning showed site E side HA receptor binding domain immunodominant across groups however stabilized immunogen shifted response toward receptor binding site RBS eliciting higher proportion neutralizing antibodies finding highlight H5 HAstabilizing mutation enhance quality antibody response across different vaccine formats underscoring potential improve pandemic preparedness vaccine targeting virus widely circulating clade",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40766360/"
    },
    {
        "pmid": "40764862",
        "title": "Recent updates regarding the management and treatment of pneumonia in pediatric patients: a comprehensive review.",
        "abstract": "Pneumonia remains one leading cause illness death among children particularly low middleincome countries review present comprehensive update pediatric pneumonia covering recent advance etiology clinical presentation diagnostic tools treatment strategies prevention efforts explore traditional emerging diagnostic methods including use biomarkers like Creactive protein procalcitonin molecular testing pointofcare lung ultrasound Treatment approach discussed detail focus appropriate antibiotic use antiviral antifungal therapies supportive care oxygen therapy fluid management newer intervention like highflow nasal cannula therapy Preventive measures including introduction global rollout pneumococcal influenza RSV vaccines also emphasized addition review highlight ongoing challenge antimicrobial resistance healthcare disparities limited accessibility advanced diagnostic tool resourcepoor settings Finally outline research gap stress need strong public health policies global collaboration continued innovation reduce burden pediatric pneumonia improve outcome child worldwide Highlights Pediatric pneumonia continues cause high morbidity mortality especially low middleincome countries Advances diagnostics including lung ultrasound procalcitonin testing molecular tools improved early detection Rational antibiotic use stewardship program vital addressing rising antimicrobial resistance New preventive tools pneumococcal influenza RSV vaccines play key role reducing disease burden Health disparity limited access care remain major challenges highlighting need policy reform global health initiatives",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764862/"
    },
    {
        "pmid": "40764767",
        "title": "Characteristics of children with influenza admitted to a pediatric hospital in Greece during the 2022/2023 and 2023/2024 seasons.",
        "abstract": "Influenza result high morbidity mortality globally year Data pediatric influenza Greece COVID19 pandemic lacking study aim evaluate characteristic outpatient hospitalized pediatric influenza case post COVID19 pandemic Greece retrospective observational study conducted Children 016 year old laboratoryconfirmed influenza presented emergency department childrens hospital 20222023 20232024 influenza season studied total 976 child mean age 7 years male 539 enrolled 48 history influenza vaccination Compared unvaccinated children vaccinated patient comorbidities 298 vs 33 p  0001 highrisk contact 43 vs 07 p  0014 total 223 child 228 hospitalized significantly younger outpatient mean age 57 vs 74 years p  0001 Younger age presence comorbidities symptom vomiting myositis respiratory distress significantly associated hospitalization p  0001 Vaccination reduce risk hospitalization OR 070 95CI 030163 p  0405 Hospitalized child frequently experienced complication 480 vs 167 received antibiotic 342 vs 144 oseltamivir 789 vs 419 p  0001 Main complication among hospitalized patient included myositis 125 acute otitis medium 121 febrile seizure 89 pneumonia 85 Two unvaccinated child comorbidities admitted PICU one died due acute necrotizing encephalopathy Hospitalized child influenza presented serious complications Although 13 comorbidities nearly half experienced complication hospitalization recently introduced universal immunization child  5 year old Greece expected reduce influenza morbidity population •Influenza acute respiratory viral infection significant impact public health representing major cause morbidity mortality worldwide •To date published data child influenza Greece postCOVID19 era •This study highlight burden influenzaassociated ED visit hospitalization Greece particularly among younger child comorbidities •While influenza vaccination decrease risk hospitalization cohort likely attributed low vaccination rate higher prevalence comorbidities vaccinated group",
        "mesh_terms": [
            "Humans",
            "Greece",
            "Influenza, Human",
            "Child",
            "Male",
            "Female",
            "Child, Preschool",
            "Retrospective Studies",
            "Infant",
            "Adolescent",
            "Hospitalization",
            "COVID-19",
            "Hospitals, Pediatric",
            "Seasons",
            "Influenza Vaccines",
            "Infant, Newborn",
            "Vaccination",
            "Comorbidity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764767/"
    },
    {
        "pmid": "40764589",
        "title": "Influenza B-associated acute myositis in a child in Sri Lanka: a case report.",
        "abstract": "Myositis characterized inflammation weakness skeletal muscles multifactorial condition caused various infectious autoimmune neuromuscular disorders Among these infective myositis rare significant clinical entity predominantly caused viral pathogens Viruses influenza enteroviruses rubella human immunodeficiency virus common culprits influenzaassociated myositis particularly welldocumented phenomenon Despite selflimiting nature many cases influenzaassociated myositis warrant clinical attention owing potential complication diagnostic challenge presents Influenza B less antigenically variable subtype compared influenza A increasingly recognized cause acute myositis especially pediatric populations report case 9yearold Sri Lankan girl central Sri Lanka presented 4day history fever cough cold followed bilateral calf pain difficulty walking examination exhibited bilateral calf tenderness normal muscle tone power reflexes without sensory impairment Basic hematological investigation within normal limits creatine kinase level markedly elevated 8370 UL indicating significant muscle damage Ultrasound imaging revealed inflammation calf muscles nasopharyngeal swab tested positive influenza B RNA confirming viral etiology Supportive care resulted complete symptom resolution within 10 day hospital discharge Influenzaassociated myositis important differential diagnosis child presenting muscle pain gait disturbance influenza season Early recognition laboratory confirmation condition prevent unnecessary investigation facilitate prompt patient management case highlight clinical diagnostic aspect influenza Bassociated myositis underscoring importance considering viral etiology pediatric patient acute myositis",
        "mesh_terms": [
            "Humans",
            "Child",
            "Influenza, Human",
            "Myositis",
            "Female",
            "Sri Lanka",
            "Influenza B virus",
            "Acute Disease",
            "Diagnosis, Differential",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764589/"
    },
    {
        "pmid": "40764134",
        "title": "[Clinical analysis of thirteen cases of pulmonary infection caused by <i>Nocardia otitidiscaviarum</i>].",
        "abstract": "bObjectiveb explore clinical characteristic patient pulmonary nocardiosis caused iNocardia otitidiscaviarumi enhance understanding disease bMethodsb retrospective analysis conducted clinical imaging pathogenic data 13 patient diagnosed pulmonary infection caused iNocardia otitidiscaviarumi Binzhou Peoples Hospital January 2022 December 2024 bResultsb patients age ranged 42 89 69±13 years 8 female 4 smoking history 5 male 3 smoking history clinical symptom included cough sputum production 8 patient including 1 dry cough fever 8 patients wheezing chest tightness 6 patients hemoptysis 3 patients Computed tomography CT scan chest showed 11 patient involvement lower lobe left lung 6 bilateral lung involvement 5 presented involvement upper lobe right lung 4 showed change middle lower lobe right lung 2 involvement upper lobe left lung imaging findings 8 patient exhibited consolidation shadows 5 displayed nodule shadows 4 necrotic cavity with 3 located lower lobe left lung Additionally 3 patient diagnosed bronchiectasis 1 necrotic lymph node 5 pleural effusion Microbial study result showed concomitant Aspergillus 3 cases iKlebsiella pneumoniaei 1 COVID19 infection 3 influenza 1 influenza B 1 13 patient demonstrated improvement following treatment trimethoprimsulfamethoxazole tablets bConclusionsb iNocardia otitidiscaviarumi rare form pulmonary nocardiosis occur individual preserved immune system pathogen associated severe clinical manifestations Furthermore risk iNocardia otitidiscaviarumi infection may exacerbated presence COVID19 virus influenza virus B Monitoring patient Aspergillus infection particularly crucial condition deteriorate rapidly posing considerable danger Consequently patient present aforementioned risk factor exhibit specific imaging features prompt screening diagnosis using metagenomic nextgeneration sequencing mNGS essential",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Nocardia Infections",
            "Middle Aged",
            "Retrospective Studies",
            "Aged",
            "Adult",
            "Nocardia",
            "Aged, 80 and over",
            "Tomography, X-Ray Computed",
            "COVID-19",
            "Lung",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764134/"
    },
    {
        "pmid": "40764073",
        "title": "Antimicrobial use for influenza-like illnesses in Nha Trang, Vietnam: a cross-sectional study.",
        "abstract": "study aimed investigate characteristic management influenzalike illness ILIs outpatient inpatient setting Vietnam crosssectional observational study conducted questionnaire survey 407 individual ILI symptom presented public community health centre paediatric ward public hospital city Nha Trang Khanh Hoa Province Vietnam December 2022 March 2023 applicable primary secondary outcome prespecified study explanatory study basic characteristic participant presented using descriptive statistics conducted multivariable logistic regression analysis examine factor associated prescription antibiotic outpatient ILIs total 198 outpatient 200 inpatient enrolled study inpatient child 5 year age experienced longer illness duration higher costs almost patient receiving antibiotics rate antimicrobial prescription ILIs 793 outpatient 995 inpatients median healthrelated quality life score participant aged ≥18 year illness 0796 IQR 06740922 Logistic regression analysis indicated negative association definite diagnosis viral infection rapid diagnostic test outpatient antibiotic prescription OR 020 p0006 study underscore widespread inappropriate antimicrobial use ILIs community Vietnam contributes avoidable economic health burden result study suggest implementing diagnostic tool may support antimicrobial stewardship efforts",
        "mesh_terms": [
            "Humans",
            "Vietnam",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Child, Preschool",
            "Adult",
            "Child",
            "Middle Aged",
            "Adolescent",
            "Influenza, Human",
            "Anti-Bacterial Agents",
            "Infant",
            "Young Adult",
            "Aged",
            "Surveys and Questionnaires",
            "Outpatients",
            "Quality of Life",
            "Logistic Models"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764073/"
    },
    {
        "pmid": "40763878",
        "title": "Immunization and cardiovascular disease in Latin America. The CorVacc study: rationale and design.",
        "abstract": "determine rate vaccination influenza pneumococcal disease general population Americas healthy sick analyze factor influencing rates InterAmerican Vaccination Registry Influenza Pneumococcus CorVacc Study crosssectional survey general population enacted 19 Latin American countries total 34 question given consecutive patient aged 18 year older online survey data analyzed country region according seven clusters demographics socioeconomic educational level cardiometabolic profile cardiovascular interventions medical followup treatments COVID19 vaccination status study conducted Prevention Council InterAmerican Society Cardiology study provide insight impact influenza pneumococcus vaccination Latin American population barrier preventing immunization target actualized Hopefully help facilitate development targeted focused health prevention strategies",
        "mesh_terms": [
            "Humans",
            "Latin America",
            "Cross-Sectional Studies",
            "Influenza Vaccines",
            "Cardiovascular Diseases",
            "Pneumococcal Vaccines",
            "Influenza, Human",
            "Vaccination",
            "Adult",
            "Registries",
            "Pneumococcal Infections",
            "COVID-19",
            "Research Design",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40763878/"
    },
    {
        "pmid": "40763596",
        "title": "Design and synthesis of norsesquiterpenoid-1,2,3-triazole derivatives and investigation of their anti-influenza virus activity.",
        "abstract": "Influenza highly contagious acute respiratory illness caused influenza virus continual emergence drugresistant viral strain created urgent need development novel antiinfluenza agents previous study identified series norsesquiterpenoids potent activity influenza virus isolated fermentation broth Streptomyces sp XM17an actinobacterial strain derived fresh panda feces Building findings synthesized core norsesquiterpene scaffold functionalized attaching various molecular fragment 123triazole linker containing heteroatoms utilizing click chemistry strategy approach aimed enhance antiviral potency structural diversification Among resulting compounds 14d demonstrated superior antiviral activity influenza virus along low 50  cytotoxic concentration Mechanistic study indicated compound 14d exerted antiviral effect later stage viral infection Notably inhibit neuraminidase activity Instead disrupted cellular nuclear factor kappa B signaling pathway suppressed virusinduced overexpression proinflammatory cytokines Collectively result highlight compound 14d promising lead candidate development novel therapeutic targeting influenza virus infection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40763596/"
    },
    {
        "pmid": "40760695",
        "title": "Healthcare workers' attitudes toward influenza vaccine prescriptions in China.",
        "abstract": "Vaccine prescription implemented applied China bolster promote vaccination campaign mitigate vaccine hesitancy study aim investigate current vaccine recommendation practice among healthcare worker HCWs China identify determinant influence willingness provide vaccination prescription informing intervention support implementation willingness practice crosssectional survey conducted among HCWs nationwide China July 3 July 10 2024 survey questionnaire distributed via link provided expertlistening platform 2024 World Influenza Conference representing diverse group across different healthcare institutions study used descriptive logistic regression analysis performed attitude toward providing influenza vaccination prescriptions Among 3140 responding HCWs 688 hospitalbased HCWs N  7781131 619 communitybased HCWs N  12432009 demonstrate willingness provide vaccine prescriptions HCWs history influenza vaccination adjusted odds ratio aOR  030 95 confidence interval CI 023039 P  0001 significantly inclined provide vaccine prescriptions Incentives including bonus reward aOR  184 95 CI 140243 P  0001 integration annualmonthly performance evaluation aOR  160 95 CI 120213 P  0001 enhanced willingness provide prescriptions term communication methods 634 HCWs N  1991 identified official public account promotion WeChat effective raising vaccination awareness significantly surpassing provide vaccine prescription 87 N  350 study emphasizes necessity evaluation vaccine prescription policy improve implementation among HCWs finding advocate tailored strategies including enhanced incentive mechanism hospital setting optimized digital engagement community health centers facilitate effective vaccine prescription practices",
        "mesh_terms": [
            "Humans",
            "Influenza Vaccines",
            "China",
            "Cross-Sectional Studies",
            "Attitude of Health Personnel",
            "Female",
            "Male",
            "Adult",
            "Influenza, Human",
            "Health Personnel",
            "Middle Aged",
            "Surveys and Questionnaires",
            "Vaccination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760695/"
    },
    {
        "pmid": "40759412",
        "title": "Respiratory and Other Infections Following COVID.",
        "abstract": "One hypothesis respiratory syncytial virus RSV surge 2022 suppression immune response following SARSCoV2 infection objective compare risk subsequent RSV infection among child without SARSCoV2 infection conducted retrospective cohort study using electronic health record data 27 US health system analyzing child aged 5 year SARSCoV2 infection testcoded March July 2022 comparison group child a influenza infection b respiratory tract infection evidence SARSCoV2influenza infection primary secondary outcome RSV infection respiratory infection subsequent 15 180 days respectively applied inverse probability treatment weighting performed weighted logistic regression modeling primary secondary cohort consisted 18 767 114 414 child SARSCoV2 infection 6697 30 424 influenza infection respectively 46 697 another acute respiratory tract infection odds subsequent RSV lower SARSCoV2 group compared influenza group adjusted odds ratio aOR 073 95 CI 061086 compared group respiratory tract infection aOR 078 95 CI 07087 odds respiratory tract infection infection lower SARSCoV2 group influenza group aOR 062 95 CI 059064 aOR 067 95 CI 06507 respectively find increased risk RSV respiratory type infection within 6 month SARSCoV2 infection compared influenza respiratory illnesses",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40759412/"
    },
    {
        "pmid": "40758871",
        "title": "Influenza A virus NS1 protein mimics oncogenic PI3K resulting in isoform specific cellular redistribution and activation.",
        "abstract": "nonstructural protein 1 NS1 influenza virus performs broad variety proviral activity infected cell primarily mediating evasion host innate immune response main viral interferon antagonist However several interaction whose biological relevance remains obscure ability NS1 bind activate class IA phosphoinositide 3kinases PI3Ks PI3Ks highly regulated lipid kinase act critical node multiple cell signaling network also important protooncogenes activation mediated NS1 binding specifically p85β subunit better understand consequence interaction developed bimolecular fluorescence complementation BiFC assay selectively track different PI3K heterodimers and using system found NS1 induces isoformspecific relocation activation different PI3K heterodimers found clinically relevant oncogenic mutation catalytic regulatory subunit PI3K could mimic effect caused NS1 partially rescue loss viral fitness recombinant virus encoding p85βbinding deficient NS1",
        "mesh_terms": [
            "Viral Nonstructural Proteins",
            "Humans",
            "Influenza A virus",
            "Phosphatidylinositol 3-Kinases",
            "HEK293 Cells",
            "Class Ia Phosphatidylinositol 3-Kinase",
            "Animals",
            "Signal Transduction",
            "Protein Binding"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40758871/"
    },
    {
        "pmid": "40758746",
        "title": "Socioeconomic determinants of protective behaviors and contact patterns in the post-COVID-19 pandemic era: A cross-sectional study in Italy.",
        "abstract": "Socioeconomic inequality significantly influence infectious disease outcomes seen COVID19 pathway socioeconomic condition affect transmission dynamic remain unclear address this conducted survey representative Italian population stratified age gender geographical area city size employment status education level surveys final aim estimate difference contact protective behavior across various population strata crucial understanding transmission dynamics initial insight based survey indicate year pandemic began perceived impact COVID19 professional economic social psychological dimension vary across socioeconomic strata extending beyond epidemiological outcomes reinforces need approach systematically consider socioeconomic determinants context using generalized linear models identified association socioeconomic factor vaccination status COVID19 influenza well influence socioeconomic condition maskwearing social distancing Importantly also observed difference contact behavior based employment status education level show significant association finding highlight complex interplay socioeconomic demographic factor shaping protective behavior contact patterns Understanding dynamic contribute improvement epidemic model better guide public health effort atrisk groups",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Italy",
            "Female",
            "Male",
            "Cross-Sectional Studies",
            "Socioeconomic Factors",
            "Adult",
            "Middle Aged",
            "Pandemics",
            "SARS-CoV-2",
            "Aged",
            "Young Adult",
            "Adolescent",
            "Influenza, Human",
            "Surveys and Questionnaires"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40758746/"
    },
    {
        "pmid": "40758339",
        "title": "Influenza With and Without Oseltamivir Treatment and Neuropsychiatric Events Among Children and Adolescents.",
        "abstract": "Reports pediatric neuropsychiatric event influenza treatment oseltamivir prompted public concerns However whether oseltamivir influenza infection associated increased risk neuropsychiatric event remains unclear determine association influenza oseltamivir serious neuropsychiatric events retrospective cohort study conducted populationbased ambulatory setting 2016 2017 2019 2020 influenza seasons Followup began first day influenza season continued earliest occurrence outcome event loss enrollment death age 18 years end season study Children aged 5 17 year enrolled Tennessee Medicaid eligible inclusion Data analysis completed July 2023 March 2025 personday followup assigned 1 following 5 mutually exclusive exposure groups 1 untreated influenza 2 treated influenza 3 posttreatment period period oseltamivir completion end influenza period 4 influenza prophylaxis 5 exposure primary outcome neuropsychiatric event requiring hospitalization event identified using validated algorithm Poisson regression estimated incidence rate ratio IRRs accounting relevant covariates measured personday Sensitivity analysis examined robustness finding alternate exposure outcome definitions timevarying outcome risk negative control outcome unmeasured confounding Among 692 975 eligible children total 692 295 child median IQR age 11 714 years 503 female experienced 1230 serious neuropsychiatric event 898 neurologic 332 psychiatric 19 688 320 personweeks followup Among 151 401 influenza episodes 667 95 CI 665670 dispensed oseltamivir 601 95 CI 596606 among high risk influenza complications common event overall mood disorder 363 suicidal selfharm behavior 342 Compared untreated influenza event rate lower oseltamivirtreated influenza period IRR 053 95 CI 033088 posttreatment period IRR 042 95 CI 024074 Subanalyses suggest finding driven reduction neurologic event IRR 045 95 CI 025082 psychiatric event IRR 080 95 CI 034188 Sensitivity analysis suggest misclassification unmeasured confounding would explain findings cohort study oseltamivir treatment influenza episode associated reduced risk serious neuropsychiatric events finding support oseltamivir use prevention influenzarelated complications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40758339/"
    },
    {
        "pmid": "40757932",
        "title": "First results from the international paediatric bronchiectasis registry (Child-BEAR-Net Registry) describing multicountry variations in childhood bronchiectasis and its management: a multicentre, cross-sectional study.",
        "abstract": "Despite increasing recognition bronchiectasis worldwide multicountry data characterising bronchiectasis children aimed describe clinical features comparing intercountry regional variations describe index overall qualityofcare standard assessed international consensus statement child young people bronchiectasis ChildBEARNet international collaborative paediatric bronchiectasis network across several continents Using International Paediatric Bronchiectasis Registry data secondary tertiary hospital across eight countries conducted multicentre crosssectional cohort study patient registry younger 18 year diagnosed bronchiectasis Data grouped four geographical regions Australia South Africa GreeceItalySpain AlbaniaTürkiyeUkraine Patients cystic fibrosis history heart lung transplantation excluded assessed baseline clinical characteristics causes treatments qualityofcare indicators compared finding across regions Data analysed using descriptive statistic nonparametric test betweengroup comparisons June 1 2020 Feb 9 2024 408 patient enrolled median age diagnosis 6·0 year IQR 3·29·0 229 56 male 179 44 female patients common underlying cause postinfection 127 31 primary secondary immunodeficiency 79 19 known genetic disorder 55 13 Common comorbidities included asthma 70 17 otorhinolaryngeal disorder 58 14 congenital major airway malformation 51 13 previous 12 months 106 38 least three exacerbation 89 49 required hospitalisation least once 107 27 400 reported daily sputum Lung function normal 133 59 227 patient considerable betweengroup difference median forced vital capacity Z score ranged 0·12 0·95 0·65 Australia 1·54 3·39 0·04 South Africa found marked intergroup difference lower airway bacteria Haemophilus influenzae 56 70 80 patient Australia three 16 19 AlbaniaTürkiyeUkraine Pseudomonas aeruginosa eight 24 34 South Africa one 5 AlbaniaTürkiyeUkraine treatment longterm azithromycin 47 50 94 GreeceItalySpain 15 19 79 AlbaniaTürkiyeUkraine inhaled corticosteroid 48 61 AlbaniaTürkiyeUkraine 28 22 126 Australia radiographic marker cystic bronchiectasis 49 45 109 South Africa three 2 126 Australia p0·0001 qualityofcare standard markers recommended panel investigation done 6695 patients 78 47 167 saw paediatric physiotherapist previous 12 months study present first internationally derived paediatric registry data highlighting geographical variation cause lung function bacteriology treatment child young people bronchiectasis well need improve quality care None",
        "mesh_terms": [
            "Humans",
            "Bronchiectasis",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Child",
            "Registries",
            "Child, Preschool",
            "Adolescent",
            "Infant",
            "Australia",
            "Quality of Health Care"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757932/"
    },
    {
        "pmid": "40757858",
        "title": "Trained ILCs confer adaptive immunity-independent protection against influenza.",
        "abstract": "Seasonal influenza cause 290000650000 death annually vaccination efficacy ranging 10 60 emergence drugresistant highly pathogenic avian influenza virus underscore urgent need novel protective strategies Epidemiological observation long suggested certain vaccines Bacillus CalmetteGuérin BCG provide protection diverse pathogen S BieringSørensen P Aaby N Lund et al Clin Infect Dis 6511831190 2017 httpsdoiorg101093cidcix525 ML Garly C L Martins C Balé et al Vaccine 2127822790 2003 httpsdoiorg101016s0264410x03001816 C A G Timmermann S BieringSørensen P Aaby et al Trop Med Int Health 2017331744 2015 httpsdoiorg101111tmi12614 cellular molecular mechanism underlying protection remain incompletely understood emerging research offer critical insight innate immune system modulation B Cirovic L C J de Bree L Groh et al Cell Host Microbe 28322334 2020 httpsdoiorg101016jchom202005014 L Kong S J C F M Moorlag A Lefkovith et al Cell Rep 37110028 2021 httpsdoiorg101016jcelrep2021110028 H Mohammadi N Sharafkandi M Hemmatzadeh et al J Cell Physiol 23345124529 2018 httpsdoiorg101002jcp26250 S J C F M Moorlag Y A RodriguezRosales J Gillard et al Cell Rep 33108387 2021 httpsdoiorg101016jcelrep2020108387 investigated whether trained innate immune system nonreplicating adenovirus could provide protection diverse influenza virus strains demonstrated replicationdefective human adenovirus effectively train innate immune system conferring protective immunity mouse multiple influenza virus strains including H1N1 H3N2 H5N2 H7N9 H9N2 addition bovine chimpanzee adenovirus also activate human innate lymphoid cell ILCs confer protection challenge influenza H3N2 virus mice Remarkably protection occurs complete absence influenzaspecific adaptive immune response influenza virusspecific hemagglutinationinhibiting antibodies neutralizing antibodies influenza nucleoproteinspecific CD8 cells Key protective mechanism include increased activation ILC1 ILC2 ILC3 populations enhanced expression interferonstimulated gene ISGs upregulation antiviral signaling pathways metabolic reprogramming ILC subsets Adoptive transfer experiment demonstrated trained ILCs sufficient protect influenza H1N1 infection ILCdeficient mice research establishes novel strategy enhancing innate antiviral immunity offering broadspectrum protection diverse influenza strains promising approach pandemic preparedness also emerging infectious diseases Training innate lymphoid cell nonreplicating adenoviral vector represents promising approach enhancing broadspectrum antiviral immunity complementing traditional vaccination strategiesIMPORTANCEThe finding represent potential gamechanger fighting influenza kill hundred thousand people worldwide year despite best vaccination efforts Current flu vaccine often provide limited protection must reformulated annually match circulating strains effectiveness varies dramatically year year scientist discovered something remarkable common adenovirus which typically cause mild coldlike symptoms essentially train immune systems first line defense recognize fight multiple type flu virus simultaneously protection work completely different mechanism traditional vaccinesit rely creating specific antibody flu proteins Instead treatment activates special immune cell called innate lymphoid cell ILCs act like bodys rapid response team trained cell provide broad protection various flu strains including dangerous bird flu variant could cause future pandemics significance lie potentially creating universal flu protection strategy could work unknown future flu strains offering hope better pandemic preparedness reducing seasonal flus devastating global impact",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757858/"
    },
    {
        "pmid": "40757817",
        "title": "Pharmacokinetics, safety, and tolerability of onradivir in participants with severe renal impairment and matched healthy control participants.",
        "abstract": "Onradivir influenza virus RNA polymerase basic protein 2 inhibitor currently development treatment influenza A Renal impairment influence drug absorption metabolism transport potentially altering pharmacokinetics PK onradivir study aimed provide guidance clinical dosing patient renal impairment evaluating impact renal impairment PK safety tolerability onradivir nonrandomized parallel singledose study Participants severe renal impairment estimated glomerular filtration rate 1529 mLmin along healthy participant ini  eight per group received single oral dose 600 mg onradivir participant exhibited good safety tolerability oral administration onradivir treatmentemergent adverse event limited mild moderate severity Compared participant normal renal function maximum plasma concentration iCisubmaxsub onradivir severe renal impairment similar however area plasma concentration time curve zero last quantifiable concentration AUCsub0itisub AUC zero infinity AUCsub0infsub slightly lower geometric mean ratio 90 confidence interval iCisubmaxsub AUCsub0itisub AUCsub0infsub 10135 638516086 7631 524711097 7656 510211490 respectively Severe renal impairment clinically meaningful effect PK tolerability safety onradivir Therefore dose adjustment necessary patient mildtosevere renal impairment taking onradivirCLINICAL TRIALSThis study registered ClinicalTrialsgov NCT06248567",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757817/"
    },
    {
        "pmid": "40757797",
        "title": "Influenza Vaccination Among Patients Undergoing Treatment for Rheumatological Disorders: Awareness, Vaccination Rates, and Influencing Factors.",
        "abstract": "BackgroundAims Patients autoimmune inflammatory rheumatic disease AIIRDs particularly vulnerable infection result underlying autoimmune conditions vulnerability exacerbated immunosuppressive treatment associated comorbidities study aim evaluate influenza vaccination rates hesitancy awareness among patient population Materials Methods descriptive study included patient AIIRD receiving treatment rheumatology pulmonary medicine outpatient clinics January April 2024 questionnaire administered assess influenza vaccination rates knowledge attitudes Results patients 343 received least 1 influenza vaccination 13 vaccinated annually Additionally 622 recognized risk influenza infection due current illness medication believed vaccinated However 592 received professional information influenza vaccine 382 aware vaccination available free charge condition Older age prolonged medication use extended duration since diagnosis presence comorbidities awareness influenza risk receiving information vaccination significantly associated received least 1 influenza vaccination statistical relationship observed type rheumatic disease vaccination P 7803 Patients relying social media TV internet source demonstrated greater vaccine hesitancy P  0001 Awareness vaccination recommendation significantly associated medication type P  0001 Hesitancy reported 387 patient 48 unvaccinated patients influenced negative experience COVID19 vaccination process Conclusion Influenza vaccination coverage among patient AIIRD remains suboptimal Physician reminder routine visit could enhance vaccination rates Health authority might consider implementing popup alert clinical system prompt physician recommend vaccination prescribing immunosuppressive medications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757797/"
    },
    {
        "pmid": "40757726",
        "title": "Influenza Virus-Associated Acute Necrotizing Encephalopathy in Two Young Children: Case Report.",
        "abstract": "bBackground Clinical Significanceb Acute necrotizing encephalopathy ANE represents severe complication mainly described children influenza virus infection report case two young girl ANE associated influenza virus infection diagnosed MRI cerebral scan bCase Presentationb 7yearold girl history previous episode ANE presented worsening drowsy state seizures second case otherwise healthy 5yearold girl presented fever seizures marked neurological deterioration cases nasopharyngeal swab testing positive influenza virus A cerebral MRI indicated ANE Despite aggressive treatment highdose corticosteroid fiveday course ofimmunoglobulins ultimate prognosis poor patients ANE serious complication viral infection children high mortality rate broad spectrum neurological sequelae date pathophysiology management influenza virusinduced ANE remain uncertain Although ANE usually sporadic familial recurrent case reported anRANbinding protein RANBP2 mutation occasionally associated occurrenceConclusions Rapid recognition neurological symptom suspicion viral trigger especially influenzalike illnesses essential timely administration effective therapy research needed clarify pathophysiology ANE establish best therapeutic strategy fight deadly disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757726/"
    },
    {
        "pmid": "40757690",
        "title": "Systemic Coagulation Derangement as an Early Sign of Oxygenator Failure in Veno-Venous Extracorporeal Membrane Oxygenation (VV ECMO) Without Anticoagulation.",
        "abstract": "bBackground Clinical Significanceb Venovenous extracorporeal membrane oxygenation VV ECMO become widely accepted supportive treatment severe acute respiratory distress syndrome ARDS intensive care unit ICUs Although gained popularity aspects including optimal anticoagulation management best mean monitoring hemostasis remain unresolved Thrombosis bleeding still important complication ECMO bCase Presentationb 44yearold male patient underlying conditions diagnosed severe acute respiratory distress syndrome ARDS due AH1N1 influenza presented severe hypoxemia despite use mechanical ventilation neuromuscular blocking agent infusion prone position VV ECMO used coagulation stopped ECLS day 6 due severe pulmonary hemorrhage systemic hemostatic disorder found patient difficult differentiate disseminated intravascular coagulation DIC sepsisinduced coagulopathy SIC improved transiently circuit exchange resolved discontinuation ECMO patient discharged fully conscious cooperative apparent neurological deficit bConclusionsb Systemic hemostatic abnormality may precede oxygenator failure mimic DIC SIC Timely oxygenator exchange may therefore considered However highrisk procedure especially fully ECLSdependent patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757690/"
    },
    {
        "pmid": "40757669",
        "title": "Inhibition Effects of Patchouli Alcohol, Carvacrol, p-Cymene, Eucalyptol and Their Formulations Against Influenza Virus Pneumonia Through TLR4/NF-κB/NLRP3 Signaling Pathway.",
        "abstract": "kind drug mostly used historically treat epidemics aromatic botanical volatile oil active components study aim evaluate antiinfluenza viral pneumonia effect volatile monomer patchouli alcohol PA carvacrol CV pCymene PC eucalyptol EC formulation various aspect influenza virus APR834 H1N1 infection experiment vivo vitro carry indepth study antiinflammatory mechanisms study found four volatile monomer mentioned could exert antiviral effect suppressing pulmonary viral load lung index improving lung lesion mouse influenza pneumonia addition elevated level cytokine chemokines serum suppressed proportion Tlymphocytes peripheral blood altered antioxidative stress index improved whose mechanism action related antiinflammation possibly acting TollLike Receptor 4Nuclear FactorκBnucleotidebinding domain leucinerich repeat pyrin domaincontaining receptor 3 TLR4NFκBNLRP3 pathway study provides experimental basis volatile monomer formulation aromatic herb treating influenza virus pneumonia",
        "mesh_terms": [
            "Cymenes",
            "Animals",
            "Toll-Like Receptor 4",
            "NF-kappa B",
            "NLR Family, Pyrin Domain-Containing 3 Protein",
            "Signal Transduction",
            "Mice",
            "Monoterpenes",
            "Eucalyptol",
            "Influenza A Virus, H1N1 Subtype",
            "Antiviral Agents",
            "Humans",
            "Orthomyxoviridae Infections",
            "Cytokines",
            "Lung",
            "Mice, Inbred BALB C",
            "Madin Darby Canine Kidney Cells",
            "Sesquiterpenes"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757669/"
    },
    {
        "pmid": "40757214",
        "title": "Blastomycosis in a Renal Transplant Recipient: A Rare Encounter in Rural Appalachia.",
        "abstract": "Blastomycosis fungal infection caused iBlastomycesi species thermally dimorphic fungi endemic midwestern southcentral southeastern United States US Organ transplant patient risk infection due longterm immunosuppressive therapy present unique case blastomycosis renal transplant patient residing nonendemic region Appalachia 67yearold patient history tobacco use atrial fibrillation type 2 diabetes hyperlipidemia bilateral deceased donor kidney transplantation DDKT 2021 presented Charleston Area Medical Centers CAMC Charleston WV Emergency Department ED fever night sweats Initial workup revealed 394 °C temperature remaining vital sign normal Corona parainfluenza influenza metapneumovirus mycoplasma pneumonia RSV negative GI PCR panel negative C difficle yersinia campylobacter giardia vibrio norovirus salmonella rotavirus Chest Xray showed 21 × 16 cm nodular density left upper lobe LUL lobe White blood cell WBC count elevated 13000mcl leftsided shift Subsequent computed tomography CT chest without contrast demonstrated 27 × 21 cm LUL mass Urine iBlastomycesi antigen tested positive prompting initiation empiric therapy blastomycosis Aspergillus ruled initially Blastomycosis rare occurrence US annual incidence reported 1 2 case per 100000 transplant recipient predisposed acquiring blastomycosis remains infrequent occurrence transplant patient presenting persistent infectious symptoms blastomycosis rare etiology considered prevent severe complications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757214/"
    },
    {
        "pmid": "40756213",
        "title": "Gut microbiota and viral respiratory infections: microbial alterations, immune modulation, and impact on disease severity: a narrative review.",
        "abstract": "Respiratory viral infection major public health concern accounting million infection annually contributing significantly global morbidity mortality Influenza respiratory syncytial virus RSV long recognized critical pathogens recent emergence severe acute respiratory syndrome coronavirus 2 SARSCoV2 led COVID19 pandemic virus typically affect upper lower respiratory tract cause broad spectrum clinical manifestations ranging mild symptom severe respiratory failure multiorgan dysfunction Gastrointestinal symptom also frequently reported suggesting potential link respiratory virus gut microbiota alterations connection highlight role gut microbiota disease pathophysiology narrative review summarizes current evidence gut microbiota change associated SARSCoV2 influenza RSV infections explores microbiotas role immune regulation host homeostasis discusses potential microbiotatargeted strategy prevention management acute respiratory syndromes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40756213/"
    },
    {
        "pmid": "40756197",
        "title": "Analysis and Impact of Infection Prevention Procedures in Long-Term Care Facilities.",
        "abstract": "Healthcareassociated infection HAIs significant healthcare complication major implication public health EUEEA 26 million new HAIs case occur annually causing significant burden economic costs Italy prevalence HAIs rising due factor like invasive devices antibiotic resistance poor infection control aim work evaluate effectiveness HAIs containment practice longterm care facility LTCF crosssectional study included eight LTCF inspected Prevention Technicians Local Health Authority Tuscany SouthEast LHATSE 2023 study evaluated noncompliance procedure legionellosis prevention cleaning disinfection laundry management management pans HAIs prevention healthcare tool disinfection hairdressing services Data analysed using descriptive statistic Mann Whitney test compare infection rate procedure compliance 2023 606 infection reported eight enrolled LTCF frequent infection COVID19 194 urinary tract infection 169 pharyngitis 156 influenzalike illness ILI 15 Laundry Procedure 3 LTCF compliant 5 not showing significant relationship influenza syndrome p  002 surgical site infection p  004 Cleaning Check procedure noncompliance linked higher fungal infection p  001 gastroenteritis p  004 Disinfection Health Tools procedure showed noncompliance correlated higher gastroenteritis p  004 conjunctivitis p  001 Gastrointestinal infection iClostridium difficilei linked noncompliance HAIs Procedures Routes p  004 Pans process p  004 cleanliness hairdressing service p  004 Herpes simplex Herpes zoster infection higher LTCF noncompliant hairdressing service room p  002 Two legionellosis case recorded LTCF reported noncompliance analytical procedure Legionellosis analysis showed significant correlation cleanliness procedure reduction fungal infections gastroenteritis ear infections Compliance laundry procedure linked ILI surgical site infections Noncompliance healthcare tool correlated higher rate gastroenteritis conjunctivitis highlighting need stronger practices data suggest effective prevention measure reduce HAIs though discrepancy implementation across facility call standardization continuous monitoring",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Italy",
            "Infection Control",
            "Cross Infection",
            "Long-Term Care",
            "COVID-19",
            "Disinfection",
            "Guideline Adherence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40756197/"
    },
    {
        "pmid": "40756189",
        "title": "Vaccine hesitancy in healthcare workers during COVID-19 pandemic: Draw on experience.",
        "abstract": "present study aimed identify factor affect healthcare workers HCWs vaccine hesitancy subsequent change psychological wellbeing 800 employee 207 M 14 aged ≤ 25 145 aged 2635 381 aged 3655 260 aged  55 years recruited San Martino Hospital first month 2021 HCWs asked fill online survey assessing a demographics b contracted COVID19 infection c vaccination history against COVID19 influenza d expected change psychological wellbeing e vaccine hesitancy f factor leading decision vaccine Information Trust Information Seeking Fear Self Sense Responsibility found that vaccinated HCW year employment adherence influenza vaccine indirectly affected vaccine hesitancy effect mediated HCWs sense responsibility information trust Moreover information trust promoted positive change psychological wellbeing vaccine hesitancy negatively affected it present study consistently point crucial role trusting information sense responsibility vaccine hesitancy and consequently psychological wellbeing discus practical implication public health findings conclusions suggest shortterm longterm strategy improving vaccine adherence",
        "mesh_terms": [
            "Humans",
            "Adult",
            "Vaccination Hesitancy",
            "COVID-19",
            "Male",
            "Female",
            "Middle Aged",
            "Health Personnel",
            "COVID-19 Vaccines",
            "Influenza Vaccines",
            "Surveys and Questionnaires",
            "Trust",
            "SARS-CoV-2",
            "Vaccination",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40756189/"
    },
    {
        "pmid": "40755950",
        "title": "Bilateral Meckel's Cave Cephalocele Presenting as Cranial Nerve VI Palsy: A Case Report.",
        "abstract": "Meckels cave cephalocele also known petrous apex cephalocele PAC rare cystic lesion caused herniation cerebrospinal fluid Meckels cave Bilateral PACs exceptionally rare 21 reported cases PACs may present headache diplopia tinnitus cranial nerve palsy 74yearold male presented acute onset headache vision changes gait instability medical history included hypertension melanoma Examination revealed left cranial nerve VI palsy Initial imaging head CT CTA showed acute intracranial abnormality revealed moderate chronic sinusitis Magnetic resonance imaging demonstrated large bilateral Meckels cave cephaloceles prominent left mass effect inferior margin cavernous sinus Steroid treatment initiated suspected influenzaassociated cranial neuropathy Followup reveal immediate improvement However several week steroid treatment symptom improved significantly patient deferred surgical intervention case highlight rare presentation bilateral PACs cranial nerve VI palsy Although surgical intervention may definitive conservative treatment provide relief symptom select cases research needed guide optimal management strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755950/"
    },
    {
        "pmid": "40755805",
        "title": "Analytical performance evaluation of a multiplex real-time RT-PCR kit for simultaneous detection of SARS-CoV-2, influenza A/B, and RSV.",
        "abstract": "Differentiating influenza respiratory syncytial virus RSV SARSCoV2 based clinical symptom alone challenging due overlap crosssectional study conducted September November 2023 evaluated analytic performance LabTurbo multiplex realtime reverse transcription polymerase chain reaction RTPCR kit simultaneous detection viruses Nasopharyngeal swab specimen tested using LabTurbo kit Cobas Liat SARSCoV2 influenza AB assay Cobas influenza AB RSV assays RNA standard serially diluted tested LabTurbo kit determine limit detection LOD crosssectional study involved analysis 350 nasopharyngeal swab samples included 250 positive case 50 case influenza A influenza B RSV along 100 case SARSCoV2 100 negative cases LabTurbo kit demonstrated 100 positive percent agreement negative percent agreement reference assay detecting SARSCoV2 influenza AB RSV LODs SARSCoV2 influenza A influenza B RSV 8333 3333 6667 8333 copiesmL respectively finding confirm diagnostic accuracy analytic performance LabTurbo multiplex realtime RTPCR kit detection SARSCoV2 influenza AB RSV simultaneously assay could substantially improve rapid identification differentiation pathogens thereby enabling timely appropriate treatment measure control spread cocirculating viruses",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "SARS-CoV-2",
            "Influenza, Human",
            "Respiratory Syncytial Virus Infections",
            "COVID-19",
            "Influenza A virus",
            "Influenza B virus",
            "Nasopharynx",
            "Multiplex Polymerase Chain Reaction",
            "Real-Time Polymerase Chain Reaction",
            "Respiratory Syncytial Virus, Human",
            "Sensitivity and Specificity",
            "Female",
            "Limit of Detection"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755805/"
    },
    {
        "pmid": "40755567",
        "title": "Tracheomalacia and Interstitial Pneumonia in a 95-Year-Old Woman With Undiagnosed Rheumatoid Arthritis: A Case Report.",
        "abstract": "case report describes 95yearold woman history cardiovascular gastrointestinal disease presented fever anorexia diagnosed influenza secondary bacterial pneumonia Despite antiviral antibiotic treatment respiratory condition worsened Detailed examination revealed characteristic joint deformities elevated rheumatoid factor anticyclic citrullinated peptide antibodies Imaging showed interstitial pneumonia paradoxical breathing elevation membranous portion trachea indicating tracheomalacia patient diagnosed previously unrecognized rheumatoid arthritis associated interstitial pneumonia tracheomalacia Immunosuppressive therapy prednisolone azathioprine improved condition case highlight importance thorough systemic evaluation elderly patient unexplained respiratory symptom need consider lateonset autoimmune diseases including rheumatoid arthritis differential diagnosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755567/"
    },
    {
        "pmid": "40755518",
        "title": "Nova Scotia Health Influenza Treatment Team: Virtual Care Pathway to Antiviral Treatment.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755518/"
    },
    {
        "pmid": "40754333",
        "title": "Multicentre, prospective, single-arm, non-controlled, open-label trial to evaluate the safety and efficacy of live attenuated influenza vaccine in paediatric patients with atopic dermatitis undergoing dupilumab therapy: a protocol.",
        "abstract": "Atopic dermatitis AD chronic inflammatory skin condition impairs quality life affected paediatric patient families Dupilumab antagonist shared alpha chain subunit cytokine interleukin4 interleukin13 revolutionised management moderatetosevere AD effectively targeting type 2 inflammation However live attenuated vaccines including live attenuated influenza vaccine LAIVs contraindicated dupilumab therapy owing limited safety data restriction pose challenge immunisation strategies particularly paediatric populations study aim evaluate safety efficacy LAIV paediatric patient AD undergoing dupilumab therapy multicentre prospective singlearm openlabel trial enrol 50 paediatric patient aged 218 year AD undergoing dupilumab treatment participant receive intranasal LAIV followed 25week observation period vaccination primary outcome proportion participant fourfold greater increase haemagglutination inhibition titre influenza strain AH1N1 AH3N2 B 4 week post vaccination secondary outcome include incidence influenza systemic local adverse events injection site reactions fever influenzalike symptom observed within 4 week vaccination Exploratory endpoint include evaluation immunosuppressive marker neutrophil counts lymphocyte subset serum immunoglobulin G levels Safety analysis assess frequency adverse event whereas efficacy analysis focus immunogenicity influenza incidence 25week followup period study aim provide critical safety immunogenicity data guide immunisation strategy biologically treated paediatric patient AD study complies principle Declaration Helsinki received ethic approval Institutional Review Board Chiba University Hospital specified clinical trial Informed consent assent obtained appropriate based participants ages finding disseminated peerreviewed journal scientific conference inform clinical vaccination strategy biologically treated populations jRCTs031240442",
        "mesh_terms": [
            "Humans",
            "Child",
            "Influenza Vaccines",
            "Dermatitis, Atopic",
            "Antibodies, Monoclonal, Humanized",
            "Prospective Studies",
            "Adolescent",
            "Child, Preschool",
            "Vaccines, Attenuated",
            "Influenza, Human",
            "Female",
            "Male",
            "Multicenter Studies as Topic",
            "Influenza A Virus, H1N1 Subtype"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40754333/"
    },
    {
        "pmid": "40753167",
        "title": "Broad neuraminidase antibodies confer protection against seasonal and avian influenza viruses.",
        "abstract": "Neuraminidase NA critical target universal influenza vaccine therapeutic antibodies yet antigenic landscape remains incompletely understood identify two broadly crossprotective monoclonal antibodies CAVF6 CAVF34 influenzainfected individuals antibody inhibit NA enzymatic activity across multiple subtypes confer protection seasonal influenza female mouse models Importantly two antibody also neutralize emerging avian strains including recent bovine H5N1 H7N9 strains pandemic potential Structural study reveal antibody target conserved region NA active site via HCDR3 blocking sialic acid interaction Furthermore observe distinct occupancy two antibody N2 tetramer likely due difference binding affinity finding provide molecular insight NAtargeted immunity offer foundation developing broadly protective influenza vaccine therapeutics",
        "mesh_terms": [
            "Animals",
            "Neuraminidase",
            "Female",
            "Mice",
            "Antibodies, Viral",
            "Humans",
            "Influenza A Virus, H5N1 Subtype",
            "Influenza Vaccines",
            "Antibodies, Monoclonal",
            "Influenza in Birds",
            "Influenza A Virus, H7N9 Subtype",
            "Influenza, Human",
            "Orthomyxoviridae Infections",
            "Mice, Inbred BALB C",
            "Cross Protection",
            "Antibodies, Neutralizing",
            "Cattle"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40753167/"
    },
    {
        "pmid": "40752148",
        "title": "When farmers' knowledge matters: Improving epidemiological understanding of Peste des petits ruminants in northern Nigeria.",
        "abstract": "Peste de petits ruminant PPR endemic disease sheep goat Nigeria represents major threat livelihood smallholders Understanding epidemiology disease management livestock farmer essential developing appropriate surveillance control programmes study aimed enhance knowledge PPR conducting largescale survey 52 village Plateau Bauchi Kano state northern part Nigeria approach involved holding focus group discussion farmers men women collect knowledge disease understand perspective management result showed farmer use several different term refer disease likely PPR term might also used refer disease caused infectious agents Farmers rarely call veterinary service prevent disease vaccination seldom practiced Disease control attempted using conventional treatments without veterinary supervision using traditional therapies limited poor implementation good farming practice biosecurity measures study increased understanding PPR management area limited public private veterinary services addition also fostered trust scientist communities paving way future participatory action research programmes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40752148/"
    },
    {
        "pmid": "40751875",
        "title": "Exploring the Therapeutic Landscape of Probiotics in Enteric and Respiratory Viral Infections.",
        "abstract": "recent times understanding human microbiome impact health disease undergone paradigm shift leading groundbreaking discovery field probiotics Probiotics live microorganism known conferring health benefit administered adequately garnered significant interest potential modulate immune systems response viral infection human animals emergence enteric respiratory virus significant global health threat prompted intensive research effort identify novel therapeutic strategies Traditional antiviral therapy often face challenge drug resistance limited efficacy adverse effects underscoring urgent need alternative approaches context probiotic emerged promising avenue prevention treatment viral infection due ability modulate host immune response enhance mucosal barrier function exert direct antiviral effects review aim provide comprehensive overview therapeutic landscape probiotic enteric respiratory viruses Based latest finding preclinical clinical studies explored mechanism underlying antiviral activity probiotic potential role mitigating viral infections Furthermore promising avenue harnessing probiotic adjunctive standalone intervention enteric respiratory viral infection discussed here",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40751875/"
    },
    {
        "pmid": "40751465",
        "title": "Influenza Vaccination and Short-Term Risk of Stroke Among Elderly Patients With Chronic Comorbidities in a Population-Based Cohort Study.",
        "abstract": "protective effect influenza vaccination stroke risk inconclusive study aimed investigate impact influenza vaccination 1year risk stroke individual aged 60 year older COPD hypertension diabetes mellitus conducted retrospective cohort study four district Shanghai China August 2017 July 2019 Data collected various information system related chronic disease management cardiovascular reporting immunizations incidence stroke within 1 year compared vaccinated unvaccinated chronic disease patients Cox proportional hazard regression used calculate hazard ratio HRs Sensitivity analysis performed using Poisson regression model examine association influenza vaccination stroke incidence propensity score matching employed address confounding found influenza vaccination associated lower risk stroke two influenza seasons 20172018 adjusted HR 027 95 CI 010073 20182019 adjusted HR 046 95 CI 021102 result Poisson regression model RR 026 95 CI 010070 consistent obtained Cox model analysis reduction stroke risk associated influenza vaccination ranged 54 73 finding suggest influenza vaccination associated lower 1year risk stroke individual chronic illnesses compared vaccinated",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Aged",
            "Influenza Vaccines",
            "Retrospective Studies",
            "Stroke",
            "China",
            "Influenza, Human",
            "Middle Aged",
            "Vaccination",
            "Hypertension",
            "Comorbidity",
            "Incidence",
            "Risk Factors",
            "Chronic Disease",
            "Pulmonary Disease, Chronic Obstructive",
            "Diabetes Mellitus",
            "Proportional Hazards Models",
            "Aged, 80 and over",
            "Cohort Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40751465/"
    },
    {
        "pmid": "40750655",
        "title": "Methodic aspects of influenza and respiratory syncytial virus detection in raw wastewater and presence in treatment plants in southeastern Germany.",
        "abstract": "COVID19 pandemic wastewaterbased epidemiology WBE developed additional tool follow epidemiological trend catchment area treatment plants Meanwhile viral agent respiratory infection included monitoring programs However difference sample processing may impair result comparison among studies identical virus strains investigated different concentration methods RNA isolation kit primerprobe combination detection influenza virus IV AB respiratory syncytial virus RSV AB procedure optimization virus enrichment RNA extraction method found relevance Conversely detection step identified relatively low influence Using standardized protocols 24 h composite sample eight wastewater treatment plant WWTP southeast Germany 2xweek analyzed January 2024 December 2024 IVAB RSVAB following rate viruspositive sample determined 205 IVA including 22 H1N1pdm09 45 IVB 326 RSVA 24 RSVB IV RSV detection showed matching trend compared reported cases study contributes better understanding factor influencing detection IV RSV wastewater well epidemiological significance virus monitoring WWTPs",
        "mesh_terms": [
            "Germany",
            "Wastewater",
            "Humans",
            "RNA, Viral",
            "Influenza, Human",
            "Respiratory Syncytial Virus Infections",
            "Respiratory Syncytial Virus, Human",
            "COVID-19",
            "Respiratory Syncytial Viruses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750655/"
    },
    {
        "pmid": "40750617",
        "title": "Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies.",
        "abstract": "Influenza responsible multiple global pandemic seasonal epidemic claimed million lives imminent threat panzootic outbreak avian influenza H5N1 virus underscore urgent need pandemic preparedness effective countermeasures including monoclonal antibody mAbs Here characterize human mAbs target highly conserved catalytic site viral neuraminidase NA termed NCS mAbs molecular basis broad specificity Crossreactive NAspecific B cell isolated using stabilized NA probe noncirculating subtypes found NCS mAbs recognized multiple NAs influenza well influenza B NAs conferred prophylactic protection mouse H1N1 H5N1 influenza B viruses Cryoelectron microscopy structure two NCS mAbs revealed rely structural mimicry sialic acid substrate NA coordinating amino acid side chain also water molecules enabling inhibition NA activity across multiple influenza B viruses including avian influenza clade 2344b H5N1 viruses result provide molecular basis broad reactivity inhibitory activity NCS mAbs targeting catalytic site NA substrate mimicry",
        "mesh_terms": [
            "Neuraminidase",
            "Humans",
            "Animals",
            "Antibodies, Monoclonal",
            "Influenza A Virus, H5N1 Subtype",
            "Mice",
            "Catalytic Domain",
            "Antibodies, Viral",
            "Cryoelectron Microscopy",
            "Molecular Mimicry",
            "Water",
            "Influenza, Human",
            "Influenza B virus",
            "Influenza A Virus, H1N1 Subtype",
            "Orthomyxoviridae Infections",
            "Viral Proteins",
            "Cross Reactions",
            "Female",
            "Mice, Inbred BALB C"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750617/"
    },
    {
        "pmid": "40750588",
        "title": "Structural basis of broad protection against influenza virus by human antibodies targeting the neuraminidase active site via a recurring motif in CDR H3.",
        "abstract": "Influenza virus evolve rapidly driving seasonal epidemic posing global pandemic threats neuraminidase NA emerged vaccine target shared molecular feature NA antibody response still well understood Here describe cryoelectron microscopy structure broadly protective human antibody DA03E17 previously identified H1N1infected donor complex NA AH1N1 AH3N2 BVictorialineage viruses DA03E17 target highly conserved NA active site using long CDR H3 feature DR AspArg motif engages catalytic residue mimic sialic acid interactions demonstrate motif conserved among several NA active sitetargeting antibodies indicating common receptor mimicry strategy also identified BCR sequence containing DR motif across donor healthy human repertoire database suggesting precursor may relatively common vaccine targeting potential finding reveal shared molecular feature NA active sitetargeting antibody harnessed design broad immunefocused influenza vaccines",
        "mesh_terms": [
            "Humans",
            "Neuraminidase",
            "Catalytic Domain",
            "Antibodies, Viral",
            "Complementarity Determining Regions",
            "Cryoelectron Microscopy",
            "Amino Acid Motifs",
            "Influenza, Human",
            "Influenza A Virus, H1N1 Subtype",
            "Influenza Vaccines",
            "Influenza A Virus, H3N2 Subtype",
            "Models, Molecular",
            "Viral Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750588/"
    },
    {
        "pmid": "40749991",
        "title": "Ubiquitin E3 ligase MARCH10 targets influenza hemagglutinin for ubiquitination.",
        "abstract": "Influenza virus infection damage airway cause acute lung injury Influenza virus infection remains difficult combat since treatment limited supportive care antiviral drug prevent influenza early condition Influenza hemagglutinin HA surface glycoprotein facilitates viral entry binding sialic acidcontaining receptor hosts lung cells Therefore promising target development antiinfluenza therapeutic drugs demonstrate understudied E3 ligase MARCH10 destabilizes influenza HA protein doseresponse manner decrease halflife influenza HA time However affect mRNA expression influenza HA Further MARCH10 specifically polyubiquitinates influenza HA targeting degradation BEAS2B cell ectopically expressed MARCH10 infected PR8 virus 1378 gene differentially expressed addition analysis reveals MARCH10 upregulates multiple pathway involved interferon signaling influenza virus infection finding suggest MARCH10 play protective role influenza virus infection may enhance airway host defense innate immunity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40749991/"
    },
    {
        "pmid": "40749838",
        "title": "Indications for corticosteroids in the treatment of Community-Acquired pneumonia.",
        "abstract": "Preceding guideline treatment management communityacquired pneumonia CAP endorse systematic use corticosteroids data literature show contradictory results suggested clinical improvement case severe CAP others reported significant benefit recent CAPECOD trial demonstrated marked reduction mortality intubation early hydrocortisone treatment 200 mgd Consequently 2025 French guideline recommend used case severe CAP requiring critical care excluding influenza myelosuppression aspiration pneumonia considered trial progressive deescalation course eight fourteen days Since benefit seen shown nonsevere CAP corticosteroid therapy recommended cases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40749838/"
    },
    {
        "pmid": "40749835",
        "title": "Value of molecular biology tests in community-acquired acute pneumonia.",
        "abstract": "patient hospitalized communityacquired acute pneumonia CAP molecular tool especially multiplex PCR syndromic panels associated significant improvement microbiological diagnosis yield compared conventional methods Two main family test currently available targeted viral PCR test influenza SARSCoV2 RSV performed nasopharyngeal swab adapted epidemic situations upper respiratory tract nasopharyngeal lower respiratory tract deep swabs syndromic panel detect broad spectrum viral bacterial agents sometimes including resistance genes test recommended routine use CAP patient treated ambulatory settings hospitalized CAP patients use must guided severity epidemic context therapeutic implications Upper respiratory tract panel useful atypical agent virus undetected targeted PCR test suspected Lower respiratory tract panel must used case severe form complex situations Clinical trial showed real diagnostic value variable clinical impact often limited absence optimization strategy antibiotic therapy Multiplex PCR syndromic panel represent promising step forward management patient hospitalized CAP clinical value still depends several factors type panel swab quick results presence mobile team infectious disease specialists capacity correctly interpret result guide treatment decisions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40749835/"
    },
    {
        "pmid": "40749819",
        "title": "A rapid CRISPR/Cas12a-based assay for the detection of HIV-1 Clade C in infants.",
        "abstract": "Early detection HIV1 infection essential initiating antiretroviral therapy ART suppress viremia prevent disease progression Timely diagnosis especially infants critical rapid antibodybased serology test ineffective due presence maternal antibodies developed CRISPRCas12abased HIV1 detection assay optimizing component coupled isothermal preamplification using recombinase polymerase amplification RPA assay targeted conserved region pol gene specific HIV1 designed CRISPR RNA crRNA CRISPRCas12amediated cleavage viral cDNA visualized collateral cleavage singlestranded DNAFAMBQ reporter enabling rapid visually detectable outcomes performance assay evaluated using plasma 41 HIV1 Clade C HIV1C seropositive individuals including 28 HIV1C infected infant samples HIV1 Indian Clade C Clade B genome plasmids viral disease control DNARNA sample Influenza RSV Parvovirus HPIV CMV HBV 31 healthy donor plasma samples Sensitivity specificity assessed detection performed using fluorescence visual readout lateral flow dipsticks CRISPRCas12abased HIV1 Clade C detection assay achieved sensitivity 96  specificity 9265  assay successfully provided result fluorescence visual readout compatible lateral flow dipstick formats facilitating easy rapid detection developed CRISPRCas12abased HIV1C detection assay demonstrates high sensitivity specificity Clade C indicating potential robust pointofcare molecular diagnostic tool HIV1C Additionally may serve rapid nucleic acid test alternative detecting mothertochild transmission HIV1C infant two year age traditional antibodybased test ineffective assay hold promise improving early HIV1 diagnosis timely initiation ART ultimately contributing better disease management outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40749819/"
    },
    {
        "pmid": "40749064",
        "title": "A pan-respiratory virus attachment inhibitor with high potency in human airway models and in vivo.",
        "abstract": "Respiratory virus cause severe infections often leading hospitalization death pose major pandemic threat broadspectrum antiviral currently available However respiratory virus use sialic acid heparan sulfate attachment receptors Here report identification panrespiratory antiviral strategy based mimicking glycans synthesized modified cyclodextrin simultaneously mimic heparan sulfate sialic acid compound demonstrated broadspectrum antiviral activity important human pathogens parainfluenza virus 3 respiratory syncytial virus influenza virus H1N1 severe acute respiratory syndrome coronavirus 2 SARSCoV2 addition compound active avian strain influenza virus revealing importance pandemic preparedness compound retains broadspectrum activity ex vivo model respiratory tissue vivo respiratory syncytial virus influenza virus using prophylactic therapeutic strategies finding contribute development future treatment preventive measure respiratory viral infections",
        "mesh_terms": [
            "Humans",
            "Antiviral Agents",
            "Animals",
            "SARS-CoV-2",
            "Virus Attachment",
            "Influenza A Virus, H1N1 Subtype",
            "Parainfluenza Virus 3, Human",
            "Heparitin Sulfate",
            "Dogs",
            "Mice"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40749064/"
    },
    {
        "pmid": "40748960",
        "title": "A bacteria-based search for drugs against avian and swine flu yields a potent and resistance-resilient channel blocker.",
        "abstract": "Influenza represents significant threat seasonal epidemic transition global pandemics crossspecies infection presenting continuous challenge vaccine several antiviral drug available constant genetic change vitiate prevention treatment options Consequently decided search inhibitor one viruss validated drug targets M2 channel blocked aminoadamantanes Regrettably widespread mutation M2 abolish antiflu activity said blockers Therefore devised bacteriabased genetic assay screen drug aminoadamantanesensitive resistant M2 channel map resistance potential identifiable blocker Subsequent cellulo testing structureactivity relationship study yielded synergistic combination two compounds Theobromine Arainosine exhibited remarkable antiviral activity directly inhibiting viruss channel drug duo potent H1N1 pandemic swine flu H5N1 pandemic avian flu aminoadamantaneresistant sensitive strain alike exhibiting activity surpassed oseltamivir leading antiflu drug market drug duo tested animal model outperformed oseltamivir considerably reducing disease symptom viral RNA progeny Importantly harnessing bacterial genetic selection could demonstrate drug duos potential eliciting drug resistance significantly smaller molecularly distinct aminoadamantanes conclusion outcome study represents new potential treatment option influenza alongside approach sufficiently general readily applicable viral targets",
        "mesh_terms": [
            "Antiviral Agents",
            "Animals",
            "Influenza A Virus, H1N1 Subtype",
            "Drug Resistance, Viral",
            "Humans",
            "Influenza A Virus, H5N1 Subtype",
            "Influenza, Human",
            "Swine",
            "Orthomyxoviridae Infections",
            "Mice",
            "Bacteria",
            "Dogs",
            "Influenza in Birds",
            "Birds",
            "Madin Darby Canine Kidney Cells",
            "Viroporin Proteins",
            "Viral Matrix Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40748960/"
    },
    {
        "pmid": "40746816",
        "title": "False-Positive Detection of Haemophilus influenzae by a Multiplex PCR Panel in a Neonate With Late-Onset Group B Streptococcal Bacteremia.",
        "abstract": "Here report case term neonate lateonset Group B Streptococcal GBS bacteremia FilmArray® MeningitisEncephalitis ME panel BioFire Diagnostics Salt Lake City UT US falsely detected iHaemophilus influenzaei cerebrospinal fluid CSF Although CSF showed mild pleocytosis elevated protein clinical sign bacterial meningitis Confirmatory testing including multiplex PCR targeting iH influenzaei siaT GBS cfb 16S rRNA well CSF culture yielded negative results Repeat FilmArray testing controlled condition also negative manufacturers investigation revealed borderline amplification one iH influenzaei targets interpreted algorithmically positive discordance highlight key limitation multiplex PCR panels lack transparency signal interpretation threshold settings patient demonstrated immunodeficiency remained clinically stable 10month followup case underscore importance confirmatory testing panel result contradict clinical picture advocate improved algorithmic clarity interlaboratory validation Increased awareness diagnostic pitfall essential particularly neonatal setting unnecessary antimicrobial intervention may pose additional risks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40746816/"
    },
    {
        "pmid": "40746183",
        "title": "Nanchangmycin suppresses influenza A virus infection by blocking endosomal acidification.",
        "abstract": "Influenza virus IAVs constitute major threat human animal health Currently M2 ionchannel inhibitors neuraminidase NA inhibitors RNA polymerase inhibitors capdependent endonuclease inhibitor applied clinically therapeutic IAVs However IAVs possess adaptive mutation inhibitors especially M2 ion channel NA inhibitors Thus novel antiviral agent developed present study screen approximately 5500 compound identify IAV inhibitor nanchangmycin possesses robust antiviral activity iin vitroi iin vivoi addition exhibit broadspectrum antiviral activity additional virus infections including pseudorabies virus herpes virus porcine epidemic diarrhea virus porcine reproductive respiratory syndrome virus importantly antiviral activity oseltamivirresistant strain subμM range promotes survival MDCK cell infected oseltamivirresistant influenza virus strain study reveal block nucleus migration viral nuclear protein NPs resulting NP accumulation cytoplasm particularly within perinuclear endosomes Also inhibits IAVs blocking endosomal acidification Overall nanchangmycin potential developed antiinfluenza agent",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40746183/"
    },
    {
        "pmid": "40746014",
        "title": "Yeast Beta-Glucan Enhances Antibody Response Following Influenza Vaccination - A Double-Blind, Randomized, Placebo-Controlled Pilot Trial.",
        "abstract": "Yeast betaglucans demonstrate immunemodulating effects however study explored potential yeast betaglucans enhance immune response vaccination pilot study aimed assess adjuvant effect yeast betaglucan supplementation antibody titer response influenza vaccination Adults ini  90 707 ± 101 years recruited two vaccination season randomized receive 500 mg betaglucan placebo 500 mg cellulose daily doubleblind study design Pre 4 wk postvaccination serum influenzaspecific antibody titer assessed using optimized Hemagglutination Inhibition HI assay Plasma cytokine 24 h postvaccination quantified immunoassay Cold flu symptoms using Modified Jackson Criteria fever selfperceived fatigue monitored daily Linear mixed model used test difference fixed effect time treatment interactions season 1 Fall 2022 despite baseline suggesting seroprotection Influenza H3N2 AWisconsin672005 92 betaglucan group 74 placebo group postvaccination antibody titer response Δ  958 favored betaglucan placebo ipi  0037 Influenza BAustria13594172021 antigen demonstrated poor detection 7 10 HI detectible antibody response seen betaglucan group season 2 Fall 2023 Influenza H1N1 AVictoria48972022 antigen demonstrated poor detection 14 precluded cohort analyses cytokines interferongamma IFNγ increased similarly group vaccination supporting adjuvant action betaglucan cellular level Reported cold flu symptom low group differ Overall finding suggest yeast betaglucan supplementation may elicit greater change antibody titer seasonal influenza vaccination However confirmation needed larger sample older adult followup assess protection disease Clinical trial registry number website httpsclinicaltrialsgovstudyNCT05074303",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40746014/"
    },
    {
        "pmid": "40745568",
        "title": "High-fat diet impairs microbial metabolite production and aggravates influenza A infection.",
        "abstract": "Alterations gut microbiom significantly impact various region human body including pulmonary tract study investigates alteration gut microbiome highfat diet HFD particularly shortchain fatty acid SCFAs metabolite affect lung infection caused Influenza virus IAV used HFDmouse model evaluate gut microbiota composition SCFA levels pulmonary outcome following IAV infection Microbial change analyzed via taxonomic functional profiling SCFA level measured nonobese obese serum donors Ultimately acetates effect tested ex vivo human precisioncut lung slice PCLS vitro pulmonary epithelial cells Mechanistic study investigated involvement SCFA receptor free fatty acid receptor 2 FFAR2 intracellular antiviral pathways data indicates increased FirmicutesBacteroidetes ratio gut microbiome altered carbohydrate metabolism leading reduced SCFA production Infected HFD mouse showed increased IAV titer sustained microbial alterations Interestingly acetate demonstrated antiviral effect human PCLS model pulmonary cell reduced viral replication effect depended FFAR2 also act IAV coreceptor acetate treatment led FFAR2 internalization influenced host cell metabolism vitro data HFD alters SCFA production reducing acetate level gut microbiome reduction may lead higher viral load worsened disease HFD mouse infected IAV finding indicate acetate antiviral effect IAV infection human ex vivo lung model pulmonary epithelial cells Here acetate prevents viral entry affect cellular metabolic state antiviral response Understanding mechanism could provide new target preventing treating viral infection individual dietrelated health issues",
        "mesh_terms": [
            "Animals",
            "Diet, High-Fat",
            "Humans",
            "Influenza A virus",
            "Mice",
            "Fatty Acids, Volatile",
            "Gastrointestinal Microbiome",
            "Orthomyxoviridae Infections",
            "Mice, Inbred C57BL",
            "Male",
            "Influenza, Human",
            "Lung",
            "Acetates"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40745568/"
    },
    {
        "pmid": "40745284",
        "title": "Burden of bacterial lower respiratory tract infections in hospitalized children and epidemiological characteristics of pathogens in Hanzhong, China (2023-2024).",
        "abstract": "analyse epidemiological characteristic bacterial lower respiratory tract infection LRTIs hospitalized child aged 014 year Hanzhong Central Hospital China provide evidence empirical treatment infection control retrospective analysis conducted bacterial detection excluding Mycoplasma pneumoniae Chlamydia pneumoniae seasonal variation gender distribution age distribution among RTI paediatric patient admitted Hanzhong Central Hospital January 2023 July 2024 Among 5463 respiratory specimen child clinically diagnosed lower respiratory tract infections 2093 bacterial strain isolated yielding culture positivity rate 3830 total 3413 specimen 6288 exhibited mixed growth normal respiratory flora classified culturenegative pathogenic bacteria based standard microbiological criteria identified bacterial pathogen included Haemophilus influenzae a recognized common cause respiratory tract infections well Staphylococcus aureus Klebsiella pneumoniae Escherichia coli typically associated severe hospitalacquired lower respiratory tract infection rather communityacquired cases Bacterial infection showed seasonal variation prevalent spring first quarter summer second quarter variation dominant bacterial strain across different quarters infection rate male child higher female quarters statistically significant difference observed particularly infection rate Staphylococcus aureus Klebsiella pneumoniae Children aged 03 year highest risk group Staphylococcus aureus infection 1161 detection rate various pathogen declined increasing age Staphylococcus aureus Haemophilus influenzae identified predominant pathogen responsible paediatric respiratory infection Hanzhong exhibiting peak prevalence spring summer greatest burden among child 3 year age marked male predominance agespecific pathogen distribution pattern highlight necessity seasonal surveillance agetailored empiric treatment strategies strengthened infection control measure childcare environments finding offer evidencebased insight inform clinical management public health intervention northwest China family caregiver healthcare provider remain vigilant epidemiological characteristic diagnosis prevention treatment",
        "mesh_terms": [
            "Humans",
            "Child",
            "Child, Preschool",
            "China",
            "Respiratory Tract Infections",
            "Infant",
            "Male",
            "Female",
            "Adolescent",
            "Retrospective Studies",
            "Infant, Newborn",
            "Seasons",
            "Bacterial Infections",
            "Bacteria",
            "Hospitalization",
            "Staphylococcus aureus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40745284/"
    },
    {
        "pmid": "40744541",
        "title": "Clustering vaccine hesitancy and social media use of nurses and nursing students: a cross-sectional study.",
        "abstract": "Nurses nursing students attitude toward COVID19 Influenza vaccine crucial protecting vulnerable patient reducing vaccine hesitancy general population Social medium key spreading vaccine information opposite effect vaccine hesitancy alongside several sociodemographic professional characteristics study aim identify characteristic vaccine hesitancy among nurse nursing students multicentre crosssectional study conducted March September 2023 Data collected online survey assess I sociodemographic occupational characteristics social medium usage II vaccine hesitancy measured Vaccination Attitudes Examination Scale III social medium addiction using Bergen Social Media Addiction Scale Kmeans cluster analysis performed identify vaccine hesitancy profiles ANOVA Chisquare adopted identify key characteristic profiles Among 604 participants three profile identified Concerns unforeseen future effect relevant factor vaccine hesitancy across profile COVID19 Influenza vaccines hesitant profile included mainly older nurses Influenza vaccination uptake highest least hesitant profile also reported greater use social medium platform like YouTube LinkedIn TwitterX study provides insight develop targeted intervention appropriate nurse nursing students profiles result support tailored vaccination campaign address relevant factor vaccine hesitancy provide evidencebased information mitigate misconception enhance vaccine uptake among nurse nursing students",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Social Media",
            "Students, Nursing",
            "Female",
            "Male",
            "Adult",
            "Vaccination Hesitancy",
            "COVID-19",
            "Middle Aged",
            "Influenza Vaccines",
            "Young Adult",
            "COVID-19 Vaccines",
            "Influenza, Human",
            "Vaccination",
            "Cluster Analysis",
            "Surveys and Questionnaires"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40744541/"
    },
    {
        "pmid": "40744420",
        "title": "Aqueous extract of Evodia lepta Merr. attenuates influenza virus infection via inhibition of the HSP90/NF-κB axis.",
        "abstract": "Evodia lepton Merr ELM traditional medicinal herb widely used southern China Southeast Asia historically applied treatment febrile illness flulike symptoms Previous study reported antiinflammatory antiviral properties efficacy influenza virus infection remains largely unexplored evaluate antiinfluenza activity aqueous extract ELM elucidate underlying mechanisms particularly role HSP90NFκB signaling axis chemical constituent ELM characterized using UPLCMS murine model H1N1 influenza infection established assess protective efficacy ELM Disease progression evaluated clinical symptoms survival histopathology inflammatory cytokine levels Viral load protein expression assessed via RTqPCR Western blot immunohistochemistry Network pharmacology used identify candidate targets validated vivo role HSP90 confirmed using selective inhibitor AUY922 combination study oseltamivir evaluated potential synergistic effects Ten major bioactive compound identified ELM Oral administration ELM significantly improved body weight recovery reduced morbidity mortality alleviated lung pathology H1N1infected mice ELM markedly decreased viral replication proinflammatory cytokine levels Mechanistic investigation revealed ELM suppressed expression HSP90 host chaperone essential influenza virus polymerase function Combination therapy oseltamivir demonstrated enhanced antiviral efficacy indicating synergistic effect ELM exerts significant therapeutic effect influenza virus infection vivo likely inhibition HSP90NFκB signaling axis finding support potential ELM novel antiviral agent adjunct therapy treatment influenza",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40744420/"
    },
    {
        "pmid": "40742643",
        "title": "The impact of COVID-19 pandemic on the etiological spectrum of respiratory infections in children.",
        "abstract": "Following outbreak novel coronavirus pandemic series preventive control measure adopted public certain impact occurrence respiratory infectious disease change etiology article aim explore change respiratory pathogen among child respiratory infection COVID19 pandemic comprehensive lifting restrictions providing basis clinical diagnosis treatment pediatric respiratory infection postpandemic era retrospectively reviewed analyzed targeted sequencing result multiple respiratory pathogen child respiratory infection treated Childrens Hospital affiliated Shandong University January 2022 December 2023 total 16571 targeted sequencing result pathogen child respiratory infection included analysis 2810 case 2022 13761 case 2023 overall positive detection rate pathogen 2022 2023 9519 9656 respectively positive detection rate single pathogen 1601 vs 1929 rate two pathogen 7918 vs 7727 top three viral pathogen highest positive detection rate 2022 2023 Rhinovirus RV Parainfluenza Virus PIV Respiratory Syncytial Virus RSV 2023 top three bacterial pathogen Streptococcus pneumoniae Haemophilus influenzae Staphylococcus aureus whereas 2022 Streptococcus pneumoniae Haemophilus influenzae Bordetella pertussis positive detection rate Haemophilus influenzae Staphylococcus aureus Mycoplasma pneumoniae MP RSV Adenovirus AdV Influenza Virus IAV RV 2023 significantly higher 2022 all P  005 However positive detection rate Streptococcus pneumoniae Bordetella pertussis PIV significantly lower 2023 2022 all P  0001 Differences positive detection rate respiratory pathogen observed across different age groups Significant change prevalence certain pathogen occurred COVID19 pandemic lifting restrictions essential strengthen longterm monitoring common respiratory infectious disease guide early clinical intervention",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40742643/"
    }
]